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Abstract 
Nosocomial infections are a cause of concern for hospital patients and the incidence rates of 
these infections are greater in intensive care units (ICUs) due to the invasive nature of 
treatments, additional risk factors and comorbidities, and therapies used.  Invasive devices, such 
as vascular central lines, Foley catheters, and mechanical ventilators pose a risk for critically ill 
patients in the ICUs to develop device-related, healthcare-associated infections (HAI). The 
purpose of this study was to describe the epidemiological characteristics of patients who 
developed device-related HAIs within 3 ICU units (medical-surgical, cardiovascular, and 
neurosurgical) of an academic medical facility. The ecosocial theory of disease distribution 
provided the theoretical framework for the study to describe how ecological and social 
determinants interact and affect health variances. Secondary data were analyzed using analysis of 
variance (ANOVA), Pearson correlations, and chi-square statistical tests.  A total of 4,213 
patients admitted to the 3 ICUs from 2010-2014 were identified. According to the chi-square 
analysis, there was significant association between race/ethnicity and type of device-associated 
infection; between gender and types of infection; and between risk factors (diabetes, obesity, 
smoking habits) and kinds of infection, all of which the statistical significance had varied for 
each individual ICU. Bacterial differences were noted between device-associated infections. The 
potential positive social change from this study could be insight on possible new processes and 
interventions to reduce nosocomial infections and improve adult ICU patient outcomes such as 
decreased HAIs, decreased length of stay, comorbidities, and cost for both the patient and the 
hospital. 
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Chapter 1: Introduction to the Study 
Introduction 
Nosocomial infections pose a threat to intensive care unit (ICU) patients and are a cause 
of increased morbidity, mortality, length of stay, and cost of care (Marschall et al., 2014). 
According to Septimus et al. (2014), healthcare-associated infections are the fifth leading cause 
of death in acute care hospitals with a 15% development of infection while in the hospital. 
Despite ICU populations being relatively small, compared to nonintensive care units, the 
incidence rate of hospital-acquired infections is greater in intensive care units. This is primarily 
due to the invasive nature of the treatments and multiple therapies used in ICUs, such as 
mechanical ventilation, central venous catheters, pulmonary artery, and urinary catheterization 
(DePalo et al., 2010). In addition to invasive therapies and treatments, ICU patients typically 
have additional risk factors and comorbidities associated with developing nosocomial infection. 
Invasive devices such as vascular central lines, Foley catheters, and ventilators pose a threat to 
the critically ill and often immunocompromised ICU patient population, resulting in a greater 
risk of developing device-associated nosocomial infections (Marschall et al., 2014).  Healthcare-
associated infections (HAIs) are problematic in the United States causing a burden to hospitals, 
patients, family members, and society in general (Scott, 2009; Umscheid et al., 2011). A 
historical, quantitative study was designed to identify and describe the epidemiological 
characteristics of ICU patients who developed device associated infections in three different ICU 
settings in a large acute care teaching hospital.  The findings from this study may offer an 
opportunity for healthcare systems to promote positive social change by supporting preventive 
techniques related to patient care that may contribute to the elimination of HAIs and improve 
patient outcomes. The study may help provide a better understanding of the pathogenesis of 
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HAIs by developing strategies or interventions that may aid in the prevention processes to 
prevent nosocomial infections. 
Background 
Obtaining and maintaining reliable vascular access has become one of the most essential 
features of medical care. However, during hospitalization, any patient who is admitted to an 
intensive care unit and has a central venous catheterization placed will have a higher chance of 
acquiring a primary bloodstream infection, which increases the chances of morbidity and 
mortality (Blot, Bergs, Vogelaers, Blot, & Vandijck, 2014; Olaechea et al., 2013). According to 
the Centers for Disease Control and Prevention (CDC, 2016), there has been progress in reducing 
HAIs; however, there is still further action needed at every level of public health to eliminate 
infections that are potential threats to each patient admitted into an acute care facility (CDC, 
2016). 
It was estimated that nearly 40% of all healthcare associated bacteremias are derived 
from vascular access (Crnich & Maki, 2009). It was also estimated that more than 250,000 
intravascular, device-associated bloodstream infections occur in the United States each year 
(Crnich & Maki, 2009). These infections are associated with increased length of hospital stay, 
excess healthcare costs, and increased chances of morbidity and mortality (CDC, 2016; Olaechea 
et al., 2013; Zimlichman et al., 2013). In a meta-analysis study of costs and financial impact of 
HAIs, inflated to 2012 U.S. dollars, it was estimated that the annual costs for major infections 
(CLABSI, CAUTI, VAP, MRSA, Clostridium difficile) in adult care facilities were between $8.3 
to $11.5 billion (Zimlichman et al., 2013). Furthermore, scholars who included all hospital 
acquired infections and pediatrics population estimated that the cost of HAIs in the U.S. 
healthcare system range from $28 billion to $45 billion per year (Scott, 2009). There are several 
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sources of intravascular, device-associated bloodstream infections that play a role in producing 
infections. Two contributors include colonization of the intravascular device and contamination 
of the fluid that is being administered through the device (Marschall et al., 2014). It is important 
that best practices such as aseptic techniques and infection prevention practices take place during 
any hospital stay. Factors associated with increased risks of central line-associated bloodstream 
infections include prolonged hospitalization; severity of the illness; and clinical states such as 
HIV, neutropenic patients, and any similar condition or illness (Lukenbill et al., 2013). 
Additional factors that contribute to the increase of central line bloodstream infections include 
insertion and maintenance of the lines (O’Grady et al., 2011). Even though, there are currently 
guidelines/bundles for HAI prevention, optimizing quality improvement processes and 
standardization of care provide potential benefits to the well-being of ICU patients (Perez-
Granda, Guembe, Rincón, Muñoz, & Bouza, 2015). The findings from this research may provide 
knowledge for clinicians to improve existing preventive guidelines (The Joint Commission, 
2013), such as an educational initiative in addition to the bloodstream bundle set that could be 
used to help improve central venous catheter insertion and reduce the rate of primary 
bloodstream infections. 
Problem Statement 
Critically ill patients have a significant risk of acquiring infections related to healthcare. 
Nosocomial infections that are device-related are considered a standard threat to a patient’s 
wellbeing in the intensive care unit and are considered to be a cause of patient morbidity and 
mortality (Chen, Wang, Liu, & Chou, 2009). The use of invasive devices is a danger to the safety 
of each patient and a potential health risk for patients because it increases the possibility of these 
patients acquiring a HAI (Lukenbill et al., 2013). These types of infections can be linked with 
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extended hospital stays, sustained costs, and correlated with higher number of comorbidities 
(Chen et al., 2009). Patients with multiple risk factors have a higher incidence rate of developing 
a central-line bloodstream infection (CLABSI), catheter-associated urinary tract infections 
(CAUTI), and ventilator associated pneumonias (VAP), (Chen et. al., 2009; Elpern et al., 2009; 
Ong et al., 2011; Clarke et al., 2013). According to Barnett, Graves, Rosenthal, and Salomao 
(2010), vascular access causes risks for a patient to develop a central line bloodstream infection. 
It was estimated that approximately 60% of all types of HAI bloodstream infections derive from 
vascular access (Barnett et al., 2010). Any patient who develops a central line bloodstream 
infection while in the ICU is inclined to stay longer in the ICU. The length of stay for an ICU 
patient with a bacteremia is estimated to be 3 to 48.5 days (Barnett et al., 2010). Despite multiple 
interventions and increased attention directed to identification and prevention of CLABSIs, 
CAUTI, and VAPs, there continues to be ongoing occurrences of these healthcare device-related 
infections that patients can succumb to during their hospitalization.  
According to the literature, there is a gap in clinical practices between interventions and 
attention focused on minimizing these infections and actual success at completely eliminating 
them (Cardo et al., 2010; Saint et al., 2008). Additional gaps in practice include determining 
differences in the types of microorganisms and understanding these pathogens in order to 
optimize diagnosis, prevention, and treatment of HAIs. It was the intent of this research study to 
address these identified gaps in the literature. By identifying the types of microorganisms most 
likely to be involved with device associated healthcare infections, the knowledge base for future 
prevention and treatment of these infections in the adult ICU populations may increase. 
Additionally, even though scholars (Callister, Limchaiyawat, Eells, & Miller, 2015) have proven 
care bundles to reduce CLABSI, device-associated infections are still prevalent in U.S. hospitals. 
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Therefore, looking at risk factors such as the ones in this study can provide additional 
information that may be beneficial for developing other preventive tools in the future. The 
answers to the research questions may provide a broader base of information to address the gaps 
in future research. The existence and continuing evolution of multidrug resistant organisms may 
necessitate adaptations to current approaches in order to help prevent HAIs. Further components 
for clinical practices and interventions include understanding human factors that may play a role 
in implementing appropriate interventions to minimize device-related infections. 
Due to there are diverse risk factors including comorbidities associated with different 
ICU patient populations (Table 1), historical analysis and comparison of three varied ICU patient 
populations and the nosocomial infections encountered may provide insight to more 
comprehensive interventions and more accommodations required to minimize CLABSIs, 
CAUTIs, and VAPs in an explicit ICU type. The teaching institution at which this study was 
conducted had implemented various interventions to help reduce the number of HAIs, but has 
unsuccessfully been able to accomplish this goal. Patients in each intensive care unit may have 
different risk factors; therefore, each unit may have to accommodate particular interventions and 
surveillance in order to improve patient outcomes. Determining if there was a causal relationship 
between device use and risk factors can provide additional information pertaining to incidence of 
infections. Addressing the device-related nosocomial infection gaps in the literature could 
contribute to creating comprehensive interventions suited for each intensive care unit population. 
There have been no recent identified scholars who have taken into account device-related HAIs 
by patient outcomes, risk factors, and microorganism epidemiological characteristics such as 
Gram-stain; biological classification (genus and species); and antibiotic susceptibility patterns 
for each CAUTI, CLABSI, and VAP. In addition, I looked at the association between age, 
6 
 
 
 
gender, and race within the three ICUs to determine if any of these factors played a role in 
contributing to device-related nosocomial infections. The data were derived from the patient line 
listing that included the microorganisms identified as contributing to the infection.   
Purpose of the Study 
The purpose of this study was to evaluate epidemiologic characteristics of device-
associated infections (CLABSI, CAUTI, and VAP) within three ICUs in a large teaching 
academic medical center, which consists of two hospitals with an infection control program. This 
research aided in the understanding of the types of device associated infections by knowing the 
distribution patterns of each ICU and determinants such as persons affected and the correlation 
of the location with the ICU type.   
In this study, I compared the incidence rates of HAIs in a medical-surgical ICU, 
cardiovascular ICU, and a neurosurgical ICU in a large, acute care teaching hospital setting. The 
aim of this study was to evaluate characteristics, such as organism types, infection patterns, and 
patient demographics, and risk of developing nosocomial infections within three ICUs in a large 
medical teaching facility. The goal was to compare and contrast ICU patient outcomes, risk 
factors, and the microorganism epidemiological characteristics such as Gram-stain, biological 
classification, antibiotic sensitivity, and resistance of each pathogen identified as causing the 
HAI within the ICU population. Attention was focused on incidence rates of device-related 
nosocomial infections, association between severity of illness and types of device-related 
nosocomial infection, demographics and acquiring device-related nosocomial infections, and the 
differences between types of microorganisms associated with device-related nosocomial 
infections in three adult ICUs. The results from this study could lead to positive social change by 
delivering insight that could lead to the development of additional future studies related to 
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nosocomial infections. This could then lead to the development of new processes and 
interventions to help minimize nosocomial infections with the ultimate goal of improving patient 
health outcomes. Ideally, improvements in critically ill patients could be beneficial with regard 
to the incidence of HAIs, decreased length of stay, comorbidities, and cost for both the patient 
and hospital. The information from this study could aid public health by focusing on ways to 
prevent and control the risk of contracting HAIs and lead to development of future studies.  
Theoretical Framework 
The ecosocial theory of disease distribution was the guiding framework for this research. 
Descriptive theory employs an empirical method to describe and classify events by summarizing 
the commonalities found in the research observations (Krieger, 2009). This research 
encompassed the identified device-related HAIs and investigated factors associated with the 
different intensive care units. The ecosocial theory of disease distribution and the ecosocial 
model provided the framework used to develop a multilevel approach that could account for the 
possible pathways for interaction between determinants, as well as the simultaneous effects of 
ecosocial levels on disparities (Krieger, 2014). This approach should also result in new 
understanding of how the levels and inequalities in social advantage (i.e., age, race and ethnicity, 
and gender) interact to produce disparities. The ecosocial model was used to understand how 
biological factors (age, gender, race, and ethnicity), processes (central-line, Foley catheter, and 
ventilator usage), and environment (three different ICUs) interact and contribute to HAIs. 
Following the guiding principles of the framework allows for the systematic approach to identify 
disease patterns and to develop an explanation of the disparities that exist in ICU populations.  
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Research Questions and Hypothesis 
RQ#1: Is there a difference in the incidence rates of device-related nosocomial infections 
between the different types of ICUs?  
H01: There is no difference in the incidence rates of device-related nosocomial infections 
between the different types of ICUs.  
H11: There is a difference in the incidence rates of device-related nosocomial infections 
between the different types of ICUs. 
RQ#2: What is the association between severity of illness, measured by the Acute 
Physiology and Chronic Health Evaluation II (APACHE II) score and CLABSI, CAUTI, and 
VAP?  
H02: There is no association between severity of illness (APACHE score) and CLABSI, 
CAUTI, and VAP. 
H12: There is an association between severity of illness (APACHE score) and CLABSI, 
CAUTI, and VAP. 
RQ#3: What is the association between age, gender, race, and ethnicity from the device 
associated HAIs identified in the three different adult ICUs within an academic medical facility? 
H03: There is no association between age, gender, race, and ethnicity from the device 
associated HAIs identified in the three different adult ICUs within an academic medical facility. 
H13: There is an association between age, gender, race and ethnicity from the device 
associated HAIs identified in the three different adult ICUs within an academic medical facility. 
RQ#4: Are there significant differences in the types of microorganisms (e.g., genus, 
species, and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et 
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al., 2015) that are associated with device-related HAIs in three adult ICUs within an academic 
medical facility?  
H04: There are no significant differences in the types of microorganisms (e.g., genus, 
species, and susceptibility) according to the Clinical and Laboratory Standards Institute (Patel et 
al., 2015) associated with device-related HAIs in three adult ICUs within an academic medical 
facility.  
H14: There are significant differences in the types of microorganisms (e.g. genus, species, 
and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et al., 2015) 
that are associated with device-related HAIs in three adult ICUs within an academic medical 
facility.  
Nature of the Study 
The approach was a nonexperimental, observational study that used a quantitative 
prospective methodology and incorporated a historical prospective study of secondary data. The 
data were collected from Epic, which is an electronic health record software used by the hospital 
to gather patient care information. Epic is a secure database that stores patient data including 
demographics, clinical synopsis, graphs of vitals, clinical events, risk scoring, and clinical 
documentation along with other vital information. This information was used to determine if 
there was an infection classified as an HAI.  National Healthcare Safety Network (NSHN) 
guidelines are used by infection preventionist to determine if infections are device-associated and 
healthcare-related. Statistical data were used to compare incidence rates of infection on any 
patient with a central line, Foley catheter, and/or ventilator placement in an adult medical-
surgical, neurosurgical, and cardiovascular ICUs. The data of patients with positive cultures were 
abstracted from Epic using TheraDoc, a data mining software, as the interface. The data were 
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collected according to guidelines established by the CDC’s NHSN, which determines the 
presence of a device-associated infection. The denominator was defined as the number of 
patients in the ICUs between 2009-2014 with a central line, Foley catheter, and ventilator. The 
incidence rates of each device-related HAI (CLABSI, CAUTI, and VAP) were calculated and 
compared separately (Table 4 and Appendix D). I assessed recorded information about intensive 
care patients without manipulating the study environment and compared three subgroups of 
patients from a hospital database (medical-surgical ICU, cardiovascular ICU, and neurosurgical 
ICU) from 2009 through 2014. An electronic database called Theradoc was used to provide 
information such as the patient line listing, infection type and acquisition, infection 
documentation and classification, demographics, and linked microbiology results. The electronic 
TheraDoc database provided the specimen source, collected and resulted dates, organism results, 
and susceptibilities. The data were abstracted from TheraDoc, which also included the 
identification of the type of device-associated HAIs. Although there were three different ICU 
population types, the devices used were the same for all three populations. Multiple variables 
were studied for each ICU type, including age, gender, ethnicity, comorbidities (diabetes and 
obesity), and severity of illness at admission. The nature of the patients (such as differences in 
demographics and severity of illness) may confound interpretations of the results. Comparing the 
sex of the patient with respect to the HAI type reveals statistically significant differences for 
MSICU and when all three ICUs were aggregated (Table 3). Additionally, there were few 
demographic groups possessing statistically significant differences in the mean APACHE score 
between patients with and without HAI, both groups possessing smoking habits across racial 
groups and ethnicities (Table 11). In this study, I evaluated device-related HAIs, risk factors, and 
the relationship of microorganisms within three intensive care units. The definitions for the 
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device-related HAIs are based upon standardized definitions, and were predetermined by NHSN 
(See Appendix B). 
This historical prospective study allowed comparison of different variables at the same 
time. This was a standardized method to capture the severity of illness upon admission.  The data 
were analyzed using SPSS version 21.0 and Stata 12, performing statistical analyses such as t-
tests, chi-squared tests, and ANOVA. 
Definitions 
The terminology used to describe and define HAIs in this study was well-defined to assist 
in the interpretation analysis. Some of the following definitions are standardized by the NHSN, a 
division of the CDC that tracks HAIs in the United States, for the classification of device-
associated and HAIs (CDC, 2015a).  
Adult patients: A patient who was admitted into a hospital setting that was 18 years of 
age or older. 
Bacteremia: Bacteremia is an infection in the bloodstream caused by the presence of 
microorganisms. Bacteremia can be transient, continuous, or intermittent (CDC, 2015c). 
Comorbidity: Disease(s) that exist(s) in a study participant in addition to the index 
condition that is the subject of study (Last, 2001, p. 36).  
Confounder: A variable whose presence affects the outcome that is being studied. It is the 
unobserved exposure that might have an effect on the outcome of interest and can be correlated 
with both the dependent and independent variables (Pourhoseingholi, Baghestani, & Vahedi, 
2012). A variable that can cause or prevent the outcome of interest (Last, 2001, p. 38).  
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Device associated infection: An infection in a patient with a device such as a central-line, 
Foley catheter, or ventilator that was used for greater than 2 calendar days before the onset of 
symptoms (CDC, 2015a). 
Device infection rate: The number of device-associated infections (cases) divided by the 
total number of device days multiplied by 1,000. Device days are the number of days each device 
was used for all the patients during a specified period (central line, Foley catheter, or ventilator; 
CDC, 2015a). 
Device utilization ratio: The number of device days divided by the number of census 
days for a particular unit. It provides a use ratio that can be compared to other units within a 
facility and/or with similar unit populations. The ratio can provide information on over usage 
(Dudeck et al., 2011). 
Disease: A physiological/psychological dysfunction (Last, 2001, p. 52). Physiology 
changes related with damages to the body’s organ system.  
Healthcare-associated infection (HAI): Can also be referred as a nosocomial infection. A 
localized or systemic condition resulting from an adverse reaction to the presence of an 
infectious agent and/or the toxins produced by the microorganism causing the infection (see 
nosocomial infection definition; CDC, 2016). 
Incidence: The number of instances of illness commencing, or of persons falling ill, 
during a given period in a specified population, or the number of new events (e.g., new cases of a 
disease in a defined population) within a specified period of time (Last, 2001, p. 91). For this 
research the study, incidence rate were analyzed quarterly and yearly for a period of 5 years, 
from 2010-2014. 
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Infection: Invasion of the body tissues of a host by an infectious agent, whether or not it 
causes disease (CDC, 2015a). The term infection was used when there was multiplication and 
invasion of microorganisms in tissue or any other body surfaces associated with tissue reaction.  
Infection involves the growth of microorganisms that result in damage to the host (Horan, 
Andrus, & Dudeck, 2008; Tao, Hu, Rosenthal, Gao, & He, 2011). The severity of the infection 
and damage depend on many factors. Some of the factors include the organism’s ability to cause 
disease, the body site of the infection, and the general health of the individual. 
Mean Standardized Infection Ratio (SIR): An average of SIR numbers. For this study, a 
calculated central value from yearly SIR averages ranging from 2010-2014. Each years SIR was 
added and then divided by how many numbers were averaged (CDC, 2016). 
National Healthcare Safety Network (NHSN): CDC’s NHSN is the nation’s tracking 
system for HAIs. NHSN provides the nation with the data needed to identify problem areas. The 
network helps facilities measure progress of prevention to provide reduction or elimination of 
HAIs (CDC, 2016). 
Nosocomial Infection: Nosocomial infections, also known as HAIs, are localized or 
systemic conditions that result from an adverse reaction to the presence of infectious agents or 
toxins (CDC, 2015a). The CDC (2015a) defined these infections as hospital-acquired if they 
developed after admission with no evidence that the infection was present or incubating during 
admission.  HAIs can be caused by endogenous sources such as skin, nose, mouth and 
gastrointestinal tract or exogenous sources such as personnel, visitors, medical devices and 
healthcare environment (CDC, 2015a).  
Present on admission (POA): This term refers to infections that occur during admission 
or within the first 2 days after admission into the hospital setting. The infection began prior to 
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admission and was not caused during hospitalization. POAs are not reported as HAIs (CDC, 
2015a). 
Septicemia or sepsis: Septicemia or sepsis is a condition where bacteria and/or their 
toxins are in the bloodstream and they are causing infection along with systematic inflammatory 
response to an individual. During sepsis the clinical manifestation can reveal fever with 
temperature >38o C or hypothermia with temperature < 36o C; chills, white blood cells >12,000, 
or hypotension (CDC, 2015c).   
Smoking:  Tobacco encased in cigarettes, pipes, and cigars that contain nicotine that is 
inhaled into the lungs and is dispersed into the rest of the body.  I classified smokers as any 
person smoking on a daily basis.    
Standardized Infection Ratio (SIR):  A summary statistic that is used to compare the 
actual number of HAIs with the predicted number based on a baseline of the U.S. standard 
population. It is used to measure relative difference in HAI occurrence during a period of time 
(CDC, 2015a; CDC, 2016). 
Urinary tract infections: The urinary tract anatomy includes the kidneys, ureters, bladder, 
and urethra, and infections to this area are characterized as either upper or lower infections. 
Urinary tract infections are defined as bacteriuria also known as bacteria in the urine. 
Quantitative cultures are used to determine if the UTI is diagnostic by determining if the urine 
culture was a contaminant, colonization, or infection (CDC, 2015b; CDC, 2016). 
Ventilator associated pneumonia: Pneumonia caused in the lower respiratory tract due to 
mechanical ventilation. Ventilator-associated pneumonias are defined as a pneumonia that is 
caused when a patient was on a mechanical ventilator for greater than 2 calendar days, with day 
of ventilator placement being Day 1 (CDC, 2015d; CDC, 2016). 
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Assumptions 
This study included several assumptions. There are defined policies and procedures to 
standardize care to ensure optimal treatment for all patients. Varying immune status, condition of 
the patient, and the potential variation of prophylactic antibiotics could result in varying 
incidence rates between the three units. Due to patients’ varying conditions upon admission and 
given the different types of ICU, the severity of illnesses was quantified using the APACHE 
score system, which addresses the degree of acute illness and chronic health status of ICU 
patients (Knaus, Draper, Wagner, & Zimmerman, 1985; Vincent & Moreno, 2010). Thus, I 
looked to see if there were statistical differences between device-associated infections and 
severity of illness of patients in the three ICUs using APACHE scores.  
APACHE II scores were used as an additional tool for analysis. The APACHE II scores 
were collected by one of the infection preventionists and the informatics analyst. It was assumed 
that the collection of the APACHE II scores were reliable because only those two individuals 
developed the data and were trained to use the same computerized worksheet format. The 
abstraction of the APACHE II score data used standardized definitions, computerized calculation 
methods, and strict adherence to the guidelines. It was assumed that the data represented the first 
24 hours after the ICU admission. The elements used to calculate the APACHE II scores and 
determine the severity of illness can be found in Table 1. The APACHE II score was an 
additional analytical tool that provided a snapshot of the patient’s severity of illness. According 
to Donahoe (2009), the APACHE II is one of the most widely used methods to describe the 
severity of illness in patients. In Donahoe’s study, the APACHE II score was found to provide a 
highly reliable severity of illness scoring system especially when the scoring was limited to 
individuals who have been trained to collect the data.   
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Another assumption in this study was that the care given to the patients was uniform in 
quality because patients are critically ill. The experience and education levels of the physicians 
and nurses placing and maintaining invasive devices should be similar if comparisons are to be 
made between units, as lower experience levels among physicians and nurses placing devices are 
associated with increased risk of infection and complication (Cardo et al., 2010; Yokoe et al., 
2008). I expected that hospital staff was following the infection prevention and control policies 
and procedures that were in place to prevent infections from occurring. For example, 
standardization care can be measured and validated by usage device-associated care bundles. 
Care bundles include central line, Foley catheter, and ventilator checklist of best practices as 
measured by hospital quality and performance improvement committees. A care bundle is a set 
of evidence-based interventions for a defined patient population. However, it was important to 
note that even implementing care bundles, which include avoiding femoral sites, strict hand-
hygiene, full barrier precautions, the use of chlorhexidine skin preps, and removal of unnecessary 
catheters, it was found that device-associated infections still remain prevalent in U.S. hospitals 
(Callister et al., 2015).  
The final assumption was that the infection control team, nurses, and physicians in the 
hospital were uniformly adept at identifying the various nosocomial infections within each of the 
three units. Validation of these nosocomial infection identifications are processed and confirmed 
by the infection prevention department by use of the standardized NHSN/CDC definitions for 
HAIs. When verifying device-associated HAIs, data such as age, gender, race and ethnicity, and 
severity of illness are not used for further comparative analysis within the infection prevention 
department. Although the infection prevention department identifies nosocomial infections, the 
gap in knowledge was the analysis of the statistical differences (if any) of incidence rates 
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between ICU types, microorganism population type, demographics, and risk factors associated 
with these types of nosocomial infections.   
With respect to the statistical tests used in the analyses, there are a number of 
assumptions. For the chi-squared tests, the dataset should be a large, simple random sample and 
the patients should not be dependent on each other (i.e., independent observations); which has 
been fulfilled, as number of observations in the data set exceeded 4,000 and the individual 
answers in the survey from each patient were independent of others.  For ANOVA there must 
exist constant variance for the groups, the relationships between variables requires linearity.  
Because demographic characteristics do not change over time (except age, which increases 
linearly) and due to the inherent traits of the APACHE II scores that have been previously 
discussed, variance was constant and relationships were linear.   
Scope and Delimitations 
The aim and scope of this research was to evaluate the causative elements of device 
associated infections in the medical surgical, neurosurgical and cardiovascular ICUs. Critically 
ill patients in the ICUs are more likely to acquire a device-associated infection (Tao et al., 2011). 
Hence, APACHE scores were included for analysis. Thus, the research may assist in the 
understanding of the nosocomial infections as well as how to plan and implement preventive 
measures in an acute care environment. This research provides information on ways to reduce 
HAIs and improve patient safety and outcomes in the acute care setting. Examining confounders 
such as gender, age, obesity, diabetes, and smoking could make the study findings more precise 
and facilitate a comparative analyses. Additionally, this research may potentially provide a guide 
in developing future interventions and incorporate different quality improvement strategies to 
reduce device-related nosocomial infections if further prospective studies are established.  
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This study was limited to the adult population, both male and female, in the medical 
surgical, neurosurgical, and cardiovascular ICUs of an academic medical center, which consisted 
of two hospitals, from 2010 to 2014. The neonatal intensive care unit (NICU) was not included 
in the study because their criteria to identify HAIs are different from adult ICUs in that birth 
weight was used. Furthermore, Foley catheters were not used in the neonatal population in this 
acute care teaching facility. Insurance was used as an indicator to determine the socioeconomic 
status of the population in the study. Although I focused on device-related HAIs in the ICUs, the 
constraints included examining each of the 21 components within three categories (age, 
physiological component, and chronic health) that make up the APACHE II score and their 
potential role in acquiring device-associated infections. The three categories used in the 
APACHE II system included information on age, physiological components, and chronic health, 
which were recorded for each ICU in the electronic patient chart in order to determine severity of 
illness (APACHE II score). The use of computerized clinical information calculated each of the 
APACHE II scores reliably. Other unforeseen factors that may influence the research outcomes 
include complications of surgical procedures, adverse reactions, debilitating conditions, and 
inadequate documentations related to lines and devices. However, because I aimed to evaluate 
factors contributing to nosocomial infections in three ICUs, the results from the findings may 
assist in developing new interventions and new processes in patient safety specific to the 
teaching facility. However, though the factors such as age, gender, and severity of illness were 
the contributing factors being analyzed, these factors could be confounding by indication as most 
patients admitted to ICUs tend to be older and already in poor health, thus predisposing them to 
other infections. To control for confounding variables, mean APACHE II scores were compared 
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between patients with and without HAI for each category of age, gender, and race/ethnicity 
under various combinations of risk factors (i.e., obesity, diabetes, and smoking habits).   
Limitations 
A major limitation of this study was that the majority of the patients in the hospital were 
referred from other facilities such as long term acute care (LTAC) and were admitted with 
lines/devices in place, thus making these patients predisposed to developing infections. It was 
assumed that patients admitted to the ICU had higher risks of developing infections due to their 
higher level of acuity upon admission. The majority of these ICU patients were referred from 
other facilities for higher level of care than the transferring facility can provide. An additional 
limitation was that the study findings were not applicable to every ICU population at a national 
level.  ICUs in different geographic areas may have diverse environmental, economic, and 
population demographics that may predispose patients to an increased or decreased likelihood of 
developing a nosocomial infection. However, the population for the acute care facility was not 
limited to a geographic area, thus providing a more diverse demographics for the study.   
Furthermore, patients residing in non-teaching facilities may be exposed to different levels of 
care or available technologies, medications, and equipment. The varying types of ICUs, for 
example neurology, cardiology, and medical surgical, may affect the types of infections and 
organisms detected.  
Limitations may exist due to the three different ICU patient populations, which may 
impact the interpretations of these results. Having three different ICUs with varying population 
may have had an impact on the analysis and the interpretation of the results. The outcomes of the 
study, which include understanding the demographic characteristics ICU patients, may highlight 
demographic limitations in future research studies of nosocomial infections. The demographic 
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findings may provide additional information about potential commonalities and patterns that may 
be involved in device-associated HAIs. Other concerning limitations included confounding 
factors such as gender, age, diabetes, obesity, and smoking. To control for these confounding 
factors, each subgroup of these factors were held constant when making comparisons across 
ICUs.  
The final limitation of the study was that the competency of the infection control 
personnel and physicians could have affected the data collection methods. The study was 
dependent on microbiology testing being ordered and collected when a patient exhibits 
symptoms of infection. If testing were not performed, the data would be skewed to show falsely 
low rates of HAIs. Additionally, the data were dependent on competent infection control 
personnel using subjective and objective criterion to classify infections. Differences in practice 
and experience in infection control personnel could render varying data. To ensure data integrity 
and accuracy, the data mining software TheraDoc was utilized to validate training and 
competency of infection preventionists. Quality assurance was performed using parallel testing 
of data from microbiology culture reports and TheraDoc data abstraction. Educational testing 
modules were used to confirm and ascertain the appropriate training of infection prevention 
personnel. Ignoring a multilevel approach and focusing on a single determinant produces an 
incomplete understanding of how to reduce HAIs and was likely to limit the effect of an 
intervention.  Although an attempt to control the confounding factors was made, a limitation of 
this approach would be that the lifestyles of the patients, such as specific dieting habits, were not 
recorded in the clinical data. The potential impact on the results may cause differences in the 
statistical significance in the chi-squared tests and thus possible estimation bias in the p-values. 
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Therefore, future research could include interventions that can systematically address the issue of 
HAIs in the intensive care unit at each ecosocial level. 
Significance 
The results to this study may lead to enhanced understanding of the elements involved    
in the transmission of infection. The purpose and significance of the study may also demonstrate 
outcomes and relationships that can possibly be helpful in understanding the relationships of the 
host, environment, and organisms involved in each device-associated HAI. It was important to 
understand the association between risk factors and infection in the different ICU settings in 
order to determine how these findings can be used to reduce infection risks for the three different 
ICU patient populations. Each of the patients were all 18 years of age or older, and each patient 
was admitted into one of the three ICUs during 2010-2014. Although there were three distinct 
ICU populations, they all were considered to be critically ill patients. However, the differences in 
population included neurosurgical ICU patients who are cared for and monitored for intracranial 
and hemodynamic monitoring such as brain injury or stroke, tracheostomy and nutritional 
support and who receive less sedation than other ICUs (Kurtz et al., 2011). As for cardiovascular 
ICU patients, that population is mainly treated for heart failure, and any other cardiovascular 
problems such as heart attacks, cardiac surgery, and cardiothoracic pathophysiology. In the 
medical-surgical ICU population, the focus is on patients who have acute exacerbation of chronic 
health problems (COPD, CHF, ESRD, etc.) with acute illness or any failure of major systems in 
the body following surgery or patients who have experienced trauma injuries and any immediate 
risk of complications. Despite these differences in ICU types, all three intensive care units 
require higher acuity and complexity of care.   
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The HAIs, specifically central line-associated bloodstream infections (CLABSI), 
represent a significant safety risk to critically ill patients. According to (Perencevich & Pittet, 
2012), HAIs have a vast economic cost of $6.5 billion in excess expenditure annually and an 
estimated 100,000 deaths in the United States. Central-line bloodstream infections are one of the 
leading causes of HAIs (Perencevich & Pittet, 2012).  According to scholars, 65% to 70% of 
CLABSI and CAUTI cases are preventable, and 55% of VAPs are also preventable if evidence- 
based practices and strategies were used (Umscheid et al., 2011). The HAIs are a primary cause 
of morbidity and mortality with an estimated 1.7 million HAI cases reported in the United States 
(Septimus et al., 2014). It was estimated that 20%-70% of HAIs are thought to be preventable 
(Nakamura, Fukushima, Hayakawa, Sekiya, & Matsumoto, 2015).   
Summary 
Patients in the intensive care units often require life-saving therapies that involve the use 
of invasive medical devices. Unfortunately, these invasive devices also carry the threat of 
nosocomial infection, which can increase patient morbidity, mortality, length of stay, and cost of 
care. According to O’Grady et al. (2011), it was estimated that in the United States alone, there 
were 15 million central vascular catheter days that occur in the intensive care units each year. It 
was estimated that 80,000 central line bloodstream infections occur in the ICUs each year 
(O’Grady et al., 2011). The total cost of nosocomial infections account for nearly a third for ICU 
in-patients (O’Grady et al., 2011). Given the severity of the threat device-associated HAIs pose 
to patients in intensive care units, it was necessary to examine the risk factors, comorbidities, and 
microbiology of different intensive care units, as well as the differences between them. In this 
historical prospective study, I examined these factors to identify any significant associations with 
device-associated HAI rates. The results of this study could result in novel approaches to address 
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device-associated nosocomial infections. The findings could help to focus on implementing 
prevention approaches and guidelines depending on the ICU patient population. The awareness 
and better understanding of healthcare associated infections (HAIs) related to devices is 
problematic and the healthcare industry should continue to promote quality improvements and 
prevention of HAIs. The following literature review on hospital-acquired infections builds the 
foundation for the research study to evaluate factors contributing to device-related infections in 
acute-care setting.  
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Chapter 2: Literature Review 
Introduction 
Device-associated HAIs are increasingly being recognized in the scientific literature as 
the preeminent threat to patient safety in the ICU, contributing to patient morbidity, mortality, 
and economic cost of care (Guanche-Garcell et al., 2011). The use of multiple therapies, invasive 
procedures, and devices including mechanical ventilators and central venous, pulmonary artery, 
and urinary catheters leaves the critically ill patient population at an increased risk of developing 
device-related healthcare associated infections DA-HAIs (Tao et al., 2011). Scholars have 
estimated that the number of HAIs in the United States was approximately 1.7 million with 
99,000 annual deaths. It was estimated that the cost of HAIs each year was over $10 billion 
dollars (Septimus et al., 2014). It was also estimated that 48% of patients in the ICU have a 
central line catheter in place (Sacks et al., 2014). According to Sacks (2014), there are 80,000 
catheter-associated bloodstream infections each year, which accounts for 24,000 deaths reported 
from CDC.  
Literature Search Strategy 
The majority of the published studies that were summarized and used for this 
investigation included scientific journals, government agency websites, and websites of 
professional organizations. A systematic literature search for comparative historical studies was 
performed on PubMed, MEDLINE, JAMA, and IDSA. Some scientific journals were searched 
by using Google search engine and PubMed library, limiting the time range from 1990 to 2014. 
The search was conducted by using keywords such as social epidemiology, ecosocial theory, 
microbiological pathogens, infection control, and infectious diseases. The use of relevant articles 
included peer-reviewed journals obtained from the Walden University Library and the UT 
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Southwestern Health Sciences Digital Library and Learning Center. The peer-reviewed journals 
used included Morbidity and Mortality Weekly Report (MMWR), The New England Journal of 
Medicine, Critical Care Medicine, Infection Control & Hospital Epidemiology, Public Medicine 
Journal, Clinical Infectious Diseases, International Journal of Infectious Diseases, and 
American Journal of Infection Control (AJIC) from 2005-2016.  
Theoretical Framework 
The ecosocial theory of disease distribution provided the theoretical framework to 
understand what and how determinants of health, both biological and social, interact and 
contribute to HAIs. Following the guiding principles of the framework allows for the systematic 
approach to identify disease patterns and to develop an explanation of the disparities that exist in 
ICU populations. This theory was developed by Krieger in 1994 to incorporate social and 
biological conditions in shaping the population’s health overtime (Krieger, 2001). Different from 
other social epidemiology theories, that focus on aspects of social and biological conditions in 
shaping the population’s health, the ecosocial theory of disease distribution (Krieger, 1994) is 
used to explain patterns of health in relation to different levels of biological, ecological, and 
social organization—from cell organization to society to the ecosystem (Krieger, 2001, 2014).   
Recognizing how social and biological factors contribute to the epidemiology of diseases, 
the central question for ecosocial theory is “who and what is responsible for population patterns 
of health, disease, and wellbeing, as manifested in present, past, and changing social inequalities 
in health?” (Krieger, 2001, p. 668). The ecosocial constructs include embodiment; pathways of 
embodiment; cumulative interplay between exposure, susceptibility, and resistance; and 
accountability and agency. Embodiment refers to the relationship between the social and 
biological world and an individual’s body (Krieger, 2001, 2014). Pathways to embodiment 
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describe the processes in which social, biological, and environmental factors interact with a 
person’s body, including evolutionary history, ecological context, and individual histories (both 
biological and social development).  
This, this theory includes spatial-time component. The cumulative interplay of exposure, 
susceptibility, and resistance explains how disease patterns are affected by people’s biological 
and social histories and experiences at multiple levels over the life course. In accountability and 
agency, institutions (individual and households, government, business, and public sector) are 
responsible for monitoring, analyzing, and addressing patterns of diseases (Krieger, 2001, 2009, 
2014). These ecosocial constructs may guide in the understanding of disease patterns and 
determinants of health of ICU populations, in relation to device-related infections. The ecosocial 
approach factors such as social determinants of health and biological determinants of health that 
led these populations to the ICU was analyzed. For this research, the ecosocial theory (Krieger, 
2009) was adapted for this research as a conceptual framework to determine factors that 
influence the incidence rates of device-associated infections in an acute care setting.  Figure 1 
illustrates the ecosocial conceptual model that includes the pathways to embodiment adapted 
from Krieger (2001).     
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Figure 1. Ecosocial conceptual model.   
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Types of Device-Related Healthcare Associated Infections 
Catheter-Associated Urinary Tract Infections 
The introduction of medical devices, such as Foley catheters, into the urinary tract that 
remain in place for extended periods of time carries a risk of infection. Device associated urinary 
tract infections are tied with pneumonia as the second most common type of nosocomial 
infection (Horan et al., 2008). These types of device-associated infections account for more than 
15% of infections in acute care facilities and are associated with more than 13,000 deaths each 
year (Horan et al., 2008). These infections can lead to further complications such as cystitis, 
pyelonephritis, prostatitis, bacteremia, epididymitis, and other complications (Horan et al., 
2008). The CAUTIs are a complication of diabetes, renal disease, and structural abnormalities 
that interfere with urine flow. It was estimated that CAUTIs are the origin for about half of all 
nosocomial infections (Clarke et al., 2013). The CAUTIs are one of the most common HAIs in 
the United States and are preventable as well (Kennedy, Greene, & Saint, 2013). 
 The CDC (2015b) defined urinary tract infections as symptomatic urinary tract infections 
(SUTI) or asymptomatic bacteremic urinary tract infections (ABUTI) based on differentiating 
criteria (Horan et al., 2008). SUTIs are divided into four different classifications (SUTI 1-4) 
based on age and the number of colony forming units (CFU)/ml present in the urine culture 
(CDC 2015b). These four classifications are further divided into subtype A and B based on 
whether the infection was catheter-associated. Subtype A requires that an indwelling catheter 
was in place >2 calendar days and was removed the day of or the day before the infection, 
whereas subtype B requires that an indwelling catheter was not in place or was in place for <2 
calendar days (CDC 2015b). SUTI 1 and 2 include any age, while SUTI 3 and 4 are limited to 
infants (CDC 2015b). Because the ICUs included in this study were exclusively from an adult 
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population, I only examined SUTI 1a, 2a, and ABUTI device associated infections. See 
Appendix A and B for CDC/NHSN criteria.  
Central-line Bloodstream Infections 
The CDC’s National Healthcare Safety Network (NHSN) defines a central line as “an 
intravascular catheter that terminates at or close to the heart or in one of the great vessels that is 
used for infusion, withdrawal of blood, or hemodynamic monitoring" (CDC, 2015c p.2). Central 
venous catheters (CVC) are used on patients for multiple purposes to provide parenteral 
nutrition, drug and other fluid administration. It is estimated that more than 5 million central 
venous catheters are placed each year increasing the incidence of adverse events (McGee & 
Gould, 2003).  One of the major problems associated with these devices is the risk of nosocomial 
infections (HAIs). According to literature review, these device-related infections are harmful to 
patients, typically increasing length of stay, cost of care, and risk of mortality (Perencevich & 
Pittet, 2012). NHSN defines a central line-associated bloodstream infection as a primary 
bloodstream infection in a patient who had a central line within the 48-hour period before the 
development of the bloodstream infection (Horan et al., 2008). These infections are of particular 
concern in intensive care units where, at any given time in the US, half of all patients have an 
indwelling CVC (Sacks, et al., 2014). Central-line bloodstream infections are a leading cause of 
HAIs with approximately 80,000 intensive care unit cases occurring annually and around 24,000 
patient deaths (Perencevich & Pittet, 2012). In all, hospital associated infections are a common 
and potentially harmful patient safety issue in the U.S. and world-wide (Krein, Kowalski, Hofer, 
& Saint, 2012).  Several mechanisms have been proposed for the occurrence of catheter-related 
infections: infection of the exit site followed by migration of the pathogen down the external 
surface of the catheter; contamination of the catheter hub, resulting in intraluminal catheter 
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colonization; and hematogenous seeding of the catheter (O’Grady et al., 2011). See Appendix B 
for CDC/NHSN criteria. 
Ventilator Associated Pneumonia 
Mechanical ventilators ease the work of breathing in those patients who are unable to 
breathe on their own, usually by connecting the patient to the ventilator via endotracheal 
intubation or tracheostomy. In addition to the life-saving benefits mechanical ventilation offers 
to those patients suffering from critical illness and respiratory failure, mechanical ventilation is 
also associated with significant risk for complications and poor outcomes. Negative outcomes 
associated with mechanical ventilation include death, ventilator-associated pneumonia (VAP), 
sepsis, acute respiratory distress syndrome (ARDS), pulmonary embolism, barotrauma, and 
pulmonary edema (Kalanuria, Zai & Mirski, 2014). These complications often result in increases 
in the duration of ventilation, length of stay in the ICU and hospital, cost of care, risk of 
disability, and risk of mortality. 
It is estimated that more than 300,000 patients receive mechanical ventilation each year 
in the United States (Peyrani, 2009). Further, Magill et al. (2014), estimated that in 2011 there 
were 157,000 healthcare associated pneumonias identified in U.S. hospitals. Half of all VAP 
cases are responsible for hospital acquired pneumonia and it is estimated that 9-27% of all 
mechanically ventilated patients acquire a VAP during the patient’s early course of 
hospitalization (Kalanuria et al., 2014). The National Healthcare Safety Network (NHSN) 
reported more than 3,957 ventilator associated pneumonias with an incidence range from 0.0-4.4 
per 1,000 ventilator days for the year 2012 (CDC, 2015d). Pneumonia clinically causes 
inflammation of the lower respiratory tract which involves the lungs airways and supporting 
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structures.  Pneumonia is a major cause of illness and death in hospital settings (Pogorzelska et 
al., 2011).   
To be considered a VAP, the patient must be intubated and ventilated at the time of, or 
within 48 hours of the onset of the event (Peyrani, 2009).  It was important to mention that the 
duration of ventilation was not relevant for identifying a VAP, i.e. there was no minimum time 
the ventilator must be in place to be considered a VAP. The diagnostic criteria for VAP for this 
research study was based on the old protocol prior to the ventilator associated events set forth by 
the CDC (Dudeck et al., 2013). The criteria used for identification separates pneumonia into 
three different classifications, PNU1, PNU2, and PNU3, based on differences in patient signs, 
symptoms, and laboratory results (Horan et al., 2008). It was important to note that a pneumonia 
diagnosis alone was not an acceptable criterion for VAP. Further, determining the presence of 
pneumonia can be complicated by other health conditions, including respiratory distress 
syndrome, pulmonary embolism, and other respiratory diseases (Kalanuria et al., 2014).   Early 
onset pneumonia can also be mistaken for tracheal colonization or upper respiratory tract 
infections. Consequently, it was important that the specific site algorithms established by the 
CDC are followed in order to ensure accurate diagnosis, treatment, and reporting (Peyrani, 
2009). All three classifications of pneumonia require the same radiology testing and results, 
requiring more than two chest x-rays that have cavitation, consolidation, and persistent infiltrates 
which may be new or progressive (Peyrani, 2009). See Appendix B for CDC/NHSN criteria. 
Surveillance and Prevention Guidelines 
In the United States, the CDC reports that surveillance plays a leading role in reducing 
DA-HAIs (Doshi, Patel, MacKay, & Wallach, 2009). Further, the Study of the Efficacy of 
Nosocomial Infection Control (SENIC) has suggested that approximately one third (32%) of 
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HAIs are preventable through programs of surveillance and infection control (Sydnor & Perl, 
2011). Active infection control surveillance and the implementation of evidence based guidelines 
and practices can increase patient safety and reduce the incidence of HAIs. Reported findings 
showed a decrease in incidence of HAIs in ICU settings by incorporating an educational program 
focused on interventions directed at ICU clinical staff (Sacks et. al., 2014). Surveillance was 
crucial in recognizing outbreaks, trends, HAIs, and emerging infectious diseases in order to 
implement control measures to aid in controlling the spread of infections (Rosenthal et al., 2012).   
Incidence and Complications 
The use of Foley catheters in an intensive care unit are used routinely to monitor urine 
output, for convenience and necessity. Urinary tract infections are problematic particularly with 
patients in the intensive care units. These urinary tract infections account for 32% of health care 
associated infections (Elpern et al., 2009). According to Nicolle (2014), CAUTIs are one of the 
most common HAIs especially with patients who have indwelling urinary catheters in place. 
Complications include lower abdominal pain, burning urination, and frequency to urinate. 
Urinary tract infections are known to be associated with secondary bloodstream infections given 
the high frequency of indwelling catheter use especially in the critically ill patients (Nicolle, 
2014). The CDC (2015b) states that urinary tract infections are the third most common 
healthcare associated infection which account for more than 93,000 infections in hospitals alone. 
The use of antibiotics can predispose an individual for acquiring other multidrug resistant 
organisms which in turn can increase the risk for potentially more severe conditions.  
Central vascular catheters are used as a resource to provide nutrients, medicine, fluids 
and even take blood samples without having to use a needle to stick a patient. There can be 
serious complications with any central line bloodstream infection (Marschall et al., 2014). The 
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complications include prolonged length of stay, mortality and the increased cost of medical 
services. The clinical manifestations of a central line bloodstream infection can include fever, 
chills, and/or hypotension (Pronovost et al., 2006). Once the microorganisms are in the 
bloodstream they can be carried to other parts of the body and in turn can cause organ damage.   
Other complications include urosepsis which can progress to septic shock. Septic shock is a 
serious and life threatening complication which can lead to a drop in heart rate and blood 
pressure along with decrease in urine output and an altered mental status.    
Risk Factors 
The most prominent risk factor for developing a CAUTI was extended use of a urinary 
catheter (Clarke et al., 2013). However, other prominent risk factors include a disconnection of 
the catheter drainage system and a lower level of professional training and experience of the 
inserter (Clarke et al., 2013). Female sex, old age, impaired immunity, having a catheter placed 
outside of an operating room, incontinence, diabetes, meatal colonization, and renal dysfunction 
are also associated with an increased risk of developing a CAUTI or catheter-associated 
bacteriuria (Edwards, Peterson, & Andrus,  2007; Gould et al., 2009). 
Nosocomial infections in ICU patients are especially at risk for adverse consequences due 
to their risk factors.  Gastmeier, Sohr, Geffers, Behnke, & Rüden, (2007) performed research in a 
German-based hospital to determine risk factors for death among patients who acquired 
nosocomial infections. The researchers used surveillance data consistent with methods 
standardized by the CDC. Based on two primary nosocomial infections in their ICUs, pneumonia 
and primary BSI, the researchers investigated risk factors that contributed to death.  Though they 
found that the types of ICUs and age to be important factors, causative pathogens particularly 
antimicrobial-resistance pathogens may influence the outcome of patients with nosocomial 
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infections. A limitation of the study, however, was their inability to adjust for severity of illness 
at hospital admission. Thus, further investigations of the role of the pathogens in different types 
of ICUs that contribute to nosocomial infections are warranted.  
The importance of investigating antimicrobial resistance organisms in critically ill 
patients who acquired nosocomial infections were further demonstrated by Chen and colleagues 
(2012). In this study, prospective surveillance was conducted to determine device-associated 
infection rates and incidence of antimicrobial resistance in adult medical-surgical ICU in Taiwan 
from 2003-2005, though the surveillance was conducted according to the CDC procedures (Chen 
et al., 2012). The findings revealed that through their infection control practices and surveillance 
program, the rates of device-associated infections and three of the most common antimicrobial 
resistance pathogens causing VAP were decreased (Chen et al., 2012).   
Microbial Transmission 
Microorganisms in the bloodstream can be continuous, intermittent or transient 
depending on the circumstances. Transient bacteremia is incidental and is likely to occur when 
brushing teeth, post dental procedures, manipulation of infected tissue, certain surgeries, or 
instrumentation of contaminated mucosal surfaces to name a few. Intermittent bacteremia is 
usually organisms that make their way into the bloodstream because of other factors such as 
abscesses, wounds and other trauma conditions. Continuous bacteremia involves constant release 
of organisms into the bloodstream and usually causes septic shock, bacterial endocarditis and 
other vascular infections. Microorganisms in the bloodstream can be a threat to any organ in the 
human body and can have serious consequences.  Some of the serious consequences include 
shock, multiple organ failure, disseminated intravascular coagulation and death (Seifert, 2009). 
Septicemia or sepsis occurs when the organisms in the bloodstream produce toxins which harm 
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the patient. Sepsis is recognized by a sudden increase in pulse rate, temperature and the onset of 
chills (Shah, Bosch, Thompson, & Hellinger, 2013). The pathogens can be bacteria, fungi, 
viruses or parasites. The organisms that are most commonly linked with bloodstream HAIs are 
gram-positive cocci such as coagulase negative staphylococcus, Staphylococcus aureus and 
Enterococcus species followed by aerobic gram-negative bacilli and then yeast. A large number 
of the gram negative bacilli causing bloodstream infections can be due to gram negative bacteria 
such as Pseudomonas aeruginosa. Studies conducted by Durojaiye Carbarns, Murray & 
Majumdar, (2011) have reported that Pseudomonas aeruginosa is a major opportunistic pathogen 
that is involved in many hospital infections. The study reported that Pseudomonas aeruginosa 
has been the cause of outbreaks in intensive care units. The organism’s ability to survive in a 
wide range of physical conditions makes it more likely to cause infections especially since 
Pseudomonas aeruginosa is essentially resistant to several antibiotics (Durojaiye et al., 2011). 
Bloodstream infections can also be caused by organisms that colonize the skin, oropharyngeal 
and gastrointestinal tract of patients. Seifert (2009) noted a landmark study by Weinstein and 
colleagues (1997) which defined the portal of entry for primary bloodstream infections as 
intravascular catheter (19.1%), and secondary sources were genitourinary tract, respiratory tract, 
the abdomen, and the skin and skin structure (Seifert, 2009; Weinstein et al., 1997).   
The urinary tract consists of the kidneys, ureters, bladder and urethra. Typically when an 
infection takes place it is either an upper or lower infection depending on the anatomic location 
of the infection. The lower urinary tract consists of the bladder and urethra while the upper 
urinary tract encompasses the ureters and kidneys. It was important to remember that the female 
gender have a relatively short urethra compared to males thus putting the female gender at a 
higher chance of acquiring a urinary tract infection. The reason females have a higher chance of 
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infection was because bacteria can reach the bladder in a quicker and easier manner. The urethra 
has resident flora that colonizes along the epithelium in the distal portion. The potential 
pathogens include gram negative bacilli such as the Enterobacteriaceae. Other pathogens include 
yeast and some gram positive cocci. The most common urinary tract pathogen was Escherichia 
coli but other frequent urinary tract infections can include bacteria such as Klebsiella species, 
and other Enterobacteriaceae (Pallet & Hand, 2010). For gram positive pathogens, 
Staphylococcus saprophyticus is a common pathogen in females that are sexually active.  
Recurrent urinary tract infections have a tendency to be caused by Proteus, Pseudomonas, 
Klebsiella, and Enterobacter (Pallet & Hand, 2010). The hospital environment plays an 
important role in determining the microorganisms involved in these types of infections. The 
hospitalized patients are inclined to develop a urinary tract infection with Escherichia coli, 
Klebsiella species, Proteus mirabilis, other Enterobacteriaceae, Pseudomonas aeruginosa, 
Staphylococcus and Enterococcus species (Pallet & Hand, 2010). The introduction of a foreign 
body such as a Foley catheter carries a substantial risk of infection (Clarke et al., 2013).  In many 
hospitalized patients, urinary tract infections are introduced during urinary catheterization or 
other manipulations of the urinary tract. Urine is typically sterile and all areas of the urinary tract 
above the urethra are sterile in healthy individuals (Clarke et al., 2013).    
The respiratory tract is divided into two separate section areas; one section consists of the 
upper area while the other section makes up the lower respiratory tract. Infections that are 
associated with mechanical ventilation are associated with organisms which can influence certain 
traits or certain products to promote colonization and subsequent infection in the host. Most of 
the organisms associated with respiratory infections have a propensity to gain foothold within the 
respiratory tract to grow to adequate numbers and produce symptoms.  Most etiologic agents of 
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the respiratory tract disease adhere to the mucosa area of the respiratory tract. The bacteria that 
possess specific adherence factors include Streptococcus pneumoniae, and other Strep species, 
Staphylococcus aureus, Haemophilus influenza, and many gram negative bacilli. These types of 
pathogens cause disease by merely growing in host tissue which in turn causes interference with 
normal tissue function. Diseases of the lower respiratory tract include both bronchitis and 
pneumonia. There are four major routes of infection with regard to pneumonia causing 
organisms. There is upper airway colonization, aspiration of organisms, by inhalation of airborne 
droplets or by seeding of the lung via the bloodstream. Hospital acquired pneumonia can be 
related to contaminated inhalation therapy equipment. Any intubated patient has an increased 
risk of acquiring respiratory nosocomial pneumonia especially when reintubation occurs. The 
organisms associated with these types of infections can be hospital specific. However the most 
common pathogens related to lower respiratory infections are Pseudomonas aeruginosa, 
Klebsiella species, other Enterobacteriaceae, Staphylococcus aureus, Streptococcus pneumonia 
and a variety of other common organisms (Kalanuria et al., 2014). Aspiration pneumonia with 
infection caused by gram negative bacilli or Staphylococcus is a major type of hospital acquired 
pneumonia followed by pneumococcal disease.   
Research Studies of Nosocomial Infections in the Intensive Care Units 
HAIs are a major cause for concern as it relates to morbidity and mortality, patient safety, 
and cost of care (Leblebicioglu et al., 2007; Scott, 2009; O’Grady et al., 2011). There have been 
research studies done to demonstrate the efficacy of surveillance to prevent nosocomial 
infections. A study related to device associated healthcare infections which was conducted to 
determine the epidemiological characteristics of nosocomial infections in combined medical-
surgical (MS) and trauma ICUs within the International Nosocomial Infection Control 
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Consortium (Guanche-Garcell et al., 2011). It was found that BSI, UTI, and respiratory tract 
infections were almost always associated with an invasive device, and device-associated 
infections in major teaching hospitals were higher than other hospitals with combined medical-
surgical units. This study, however, only looked at two medical-surgical ICU populations from 
2006 – 2009. An updated epidemiological study of nosocomial infections is warranted and this 
proposed research addresses that gap in knowledge. 
 In Turkey a prospective study of HAI surveillance was performed in 13 ICUs from 12 
hospitals, which were all members of the International Nosocomial Infection Control Consortium 
(INICC) (Leblebicioglu et al., 2007). The objective of the study was to determine the incidence 
of device-associated infections in the ICUs of the Turkish hospitals to compare them with 
international infection control standards, and to plan infection control activities based on the 
data. The study looked at CAUTI rates, VAP, and central venous catheter-related BSI. It was 
found that device utilization in the ICUs used in the study was similar to that reported in the U.S. 
rates of device-association infections in the Turkish ICUs were higher than the CDC National 
Nosocomial Infections Surveillance System. The findings of the study were used to inform the 
researchers about hospital practices that contribute to nosocomial infections. According to their 
study, one of the limitations of this research study was not taking into account patients’ severity 
of illness, which might skew the results of the study (Leblebicioglu et al., 2007). 
Another study of device-associated nosocomial infections of critically ill patients was 
conducted in nine Colombian hospitals (Moreno et al., 2006). The study was conducted in 
respond to other published studies of nosocomial infections in the ICUs in developed countries 
using CDC standardized definitions. However, few surveillance studies have been performed in 
developing countries using standardized definitions (Moreno et al., 2006). The objective the 
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study was to perform a prospective study to measure the rate of device-associated infections, 
organisms causing the infections, the difference in mortality rates between patients with and 
without a device in adult ICU settings (Moreno et al., 2006). It was found that the device-
associated infections were lower than other published studies in Latin America, but still higher 
than those reported in the US (Moreno et al., 2006). The study limitations included the use of 
data from only one population -type of ICU (medical-surgical) and the use of a less  
sophisticated severity of illness scoring system (Moreno et al., 2006). 
Cost of HAIs 
Many studies have been conducted to measure the cost of healthcare associated infections 
and each type of HAI has its own cost. A study on cost was conducted by Scott (2009), using 
results from medical and economic literature to provide a range of estimates for treating 
healthcare associated infections. Adjustments were made in the cost with regard to the use of 
infection prevention and control interventions. The cost for central line-associated bloodstream 
infections are estimated to range from $5,734 to $36,441. The cost for CLABSIs can be 
substantial with the possibility of morbidity and financial resources expended (O’Grady et al., 
2011). The estimated cost for ventilator associated pneumonia infections ranged from $11,897 to 
$25,072. The estimated cost for catheter associated urinary tract infections ranges from &758 to 
$1,006. It was important to keep in mind that each HAI increases the length of stay and increases 
the possibilities of prolonged care and can contribute to negative outcomes. 
Control and Prevention 
Understanding certain factors related to device-related HAIs can provide guidelines and 
important solutions in the ICU. The Infection Prevention & Control Program includes 
surveillance, data abstraction and preventive measures. However, though surveillance is an 
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important aspect of Infection Prevention & Control programs, it can be labor intensive and time 
consuming; thus, limiting resources for quality improvement (Reilly, McCoubrey, Cole, Khan, & 
Cook, 2015). It is important to focus on prevention from the start rather than treatment after the 
fact. The novel approach to this research study was comparing three different ICUs within an 
academic medical center. Control and prevention should use measures for early detection and 
prompt intervention to control a healthcare problem and minimize the consequences related to 
device associated infections. Since policies and guidelines evolve constantly, the findings from 
this study may possibly aid in the development of a more comprehensive plan to prevent 
nosocomial infections within this facility. However, assessing interventions was not focus of this 
study. The use of comparison data with regard to disparities can possibly aid in the development 
of policies and procedures to reduce the possibility of device-associated infections and better 
treatment strategies in the future. The ability to recognize the differences between risk factors 
can contribute to prevention or reduction of HAIs. 
The Healthcare Infection Control Practices Advisory Committee (HICPAC) has 
established prevention strategies and guidelines to reduce the incidence of CAUTIs. The core 
prevention strategies established by HICPAC are evidence based and have demonstrated 
feasibility. These strategies include the following: 1) insert catheters only when appropriate, 
minimizing use in all patients; 2) remove catheters as soon as they become unnecessary; 3) 
ensure that only trained and experienced persons insert and maintain catheters; 4) insert catheters 
using aseptic technique and sterile equipment, including performing hand hygiene pre and post 
insertion as well as wearing proper PPE; 5) maintain a closed drainage system; 6) maintain 
unobstructed urine flow, keeping the collecting bag below the level of the bladder at all times; 7) 
use hand hygiene and standard or isolation precautions; 8) implement quality improvement 
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programs to reduce the risk of CAUTI by decreasing inappropriate use of indwelling catheters 
(Gould et al., 2009). 
Summary 
Device associated healthcare related infections are associated with an increased length of 
hospital stay, an increased chance of additional complications and excessive healthcare costs.  
These infections impose significant economic consequences to the healthcare system. All 
intensive care unit patients are at increased risk of acquiring HAIs because of the many pre-
existing comorbidities which may be present in ICU patients. Risk factors play a role in reducing 
the body’s resistance to infections however it may be difficult to determine how each of these 
risk factors would contribute to HAIs.   Physical environmental factors play a role in contributing 
to the development of HAIs. The goal must be to prevent these infections rather than identify and 
treat these infections. Promotion of best practices must be initiated to include maximal barrier 
protection, use of chlorhexidine for skin prior to insertion, avoiding femoral sites for central line 
placement, removal of devices when no longer needed. Educational modules should be used 
pertaining to the prevention of CLABSI, CAUTI, and VAP. A combination of heightened 
awareness with increased accountability, empowerment of frontline staff, and the opportunity for 
feedback provides important downward pressure on device associated healthcare infections. The 
ultimate goal of this research was to identify the types of device associated infections within 
each ICU, the significant risk factors associated with these infections and the microorganisms 
linked to these types of infections surrounding the healthcare setting. This research may provide 
information which may help guide strategic procedures and consideration of narrowing the 
spectrum of antibiotic usage, shortening the utilization of devices such as Foley catheters and 
central lines in order to prevent complications and reduce the risk of death. The research could 
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provide a positive social change which could benefit the hospitals by conveying an 
understanding on the types of problems related to infections due to vascular lines, Foley 
catheters and ventilators.  Information regarding types of lines, microorganisms, and/or the 
environment plays a role in eliminating healthcare associated infection. In conclusion, 
determining the underlying relationships related to the microbial growth associated with these 
types of infections could help prevent unnecessary prolonged hospital stay, complications, and/or 
death.   
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Chapter 3: Methodology 
Introduction 
Nosocomial infections are a cause of concern and have been shown to increase morbidity, 
mortality, length of stay, and cost of care in hospitals (Marschall et al., 2014). Critically ill 
patients in ICUs are more at risk of acquiring infections due to the invasive nature of treatments 
and multiple therapies used, such as mechanical ventilation, central venous, pulmonary artery, 
and urinary catheterization (DePalo et al., 2010).  Patients with multiple risk factors have higher 
incidence rates of developing CLABSI, CAUTI, and VAP (Barnett et al., 2010).  
Despite multiple interventions and increased attention directed towards identification and 
prevention of CLABSIs, CAUTI, and VAPs, there continues to be ongoing occurrences of these 
healthcare device-related infections that patients succumb to during their hospitalization. After 
reviewing the literature, a gap in clinical practices was identified between interventions and 
attention focused on minimizing these infections, and actual success at completely eliminating 
those types of infections (Cardo et al., 2010). Although the focus of this research was not on 
assessing clinical practices, the findings of this study may provide suggestions for future 
researchers to develop interventions to minimize infections. Specifically, the research aimed to 
address the gap in knowledge in regards to the statistical difference analyses (if any) of incidence 
between ICU types and risk factors that include severity of illness. Additionally, I included types 
of microorganisms identified in each type of device-associated infection. I addressed the 
knowledge gap in the associations between the ICUs, device-associated infections, and 
microorganisms. The purpose of this historical prospective study was to analyze and compare the 
key pathogens, risk factors of ICU patients, and trends of nosocomial infection rates in three 
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ICUs (medical-surgical, cardiovascular, and neurosurgical) of a large acute care teaching 
hospital setting.   
Research Design and Rationale 
Reason for Selection of Design 
 This was a historical prospective study in which data were analyzed from a 5-year 
period, enabling examination of the relationship between characteristics of nosocomial infections 
in three different ICUs. Quantitative data are more efficient and provide the researcher a greater 
ability to test the hypotheses. The study was less time consuming because analysis was from 
secondary data using statistical software. Additionally, quantitative evaluation was selected 
because the data for this research study included actual numbers, frequencies, and counts of 
cases that may help identify data patterns. The goal for the quantitative research was to classify 
features and be able to count them and then be able to construct statistical models so that the 
research could be explained by what was observed. The clinical component provided quantitative 
health status measures of device-associated infections that can impact knowledge, policy 
changes, clinical technique changes, and behavioral changes regarding quality healthcare. 
Strengths and Key Points of the Research Design 
 Key points with regard to the strengths of a quantitative research design include 
statistical representation, estimation of magnitude and distribution impacts, clear documentation 
methods, addressing confounding factors by holding constant certain demographic traits and risk 
factors (i.e., diabetes, obesity, and smoking habits), and a standardized approach. Control of 
biases, including selection bias, was completed by selecting all ICU patients with device-
associated HAIs while determining the dissimilarities and similarities of patients by comparing 
differences in mean APACHE II scores and chi-squared tests for each subgroup of demographic 
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traits and risk factors. In this study I addressed confounding factors, such as controlling for age 
and gender, when comparing the mean APACHE II scores for each HAI type and non-DAIs 
(Tables 10-19). I took into account patients’ illness severity scores using the APACHE II score. I 
did not aggregate the three ICU patient populations in order to prevent masking of aggregated 
data that can provide better insights to the data. Confidentiality of the patients was maintained by 
randomly assigned numbers.  
Methodology 
Study Variables and Measures 
Dependent variables included numbers of nosocomial device-related infections 
(CLABSI, CAUTI, and VAP), the three ICUs, and incidence rates of device-related nosocomial 
infections (Table 1). Independent variables included demographics that were age, gender, and 
race; risk factors such as diabetes, obesity, and smoking; types of microorganisms; and severity 
of illness (APACHE II Score). The data were collected by identifying the number of device-
related infections and device days from 2010 – 2014. Data from positive lab results from the 
electronic health record, for patients with device-related infections, were used in a systematic, 
empirical investigation to determine the number of cases and incidence rates of infections. The 
denominator was a count of the number of patients with a device, such as central line, Foley 
catheter, and ventilator, in each of the ICUs for each month. Microorganisms were investigated 
to determine if there were any trend clusters with regard to these types of factors. Trend clusters 
represent same genus and species observed three or more times within a unit. The data were 
collected, and the comparisons were examined by creating frequency tables and percentage rates 
to calculate for each factor. Incidence rates were the number of each device-associated infection 
calculated for each month. The denominator was the population at risk, which was reflected in 
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the device days. In the incidence rates for the study, I looked at the number of HAIs on a yearly 
basis for 5-years. The SIR used NHSN data, which were comprised of observed (number of 
infections) to the expected (expected number of infections) HAIs. For example the denominator 
was the expected number of CLABSI for each location, which was calculated by multiplying the 
location’s number of central line days by the NHSN rate and dividing by 1,000. The SIR is a 
summary measure used to track HAIs at a national, state, or local level over time within each 
population type. A SIR of 1.0 means the observed number of infections is equal to the number 
that was expected or predicted using NHSN aggregate data. A SIR above 1.0 means the number 
of infections observed in a particular unit is higher than what was predicted for that particular 
population. By NHSN definition, if a patient has been classified for one device-associated 
infection, the patient was not counted twice for other infections if the organism was the same 
(See Appendix B for definitions). Conversely, each device-associated infection with a different 
microorganism was counted as a separate infection (CDC, 2015a). These data were analyzed and 
compared between three different types of ICUs. The aggregate NHSN national pooled mean of 
similar patient populations in other academic medical centers in the United States was used to 
compare the ICU populations for this academic medical center. The data for each ICU 
population were derived from aggregate pooled means of comparable patient populations. The 
SIR allows summarization of data within similar patient populations by adjusting for differences 
in incidence in infections among the population/location types. The SIR adjusts for patients of 
varying risk within each facility, which includes risk factors associated with different patient 
populations. Data analysis included descriptive statistics; incidence infection rates; and 
frequency distributions with tables, bar graphs, and/or charts using an Excel database, IBM SPSS 
21, and Stata (IC 12.1 version).  
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Study Population 
The population for this study was adult male and female patients admitted to the three 
ICUs (medical-surgical, cardiovascular, and neurosurgical) of a large acute care teaching 
hospital within a period of 5 years, from 2010 – 2014. An official record of patients admitted 
was obtained from TheraDoc, which is a data mining software that abstracts information from 
EPIC, the electronic patient health record at the institution. Inclusion criteria included HAI (1-5) 
and non-HAI patients (1-4): 
1. Patient must be adult male or female >18-years-old. 
2. Admitted to one of three ICUs (medical surgical, cardiovascular, and 
neurosurgical) of the acute care teaching hospital between the time period of January 1, 
2010–December 31, 2014. 
3. Length of stay in the acute care facility >2 days. 
4. Device used while hospitalized (central-line, Foley catheter, or ventilator). 
5. Met NHSN criteria for a device-related infection for CAUTI, CLABSI, and VAP 
(Appendix B). The NHSN criteria is met by taking the number of device associated 
infections for a given period divided by the number of device days for the same time 
period for each ICU population. 
There were three ICU types being evaluated in this study. The three units included a 
medical-surgical ICU, cardiovascular ICU, and a neurosurgical ICU. Each ICU was analyzed 
separately and compared to one another for similarities and differences. The total number of beds 
for all combined intensive care units was 67. The investigation included any positive device-
related HAI that was linked to the use of central lines, Foley catheters, and mechanical 
ventilation. The denominator included the entire ICU populations who had devices in a given 
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month. This included patients who had device associated HAIs and those at risk but without 
device-associated infections. This enabled incidence rates to be developed. The study population 
size included all patients identified as having a central line, Foley catheter, and/or on a ventilator 
in a medical surgical ICU, cardiovascular ICU, and neurosurgical ICU during the 5-year period. 
Each DAI identified was counted once, and there were no duplication of HAIs counted per 
device according to NHSN criteria. For example, a patient may acquire a CLABSI, CAUTI, 
and/or VAP. The NHSN guidelines and criteria were used when identifying all of the device 
associated infections (Appendix B). 
Data Collection 
The research analyzed secondary data of all patients that were admitted to the three ICUs 
from 2010–2014 extracted from Epic, a health information management system of medical 
records. The data was validated by the Infection Prevention and Control Department of the acute 
care research hospital using TheraDoc. The data analyzed was the number of device-related 
infections and device days by month and year, demographics, patient APACHE score, and 
microorganisms related to their infections. Patients with a device (central line, Foley catheter, 
and/or ventilator) were (according to IC policy) to be monitored daily, along with monthly 
evaluations of device utilization rates, infection incidence rates and SIRs. The utilization ratio for 
central lines, Foley catheters and ventilators was estimated by month and year by the researcher. 
This was done by taking the number of device days for each ICU.  Device days were obtained by 
counting the devices to estimate the total number of CLABSIs, CAUTIs, and VAPs among 
patients in the ICUs, the infection prevention department used the total number of infections and 
divided by the number of device days in order to obtain the infection rates per 1000 (Appendix 
D). To calculate device utilization rates, the number of device days were divided by census days 
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for each CLABSI, CAUTI, and VAP. The pooled mean for CLABSI, CAUTI, and VAP 
infection rates were specific to each ICU and were obtained from the National Healthcare Safety 
Network (NHSN). The guidelines used were from the NHSN (Appendix B) and were 
implemented by both the ICUs and the Infection Prevention Department. Table 1 provides 
information about which variables were used to answer each research question. The SIR is 
calculated by determining the expected number which equals to the number of device days 
multiplied by NHSN rate divided by 1000. The formula is Expected Number = Number of 
Central Line Days x (NHSN Rate/1000). Once the expected number of infections is calculated, 
the SIR calculation can be determined by using the Observed Number of infections divided by 
the Expected Number of infections. The formula for SIR is: Observed/Expected.  
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Table 1 
Description of Variables Corresponding to Research Questions and Database Source 
Research 
Question Dependent Variable Independent Variable Source 
RQ1 
# of CLABSI 
# of CAUTI 
# of VAP 
Medical/Surgical ICU 
Cardiovascular ICU 
Neurosurgical ICU 
Epic 
TheraDoc 
RQ2 
CLABSI 
CAUTI 
VAP 
APACHE Score includes 
Severity of Illness measured by: 
temperature, mean arterial 
pressure, heart rate, respiratory 
rate, oxygenation, arterial pH, 
serum potassium, serum sodium, 
serum creatinine, hematocrit, 
white blood cells count, coma 
score, age, and  chronic health; 
obesity, diabetes, smoking 
Epic  
Patient chart review 
RQ3 
Healthcare-associated 
Infections (HAIs) 
ICU type 
Age, gender, ethnicity, and race 
Epic 
TheraDoc 
RQ4 
Types of HAI 
# of HAI 
 
Microorganisms 
Gram-stain Genus/species 
Susceptibility patterns 
ICU type 
Epic 
TheraDoc 
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Data Analysis 
The Informatics Department from the Academic Medical Center provided de-identified 
datasets for the purpose of this research.  Information was abstracted from the limited dataset 
needed for this research study. Data was downloaded to Excel from Epic and TheraDoc by the 
Infection Prevention & Control Department personnel.  A clarity report was created with a line 
listing for each patient that was admitted into the ICUs during 2010 through 2014. All the 
patients required information was included in the report. During the same admission, if a patient 
had multiple microbiological cultures from the same source and same organism, the duplicate 
patient listing was removed to prevent double counting. The academic medical center agreed to 
provide the de-identified data from the Informatics Department, and therefore, there should not 
have been a conflict of interest. The data was analyzed using SPSS software, version 21 and 
Stata IC 12.1 version. Descriptive statistics, as frequencies, were used for categorical 
demographic data (gender, race, and ethnicity). For this study American Indian/Alaska Native, 
Asian, and Native Hawaiian or Other Pacific Islander were grouped into “Other” category for 
Race and Ethnicity for data analysis purposes due to the small number of population within each 
group. The mean age was calculated for each set of device-associated infections (CLABSI, 
CAUTI, and VAP) and compared for differences. Setting parameters helped to standardize the 
study into select age groups which was useful for comparing rates between population and 
determining the severity of disease using the APACHE II scores. The APACHE II score uses a 
standardized scoring system which can help to predict mortalities.  Calculations were performed 
with the HAI groups in this study. The HAI and non-HAI groups were further analyzed in regard 
to their association with the following comorbidities: diabetes and obesity. Another risk factor 
examined was smoking. The research population was adult male and female. Additionally, 
52 
 
 
 
descriptive statistics such as frequencies were used for reporting microorganisms and 
comorbidities within the known device associated HAI patients. As for the device-associated 
infections, it was the average of infections per device days. The mean and the standard deviation 
were used to compare the average and the measure of dispersion of device associated infections 
between the three ICUs according to the NHSN data.  
The research questions were analyzed as follows: 
RQ#1:  Is there a difference in the incidence rates of device-related nosocomial infections 
between the different types of ICUs?  
H01: There is no difference in the incidence rates of device-related nosocomial infections 
between the different types of ICUs.  
H11: There is a difference in the incidence rates of device-related nosocomial infections 
between the different types of ICUs. 
To determine the device (central-line, Foley catheter, or mechanical ventilator) which 
increases the chances of an ill person in the ICU of developing an HAI, the device-related 
infection incidence rates for CAUTI, CLABSI, and VAP were compared against the utilization 
ratio in each ICU. Utilization ratio was calculated by dividing device days by patient days (the 
number of patient in that unit daily). The utilization rate compared to the NHSN national pooled 
mean provided a picture of how many intra-devices were being used on a particular unit in order 
to determine over usage which can increase infections. Descriptive statistics as frequencies were 
used for device types in each ICUs. To determine if infection rates were higher in one type of 
ICU compared to other ICUs, the incidence rates and SIRs of CAUTI, CLABSI, and VAP in 
each ICU were compared. To calculate the incidence rates of device associated HAIs in each 
ICU, the number of cases was divided by device days multiplied by 1000 for each case identified 
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per month and year. The device days for central-lines, Foley catheters, and mechanic ventilators 
were calculated based on the number of patients with a device per day.  To calculate device days, 
the number of patients who had a device was recorded each day at the same time, and the daily 
counts were added together at the end of the months. A SIR was determined by calculating the 
number of observed cases divided by the number of expected infections. The number of expected 
infections, known as the statistical prediction, is where each device associated infection such as 
CLABSI, CAUTI, and VAP ratio was calculated using a standard population during a baseline 
period. This period represented a standard population experience in each of the device associated 
healthcare associated infection categories. The expected number of infections was calculated by 
multiplying the number of device days by the NHSN pooled mean and dividing by 1000. The 
pooled mean originates from a defined baseline report (Dudeck et al., 2011). The SIR was a 
summary measure used to compare the hospital acquired infection (HAI) rate among one or more 
groups of patients to the mean rate for the similar NHSN patient population. An SIR greater than 
1.0 indicated that more HAIs were observed than predicted, and an SIR less than 1.0 indicated 
that fewer HAIs were observed than predicted. The calculation of HAI rates for each device was 
the number of hospital acquired infections divided by the number of device days multiplied by 
1000 in order to obtain rates. The numerator was each identified case of device associated HAI 
which occurred during the month. The denominator was the number of device days counted 
during the day, at the same time, in each intensive care unit for each infection category (see 
Table 2). Quarterly data were analyzed for the five year period (2010–2014) from the data 
provided by Infection Prevention. The standard deviations for the rates were calculated, and the 
mean was calculated yearly based on NHSN guidelines. The 50th percentile bar is a standard 
provided by the NHSN for comparisons to the national average. The data were collected and the 
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comparisons were done by creating rate tables and SIR for each device.  To test for differences in 
the infection rates and SIR by ICUs, analysis of variance (ANOVA) was used. Assumptions 
were tested and met for ANOVA. Post-hoc analysis was done to determine where the ICUs 
differed.  
Table 2  
Calculation of Device-related Healthcare Associated Infection Rates 
Types of Device Associated Healthcare 
Associated Infections 
Calculations 
Ventilator Rates # VAP cases/# of ventilator device days x 1000 
Foley Catheter UTI Rates # CAUTI cases/# of FC device days x 1000 
Central Line BSI Rates # CLABSI cases/# of CL device days x 1000 
 
RQ#2:  What is the association between severity of illness, measured by the Acute 
Physiology and Chronic Health Evaluation II (APACHE II) score, and CLABSI, CAUTI, and 
VAP?  
H02: There is no association between severity of illness (APACHE score) and CLABSI, 
CAUTI, and VAP. 
H12: There is an association between severity of illness (APACHE score) and CLABSI, 
CAUTI, and VAP. 
The research study utilized the Acute Physiology and Chronic Health Evaluation 
(APACHE II) scoring system as a tool to determine the severity of a patient’s illness within the 
first 24 hours of admission to the ICU (Knaus et al., 1985; Le Gall, 2005; Vincent & Moreno, 
2010). The APACHE II scoring system is based on age, chronic health problems, and 12 
physiologic variables (temperature, mean arterial pressure, heart rate, respiratory rate, 
oxygenation, arterial pH, serum sodium, serum potassium, serum creatinine, hematocrit, white 
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blood cells count, and Glasgow coma score for measure of neurologic function) (Knaus et al., 
1985; Vincent & Moreno, 2010). The APACHE scoring system was used to determine the 
severity of illness and to abstract the data manually (Table 7-9). By quantifying the disease 
severity upon admission to the ICUs, the study was able to identify the association between 
patients’ conditions and device-related HAIs. Table 1 shows the components used to determine 
severity of illness for research question 2.  
APACHE II scores of patients admitted to the ICUs were calculated using a web-based 
APACHE II analysis system. Descriptive statistics were used to analyze APACHE II scores by 
computing the mean total score and standard deviation of patients with a device.  To determine 
the correlation between each of the device-associated HAIs (CAUTI, CLABSI, and VAP) and 
APACHE II score, odds ratio and Chi-square analyses were used. To test for differences in 
APACHE scores between patients who had CLABSI, CAUTI, and VAPs, analysis of variance 
(ANOVA) was used.  
RQ#3: What is the association between age, gender, race and ethnicity from the device 
associated HAIs identified in the three different adult ICUs within an academic medical facility? 
H03: There is no association between age, gender, race and ethnicity from the device 
associated HAIs identified in the three different adult ICUs within an academic medical facility? 
H13: There is an association between age, gender, race and ethnicity from the device 
associated HAIs identified in the three different adult ICUs within an academic medical facility? 
Descriptive statistics (frequencies) were used for categorical risk factors (age, gender, 
race and ethnicity). To determine the association between categorical risk factors and acquiring 
device-related HAI in the three ICUs, the frequencies of patients with devices who developed 
HAIs and patients with devices who did not develop HAIs was compared using Chi-square 
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statistics. The categories for age were divided into 18-29, 30-39, 40-49, 50-59, and ≥60 years of 
age, and male and female for gender. Race and ethnicity were grouped by White/Caucasian, 
Hispanic, Black/African-American, and Other. This categorization was used for race and 
ethnicity consistent with the distribution utilized by the Texas Department of State Health 
Services for disease distribution analysis.   
RQ#4: Are there significant differences in the types of microorganisms (e.g. genus, 
species and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et 
al., 2015) which are associated with device-related HAIs in three adult ICUs within an academic 
medical facility?   
H04: There are no significant differences in the types of microorganisms (e.g. genus, 
species, and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et 
al., 2015) associated with device-related HAIs in three adult ICUs within an academic medical 
facility.  
H14: There are significant differences in the types of microorganisms (e.g. genus, species 
susceptibility according to the Clinical and Laboratory Standards Institute (Patel et al., 2015) 
which are associated with device-related HAIs in three adult ICUs within an academic medical 
facility.  
Descriptive statistics (frequencies and mean) were used to identify the different types of 
microorganisms associated with each of the HAIs within the three ICUs. Analysis of variance 
(ANOVA) was used to determine if there were differences in the types of microorganisms 
associated with device-related HAIs within the three ICUs. Prior to the use of the data, the 
assumptions were tested and conditions were met with the use of ANOVA. Additionally, for 
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each categorical risk factor, the study identified the predominant microorganisms in patients that 
develop device-related HAIs within the three ICUs. 
Threats to Validity 
The results of this research may help to establish association between the possible risk 
factors (such as age, gender, race, and ethnicity), disease severity, device utilization, ICU types, 
and HAIs. However, it was important to consider other variables that might affect the rate of 
infections. Variables that might affect infection rates include comorbidities of individual patients 
(see Table 10-17), varied ICU environments from year to year, and clinical staff turnover. 
Utilizing a standardized acuity scoring system, using the same ICU units for the patient 
population being studied may minimize possible sources of bias. Another threat to validity was 
that the NHSN definitions of healthcare-associated infections are periodically updated from year 
to year, which affects hospital staff in determining device-related infections, thus affecting the 
data.   
Ethical Procedures 
The researcher conducting the study is knowledgeable in infection prevention and control 
and has worked in an acute health care setting. Additionally, I manage the Infection Prevention 
and Control Department in the acute care hospital. For this study, the researcher completed the 
National Institute of Health “Protecting Human Research Participants” training course. Access to 
hospital patient database was granted by the Vice President of Hospital Quality, who also serves 
as the Hospital Chief Quality Officer (Appendix C). Patient data was de-identified and replaced 
with a unique study identification number to maintain patient confidentiality and privacy. The 
Academic Medical Center provided personnel from the Informatics Department to extract the 
necessary data set for this study. The dataset contained a unique identifier for each patient. I only 
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accessed patient information as a student according to HIPAA guidelines. The limited data set 
was transferred into an Excel spreadsheet without patient identifiers. No experimental medical 
procedures were performed for this research study.  Since this was a retrospective study, future 
patient admissions were not used. Data was secured on my personal computer to enable access 
and data was not altered. De-identified data will be maintained for 5 years and then destroyed. 
The research study was approved by the Walden University Institutional Review Board (IRB-07-
31-15-0151358) and the hospital Institutional Review Board (IRB-8843) prior to 
implementation.  
Summary 
This historical prospective study used targeted surveillance to measure device associated 
infections in three different ICUs by using the definitions of the NHSN. This research used a 
quantitative historical prospective methods approach and was conducted at a University Medical 
Center that included an initiative that was in line with a current organizational priority to reduce 
the incidence of device associated HAI, such as CLABSI, CAUTI, and VAP. The target 
population was all patients who had a positive confirmed healthcare associated infection with 
central venous lines, Foley catheters, or on a ventilator in a medical surgical, cardiovascular, and 
neurosurgical adult acute care intensive care unit. The measurement of device-associated 
infection rates, incidence, microbiological pathogen profiles and risk factors were essential in 
determining any patterns or trends within each ICU. The statistical analysis provided in Chapter 
4 presents the necessary comparative tools to evaluate and examine the components of device 
associated infections in the three different ICUs noted. 
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Chapter 4: Results 
Introduction 
This research study was implemented in order to examine and compare device associated 
nosocomial infections with three different ICUs within an academic medical hospital. I 
compared multiple factors and attempted to compare incidence rates of device-related 
nosocomial infections between three types of ICUs (cardiovascular, medical-surgical, and 
neurosurgical) within an academic medical institution. The hypothesis was that there was no 
difference in the incidence rates of device-related nosocomial infections between the three ICUs. 
I also looked at the association between the severity of illness of patients, measured by the 
APACHE II score, and CLABSI, CAUTI, and VAP. There was a statistically significant 
difference in APACHE II scores of those who acquired device-associated infections between the 
three ICUs (Tables 7-8). Furthermore, I examined the association between age, gender, race, 
ethnicity, and HAI status of patients in the three adult ICUs. It was found that age, gender, race, 
and ethnicity were not associated with an HAI (Tables 3 and 9). Finally, I looked for significant 
differences in the types of microorganisms associated with device-related nosocomial infections 
in the three adult ICUs. For Research Question 3, it was found that there was an association 
between types of microorganisms associated with device-related HAIs in the three adult ICUs 
within an academic medical facility (Tables 23-24). This chapter provides the results of the data 
analysis conducted to answer the research questions related to HAIs within the three academic 
ICUs studied. 
Data Collection 
I analyzed secondary data of all patients admitted to the three ICUs (cardiovascular, 
medical-surgical, and neurosurgical) from 2010-2014 who developed a device-related 
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nosocomial infection and those patients who did not develop a HAI. The data were extracted 
from Epic, a health information management system of medical records and validated by the 
infection prevention and control department at the academic medical center. This included 
calculating APACHE II scores, identification of device-associated nosocomial infections, 
identifying organisms, and capturing demographic data. Patient identifiers were removed prior to 
obtaining the data for analysis, and numerical identifiers were assigned for each case to avoid 
duplicate counts of the same HAI. The timeframe for data collection was 4 weeks. There were a 
total of 321 patients identified as having device-related nosocomial infections; however, two 
patients were excluded from the study because they did not meet the inclusion criteria due to age. 
The research study was specific to the three ICUs within two hospitals of an academic medical 
facility that serve surrounding areas including nearby states. There were a total of 4,213 patients 
admitted to the three ICUs who met the inclusion criteria from 2010-2014, with an average age 
of 59.13 (SD = 16.10). From 2010-2014, most patients were admitted to the medical-surgical 
ICU (MSICU; 55.31%, n = 2,330), followed by the neurosurgical ICU (NSICU; 27.46%, n = 
1,157). Over half of the study population were males (53.07%, n = 2,236); female: 46.93%, n = 
1,977. The majority of the population were Caucasians (60.43%, n = 2,546), followed by African 
Americans (25.30%, n = 1,066; Table 3). The population included all patients admitted to the 
ICU within the 5-year study time frame that met the device-associated HAI criteria and those 
who did not have an HAI. 
Results 
  The demographics of patients who met criteria for the study were 60.43% Caucasian, 
25.30% African American, 13.05% Hispanic or Latino, and 1.21% in other category (Table 3). 
Most of the patients in the study were male (53.07%, n = 2,236) with the distribution being 
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statistically significant at p < 0.001. The majority of patients who were admitted to the three 
adult ICUs between 2010 and 2014 were ≥60 years of age (53.52%, n = 2,255) followed by 50-
59 years (21.55%, n = 908), 40-49 years (11.56%, n = 487), 30-39 years (7.24%, n = 305), and 
18-29 years (6.12%, n = 258). Between 2010 and 2014, all patients who met the study inclusion 
criteria were admitted to the medical-surgical ICU (55.31%, n = 2,330) followed by 
neurosurgical ICU (27.46%, n = 1,157) and cardiovascular ICU (17.23%, n = 726). The majority 
of patients who developed HAIs were Caucasians (65.52%, n = 209) followed by African 
Americans (20.38%, n = 65), and Hispanic or Latino (10.66%, n = 34), being statistically 
significant at p < 0.001; and these 319 HAI patients had a mean age of 58.49 (SD = 14.41), and 
the non-HAI group had a mean of 59.19 (SD=16.23); however, the differences in age were not 
statistically significant by the t-test (p = 0.455). Within the 5-year period, the majority of patients 
identified with device-related nosocomial infections were in medical-surgical ICU (40.75%, n = 
130), followed by neurosurgical (33.54%, n = 107), and cardiovascular ICU (25.71%, n = 82). 
The distribution was statistically significant (p < 0.001). 
With respect to the demographic and infection distribution in CVICU, most of the 
patients were male (n = 437, 60.19%; Table 3). According to the chi-square test for gender and 
patients with or without HAI, there was no statistically significant association found between 
patients of either gender with an HAI and those without an HAI (p = 0.297). While most patients 
were at least 60 years of age (n = 388, 53.44%), there was no statistically significant association 
between patients of any age group with an HAI versus those without an HAI (p = 0.100). In 
contrast, there was a statistically significant association between patients of any ethnicity without 
an HAI and those with an HAI (p < 0.001). The majority of patients were Caucasian (n = 421, 
57.99%), followed by African Americans (n = 194, 26.72%), Hispanic/Latino (n = 99, 13.64%), 
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and all other racial/ethnic groups (n = 12, 1.65%); the distribution among the racial/ethnic 
groups was statistically dissimilar (p < 0.001). 
With respect to the demographic and infection distribution in MSICU, 54.03% of the 
patients were male (n = 1,259; Table 3). According to the chi-square test for gender and patients 
with or without HAI, the distribution was statistically dissimilar (p < 0.001). While 56.65% 
patients were at least 60 years of age (n = 1,320), there was no significant association between 
age group and the number of patients with or without HAI (p = 0.477). There were more 
Caucasians (55.32%, n = 1,289) than any other racial/ethnic group: there were 676 African 
Americans (29.01%), 335 Hispanics/Latinos (14.38%), and 30 for all else (1.29%). There was no 
statistically significant association between racial/ethnic groups and the number of patients with 
or without HAI (p = 0.138). 
With respect to the demographic and infection distribution in NSICU, there were more 
female patients (n = 617, 53.33%) than male patients (n = 540, 46.67%; Table 3). According to 
the chi-square test for gender and patients with or without an HAI, there was no statistically 
significant association (p = 0.069). While more patients aged at least 60 years had acquired an 
HAI compared to other age groups (n = 40, 37.38%), there was no significant association 
between the age of the patient and the number of patients with or without an HAI (p = 0.176). 
Caucasians were the majority racial/ethnic group (n = 836, 72.26%), followed by African 
Americans (n = 196, 16.94%), Hispanic/Latinos (n = 116, 10.03%), and all other race/ethnic 
groups (n = 9, 0.78%). Although most patients who acquired an HAI were Caucasian (n = 73, 
68.22%), the distribution between race and HAI status was statistically similar (p = 0.054). 
Overall, HAIs increase as the patient’s age increases. The study did show that confounder of 
HAI was age.   
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Table 3  
Demographics and Clinical Characteristics of Patients across Three Adult Intensive Care Units, 
2010-2014 
Demographic and Infection 
Distribution 
All Patients 
(n = 4213) 
Patients without 
HAI (n = 3894) 
Patients with 
HAI (n = 319) 
P value 
Sex -- n (%)    <0.001* 
    Male 2236 (53.07) 2101 (53.95) 135 (42.32)  
    Female** 1977 (46.93) 1793 (46.05) 184 (57.68)   
Age -- n (%)    0.751 
    18-29 258 (6.12) 244 (6.27) 14 (4.39)  
    30-39 305 (7.24) 282 (7.24) 23 (7.21)  
    40-49 487 (11.56) 448 (11.50) 39 (12.23)  
    50-59 908 (21.55) 837 (21.49) 71 (22.26)  
    ≥60 
 
2255 (53.52) 
 
2083 (53.49) 
 
172 (53.92) 
 
  
Race/Ethnicity† -- n (%)    <0.001* 
    African American 1066 (25.30) 1001 (25.71) 65 (20.38)  
    Caucasian 2546 (60.43) 2337 (60.02) 209 (65.52)  
    Hispanic or Latino 550 (13.05) 517 (13.25) 34 (10.66)  
    Other 51 (1.21) 40 (1.03) 11 (3.45)   
ICU Location -- n (%)    <0.001* 
    Cardiovascular (CVICU) 726 (17.23) 644 (16.54) 82 (25.71)  
    Medical-Surgical (MSICU) 2330 (55.31) 2200 (56.50) 130 (40.75)  
    Neurosurgical (NSICU) 1157 (27.46) 1050 (26.96) 107 (33.54)   
Note. Chi-square test was used to obtain the p-values 
† Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander  
* Statistically significant at p ≤ 0.05 
** Females comprised 46.93% of all patients, however, females with HAI comprised 57.68%  
Mean age for the 319 HAI patients was 58.49 (SD = 14.41), while those without an HAI had a mean age of 59.19 
(SD = 16.23, n = 3,894).  The mean age differences were not statistically significant p = 0.455 by t-test. 
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Table 3 continued 
Demographics and Clinical Characteristics of CVICU Patients, 2010-2014 
CVICU 
Demographic and 
Infection Distribution All Patients 
Patients 
without HAI 
Patients with 
HAI  P value 
Sex  -- n (%)    0.297 
    Male 437 (60.19) 392 (60.87) 45 (54.88)  
    Female 289 (39.81) 252 (39.13) 37 (45.12)  
Age  -- n (%)      0.102 
    18-29 43 (5.92) 43 (6.68) 0 (0.00)  
    30-39 51 (7.02) 45 (6.99) 6 (7.32)  
    40-49 88 (12.12) 77 (11.96) 11 (13.41)  
    50-59 156 (21.49) 142 (22.05) 14 (17.07)  
    ≥60 388 (53.44) 337 (52.33) 51 (62.20)  
Race/Ethnicity†  -- n (%)    <0.001*  
    African American 194 (26.72) 182 (28.26) 12 (14.63)  
    Caucasian 421 (57.99) 366 (56.68) 56 (68.29)  
    Hispanic or Latino 99 (13.64) 90 (13.98) 9 (10.98)  
    Other† 12 (1.65) 7 (1.09) 5 (6.10)  
Note. Chi-squared tests were used to obtain the p-values 
* Statistically significant at p ≤ 0.05 
† Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander 
Table 3 continued 
Demographics and Clinical Characteristics of MSICU Patients, 2010-2014 
MSICU 
Demographic and 
Infection Distribution All Patients 
Patients 
without HAI 
Patients 
with HAI  P value 
Sex  -- n (%)    <0.001* 
    Male 1,259 (54.03) 1,210 (55.00) 49 (37.69)  
    Female 1,071 (45.97) 990 (45.00) 81 (62.31)  
Age  -- n (%)    0.477 
    18-29 143 (6.14) 134 (6.09) 9 (6.92)  
    30-39 157 (6.74) 151 (6.86) 6 (4.62)  
    40-49 243 (10.42) 234 (10.64) 9 (6.92)  
    50-59 467 (20.04) 442 (20.09) 25 (19.23)  
    ≥60 1,320 (56.65) 1,239 (56.32) 81 (62.31)  
Race/Ethnicity†  -- n (%)   0.138 
    African American 676 (29.01) 640 (29.09) 36 (27.69)  
    Caucasian 1,289 (55.32) 1,209 (54.95) 80 (61.54)  
    Hispanic or Latino 335 (14.38) 325 (14.73) 11 (8.46)  
    Other† 30 (1.29) 27 (1.23) 3 (2.31)  
Note. Chi-squared tests were used to obtain the p-values 
* Statistically significant at p ≤ 0.05 
† Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander 
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Table 3 continued 
Demographics and Clinical Characteristics of NSICU Patients, 2010-2014 
NSICU 
Demographic and 
Infection Distribution All Patients 
Patients 
without HAI 
Patients 
with HAI  P value 
Sex  -- n (%)    0.069 
    Male 540 (46.67) 499 (47.52) 41 (38.32)  
    Female 617 (53.33) 551 (52.48) 66 (61.68)  
Age  -- n (%)    0.176 
    18-29 72 (6.22) 67 (6.38) 5 (4.67)  
    30-39 97 (8.38) 86 (8.19) 11 (10.28)  
    40-49 156 (13.48) 137 (13.05) 19 (17.76)  
    50-59 285 (24.63) 253 (24.10) 32 (29.91)  
    ≥60 547 (47.28) 507 (48.29) 40 (37.38)  
Race/Ethnicity†  -- n (%)   0.054 
    African American 196 (16.94) 179 (17.05) 17 (15.89)  
    Caucasian 836 (72.26) 763 (72.67) 73 (68.22)  
    Hispanic or Latino 116 (10.03) 102 (9.71) 14 (13.08)  
    Other† 9 (0.78) 6 (0.57) 3 (2.80)  
Note. Chi-squared tests were used to obtain the p-values 
† Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander 
Research Question 1 and Hypothesis 
RQ#1: Is there a difference in the incidence rates of device-related nosocomial infections 
between the different types of ICUs? 
H01: There is no difference in incidence rates of device-related nosocomial infections 
between the different types of ICUs.  
H11: There is a difference in the incidence rates of device-related nosocomial infections 
between the different types of ICUs. 
There were 204 identified Catheter-associated Urinary Tract Infections (CAUTI), 61 
Central-line Bloodstream Infections (CLABSI), and 54 Ventilator-associated Pneumonias (VAP) 
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(Table 5). It was found that from 2010 – 2014, CVICU had the highest incidence rate for 
CLABSI (1.16 per 1000 CL days, sd = 0.56, range = 0.5 – 1.8) (Table 4). In 2012, CLABSI rates 
were lowest for the three ICUs (Appendix D). However, the difference in CLABSI incidence 
rates in the three ICUs was not statistically significant (p = 0.349) (Table 4). MSICU had the 
highest CAUTI rate from 2010 – 2014 between the three ICUs (3.98 per 1000 Foley days, sd = 
1.07, range = 2.6 – 5.1) (Table 4). However, CAUTI rates were lowest in 2014 for the three ICUs 
(Figure 3). The difference in the CAUTI infection rate between the three ICUs was not 
statistically significant (p = 0.187) (Table 4). NSICU had the highest incidence rate for ventilator 
associated pneumonia (4.67 per 1000 vent days, sd = 3.60, range = 1.6 – 10.4) compared to other 
ICUs with the highest rate being in 2010 (Table 4, Figure 4). A chi-square test shows that the 
distribution of the VAP rate across the ICUs is statistically similar (p = 0.052) (Table 4); 
however, a Pearson correlation has shown statistical significance for VAP rates specifically in 
NSICU (Appendix D). If the study would have used a larger sample, there may have been 
possible significance in the p value. In this study, NSICU patients were shown to have a higher 
rate of developing a ventilator associated pneumonia than the other two ICUs.  From this study it 
can be concluded that neurologic disease may be a risk factor for VAP development. The 
implication is that while the distribution of the VAP rate is statistically similar across the ICUs, 
the VAP rate is correlated with the VAP rate within NSICU. Comparison of device associated 
infection rates total in the three ICUs from 2010 to 2014 is seen in Figure 5.   
In the 5-year period of 2010-2014, CVICU had the highest mean SIR for CLABSI 
compared to the other two ICUs; however, the difference was not statistically significant (p = 
0.136) (Table 5). The difference in mean SIRs for CAUTI in the three ICUs was statistically 
significant (p = 0.027) (Table 5). In contrast, differences in VAP SIR across the ICUs were 
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statistically insignificant (p = 0.096) (Table 5). The Bonferroni post-hoc analysis was used to 
compare between the HAI groups because the post-hoc analysis test was flexible enough to be 
used on any statistical test.  Bonferroni post-hoc analysis revealed that the CAUTI SIR for 
NSICU was statistically significant (p = 0.046; Table 5, Appendix E). 
Table 6 shows the aggregated correlation between device utilization and device infection 
rate in 2010-2014 across the three ICUs. The mean device infection rate (DIR) for CAUTI is 
3.58 ± 1.02; for CLABSI is 0.92 ± 0.64; and for VAP is 1.75 ± 2.77. The mean device utilization 
ratio (DUR, which is calculated by number of device days divided by the number of patient 
days) for CAUTI is 0.61 ± 0.11; for CLABSI is 0.62 ± 0.16; and for VAP is 0.31 ± 0.06. CAUTI 
has a Pearson correlation coefficient of 0.43, being statistically insignificant at p = 0.11. 
Similarly, CLABSI has a 0.35 correlation coefficient that is statistically insignificant at p = 0.21. 
Finally, the coefficient for VAP is -0.34 at p = 0.21. Overall, aggregating the information for the 
three ICUs does not reveal a statistically significant association between a device-associated 
infection and its infection rate nor its utilization ratio. The research compared the device 
utilization rates in the five year period between the three ICUs (Figure 6, Appendix E). CVICU 
had the highest central line utilization and ventilator utilization rates compared to other ICUs, 
and their rate was above the NHSN national pooled mean (Figure 6). NSICU had the highest 
CAUTI utilization rates compared to CVICU and MSICU, and the national pooled mean (Figure 
6). However, utilization rates of any device were not correlated to device infection rates.   
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Table 4 
Incidence Rates of Device-related Nosocomial Infections in the Three ICUs, 2010 – 2014 
  Location Mean 
Std. 
Deviation 
Minimum Maximum    p-value 
CLABSI Rate 
CVICU 1.16 0.56 0.5 1.8   
MSICU 1.10 0.41 0.6 1.5   
NSICU 0.6 0.87 0 1.9   
Total 0.95 0.65 0 1.9 0.349 
CAUTI Rate 
CVICU 2.86 1.24 1.5 4.6   
MSICU 3.98 1.07 2.6 5.1   
NSICU 3.92 0.61 3.2 4.6   
Total 3.59 1.08 1.5 5.1 0.187 
VAP Rate 
CVICU 1.36 1.54 0.50 4.10   
MSICU 0.99 0.91 0 2.44   
NSICU 4.67 3.60 1.60 10.4   
Total 2.34 2.75 0 10.4 0.052 
Note. Rates are calculated per 1000 device line days 
Statistical significance tests performed with ANOVA 
Pearson correlation demonstrates within ICU statistical significance (p ≤ 0.05) in NSICU with VAP rate 
(Appendix D) 
 
Table 5  
Standardized Infection Ratio (SIR) of Device-related Nosocomial Infections in the Three ICUs, 
2010 – 2014 
 Location 
 
n 
Mean 
SIR 
Std. 
Deviation 
Minimum Maximum p-value 
CLABSI 
SIR 
CVICU 24 1.46 0.72 0.6 2.3  
MSICU 30 0.90 0.35 0.5 1.3  
NSICU 7 0.56 0.82 0 1.8  
Total 61 0.97 0.72 0 2.3 0.136 
CAUTI 
SIR 
CVICU 45 1.60 0.72 0.8 2.6  
MSICU 87 1.66 0.44 1.1 2.1  
NSICU†† 72 0.78 0.13 0.6 0.9  
Total 204 1.35 0.62 0.6 2.6 0.027† 
VAP 
SIR 
CVICU 13 0.78 0.91 0.30 2.4  
MSICU 13 0.62 0.55 0 1.5  
NSICU 28 2.24 1.74 0.70 5  
Total 54 1.21 1.33 0 5 0.096 
 Note. †ANOVA shows significant difference in mean CAUTI SIR by unit location (p=0.027) 
††Significant difference based on Bonferroni post-hoc analysis within unit (p=0.046) 
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Figure 2. Central-line associated bloodstream infection (CLABSI) rate over a period of 5 years 
in three intensive care units.  
The difference in CLABSI incidence rates in the three ICUs was not statistically significant (p = 
0.349) as shown on Table 4.  
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Figure 3. Cather-associated urinary tract infection (CAUTI) rate over a period of 5 years in three 
ICUs.  
CAUTI infection rate was not statistically significant as shown by ANOVA (Table 5: p = 0.187).  
 
 
Figure 4. Ventilator-associated pneumonia (VAP) rate over a period of 5 years in three ICUs.  
VAP rate difference was not statistically significant between the three ICUs as shown by 
ANOVA (Table 4: p = 0.052). 
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Figure 5. Comparison of device associated infection rates per 1000 device line days in the three ICUs 
from 2010-2014 
 
Figure 6. Device utilization rates in the three ICUs from 2010-2014 compared to NHSN national utilization 
rates pooled mean 
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Table 6  
Correlation between Device Utilization and Device Infection Rate across the ICUs, 2010-2014 
Device 
Associated 
Infection 
Device Infection Rate 
Device Utilization 
Ratio (DUR)* 
Pearson 
correlation 
     p-value 
Mean 
Standard 
Deviation 
Mean 
Standard 
Deviation 
CAUTI 3.58 1.02 0.61 0.11 0.43 0.11 
CLABSI 0.92 0.64 0.62 0.16 0.35 0.21 
VAP 1.75 2.77 0.31 0.06 -0.34 0.21 
Note. *DUR is calculated by number of device days/number of patient days 
Research Question 2 and Hypothesis 
RQ#2:  What is the association between severity of illness, measured by the Acute 
Physiology and Chronic Health Evaluation II (APACHE II) score, and CLABSI, CAUTI, and 
VAP?  
H02: There is no association between severity of illness (APACHE score) and CLABSI, 
CAUTI, and VAP. 
H12: There is an association between severity of illness (APACHE score) and CLABSI, 
CAUTI, and VAP. 
The mean severity of illness score for the patients identified with an HAI was 20.99 (SD 
= 8.71) with possible score of 71 indicating the most severe condition of a patient within 24 
hours of admission within the intensive care unit (Table 7). The mean score for non-HAI patients 
was 20.67 ± 7.88 (Table 7). APACHE II scores among Non-HAI patients were similar across all 
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3 ICU types. Aggregating all three ICUs has led to a statistically insignificant association 
between the APACHE II score of patients who did and did not acquire a device associated 
nosocomial infection (p = 0.494) (Table 7). Disaggregating the ICUs, patients who acquired 
VAP in all three ICUs combined had highest mean APACHE score compared to those who 
acquired CAUTI and CLABSI; however, the difference in mean APACHE scores between the 
three types of device associated infections was not statistically significant (p=0.333) (Table 8).  
Those who were admitted to CVICU had a higher mean score (23.22 ± 8.67) than the patients 
without an HAI (20.51 ± 7.94) (p = 0.004). Similarly, patients in the MSICU with an HAI had a 
higher mean score (23.15 ± 8.72) than the non-HAI patients (20.76 ± 7.92) (p < 0.001) (Table 7). 
In contrast, the HAI APACHE II scores (16.65 ± 7.01) (p < 0.001) were significantly lower than 
the Non-HAI APACHE II scores (20.58 ± 7.74) among NSICU patients (Table 7). As such, there 
were unit-level statistical significant associations (pCVICU = 0.004, pMSICU < 0.001, and pNSICU 
<0.001), revealing that the aggregation has masked significant differences. 
There were statistically significant differences in mean APACHE scores between the 
units for each HAI type when analyzing each ICU individually (Table 8). For CAUTI, CVICU 
had a mean score of 23.11 ± 8.53, MSICU had 22.51 ± 8.03, and NSICU had 16.29 ± 7.15 (p < 
0.001). For CLABSI, CVICU had a mean score of 20.54 ± 9.21, MSICU had 24.13 ± 11.17, and 
NSICU had 14.00 ± 3.79 (p = 0.048). For VAP, CVICU had a mean score of 28.54 ± 5.75, 
MSICU had 25.15 ± 6.64, and NSICU had 18.25 ± 7.12 (p < 0.001). For non-device-associated 
infections, the mean APACHE score was 20.67 ± 7.88; however, their distribution among the 
ICUs was statistically similar (p < 0.708). 
Across all infections, there statistically significant differences in the distribution for each 
ICU (Table 8). In the CVICU, the total mean APACHE score for every infection (including non-
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infection) was 20.82 ± 8.07 (p < 0.001). In the MSICU, the total mean score was 20.89 ± 7.99 (p 
= 0.005). In the NSICU, the total mean score was 20.21 ± 7.76 (p < 0.001). Thus, similarly to the 
results of Table 7, the implications are that aggregating the ICUs dilutes significant differences, 
whereas associations exists at the unit level and infection level. 
Table 7  
Comparison of Mean APACHE II Scores Between HAI and Non-HAI Patients Within and Across 
Three ICU Units, 2010-2014 
            Without HAI                     With HAI  
Unit Location N 
Mean 
APACHE  
N 
Mean 
APACHE 
Score ± sd 
P-value 
from t-
test Score ± sd 
Cardiovascular ICU (CVICU) 644 20.51 (±7.94) 82 23.22 ± 8.67  0.004* 
Medical Surgical ICU 
(MSICU) 2200 20.76 (±7.92) 130 23.15 ± 8.72  <0.001* 
Neurosurgical ICU (NSICU) † 1050 20.58 (±7.74) 107 16.65 ± 7.01  <0.001* 
Total 3894 20.67 (±7.88) 319 20.99 (± 8.71)  0.494† 
Note. *Statistically significant at p ≤ 0.05. 
† Significant difference of APACHE II scores based on Bonferroni post-hoc analysis in NSICU (p < 0.001)  
††ANOVA results reveal a significant difference of APACHE II scores between ICU units (p < 0.001). Differences 
in mean scores are statistically significant even when controlling for age and sex (p < 0.001). 
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Table 8  
Severity of Illness of ICU Patients within the Three ICUs which were Measured by the Acute 
Physiology and Chronic Health Evaluation II (APACHE II) Score in 2010-2014 
  Unit    
Type of Device-
associated 
Infections 
CVICU MSICU NSICU 
Total 
P-value 
from 
ANOVA 
Mean 
APACHE 
Std. Deviation 
N 
Mean APACHE 
Std. Deviation 
N 
Mean APACHE 
Std. Deviation 
N 
 
Catheter Associated 
Urinary Tract 
Infection (CAUTI) 
23.11 22.51 16.29 20.45 <0.001* 
 8.53 8.03 7.15 8.40  
 45 87 72 204  
Central Line 
Associated 
Bloodstream 
Infection (CLABSI) 
20.54 24.13 14.00 21.56 0.048* 
 9.21 11.17 3.79 10.23  
 24 30 7 61  
      
Ventilator 
Associated 
Pneumonia (VAP) 
28.54 25.15 18.25 22.39 <0.001* 
 5.75 6.64 7.12 7.97  
 13 13 28 54  
      
No Device-
associated 
Infections 
20.51 20.76 20.58 20.67 0.708 
 7.94 7.93 7.74 7.88  
 645 2,201 1,050 3,894  
      
Total 20.82 20.89 20.21 20.69  
 8.07 7.99 7.76 7.94  
 727 2,331 1,157 4,213  
p-value from 
ANOVA 
<0.001* 0.005* <0.001*  0.333† 
Note. *Statistically significant at p ≤ 0.05. 
†ANOVA has revealed further insignificant difference in mean APACHE score across the ICUs when controlling for 
age and sex (p = 0.262). NSICU have HAI patients with significantly lower APACHE II scores.   
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For individuals without risk factors (i.e. those without obesity, smoking habits, and 
diabetes) in each of the ICUs, an ANOVA reveals statistically significant differences in mean 
APACHE II scores between those without an HAI and those with an HAI for some subgroups of 
the sample as shown in Table 9. In the CVICU, the mean APACHE II score for male patients 
without an HAI is 19.80 ± 6.14, while male patients with an HAI have a mean score of 24.82 ± 
6.98; and the difference in the means is statistically significant (p = 0.013). Additionally, the 
differences in the mean scores for those aged 60 and over are statistically significant (p = 0.002): 
the mean score of non-HAI patients aged at least 60 years is 19.41 ± 6.46 and the mean score for 
those with HAI for the same age group is 26.78 ± 6.14. The mean APACHE II score for 
Caucasian patients without an HAI is 19.36 ± 6.15, while Caucasian patients with an HAI have a 
mean APACHE II score of 25.80 ± 6.86. The differences in the mean APACHE scores are 
statistically significant (p = 0.002).  
In the MSICU, female patients with an HAI (21.97 ± 8.62) have a statistically higher 
mean score than female patients without an HAI (19.96 ± 6.03) at p = 0.093. There is no 
statistically significant differences in mean APACHE score between male patients with and 
without an HAI in the MSICU (21.67 ± 3.79 vs. 20.03 ± 6.04, p = 0.640). As with CVICU 
Caucasian patients, there is a statistically significant difference in MSICU Caucasian patients 
with an HAI (21.67 ± 8.03) and without an HAI (19.97 ± 5.87) with p = 0.035.  
Finally, for the NSICU, female patients without an HAI have a higher mean APACHE II 
score (18.76 ± 5.63) than female patients with an HAI (14.04 ± 8.48) at p ≤ 0.001. With respect 
to age groups in the NSICU, there are statistically significant differences in mean APACHE II 
scores for those aged 18-29 (18.25 ± 6.38 without HAI vs. 14.04 ± 8.48 with HAI, p = 0.003) 
and those aged 50-59 (19.28 ± 5.57 without HAI vs. 12.91 ± 6.85 with HAI, p = 0.001). African 
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American NSICU patients are also found to have statistically significant different mean 
APACHE II scores (19.49 ± 4.98 without HAI vs. 10.40 ± 8.17 with HAI) at p = 0.001, as well 
as Hispanic/Latino patients (18.88 ± 5.45 without HAI vs. 10.00 ± 5.20 with HAI) at the same p-
value of 0.001. Overall, the severity of illness for HAI patients entering into the neurosurgical 
ICU were lower, possibly due to the patient population comorbidities which were not as high as 
patients entering into the CVICU or MSICU. 
In turn, patients without any risk factors were likely more at risk of contracting an HAI in 
CVICU and MSICU, but not at NSICU, which may be due to unobserved factors in the NSICU 
that is unaccounted in the data such as quality of care and medical history of the patient. CVICU 
and MSICU had HAI patients with significantly higher APACHE scores, as compared to the 
significantly lower APACHE scores for NSICU. Due to their more severe comorbidities, patients 
admitted to either MSICU or CVICU have a higher severity of illness. Neurological patients 
have lower mortality rates and are apt to have better outcomes than other types of ICUs due to 
their lower number of comorbidities as demonstrated by their lower APACHE II scores (Kurtz et 
al., 2011) (Table 7).   
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Table 9  
 
Severity of Illness as Measured by APACHE II across the ICUs, 2010-2014 by 
Demographics (without Risk Factors) 
          
Unit 
Mean APACHE 
Score (SD)  
No HAI 
Mean APACHE Score 
(SD) 
with HAI  
N** P-value (ANOVA) 
CVICU     
Gender     
Female 18.87 (5.85) 22.67 (3.21) 79 0.357 
Male 19.80 (6.14) 24.82 (6.98) 108 0.013 
Age Group     
18-29 18.42 (3.82) - 12 - 
30-39 20.70 (3.56) 17.00 (2.83) 12 0.802 
40-49 19.77 (6.49) 22.00 (0.00) 27 0.739 
50-59 19.08 (5.87) 22.00 (5.66) 41 0.496 
≥60 19.41 (6.46) 26.78 (6.14) 95 0.002* 
Ethnicity/Race     
Caucasian 19.36 (6.15) 25.80 (6.86) 114 0.002* 
African American 19.85 (6.17) 18.50 (0.71) 49 0.761 
Hispanic or Latino 18.73 (5.11) 22.00 (0.00) 23 0.538 
Other 
16.00 (0.00) 24.00 (0.00) 2 - 
MSICU     
Gender     
Female 19.96 (6.03) 21.97 (8.62) 323 0.093 
Male 20.03 (6.04) 21.67 (3.79) 359 0.640 
Age Group     
18-29 20.45 (6.85) 23.75 (4.03) 35 0.357 
30-39 20.08 (6.18) 20.50 (16.26) 50 0.0931 
40-49 20.03 (5.92) 20.75 (10.75) 67 0.824 
50-59 19.76 (5.60) 21.50 (8.40) 137 0.410 
≥60 20.02 (6.14) 22.19 (8.49) 393 0.175 
Ethnicity/Race     
Caucasian 19.97 (5.87) 21.67 (8.03) 391 0.035* 
African American 20.12 (6.30) 18.00 (9.51) 186 0.427 
Hispanic or Latino 19.80 (6.35) 25.25 (7.89) 95 0.099 
Other 
19.00 (6.02) 27.33 (7.23) 11 0.083 
 
NSICU 
    
Gender     
Female 18.76 (5.63) 14.04 (8.48) 157 ≤0.001* 
Male 19.13 (6.06) 16.91 (4.70) 145 0.238 
Age Group     
18-29 18.25 (6.38) 5.67 (3.06) 27 0.003* 
30-39 19.80 (4.97) 17.33 (5.51) 23 0.437 
40-49 19.68 (5.88) 15.86 (11.04) 41 0.192 
50-59 19.28 (5.57) 12.91 (6.85) 80 0.001* 
≥60 18.54 (6.04) 18.27 (4.56) 131 0.886 
Ethnicity/Race     
Caucasian 18.83 (6.10) 17.23 (7.13) 218 0.253 
African American 19.49 (4.98) 10.40 (8.17) 50 0.001* 
Hispanic or Latino 18.88 (5.45) 10.00 (5.20) 32 0.001* 
Other 19.00 (0.00) 22.00 (0.00) 2 - 
Note. *Statistically significant at p ≤ 0.05. 
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, 
HAI patients, or both 
**N represents the Total for both HAI and Non-HAI patients for each unit. 
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For patients with diabetes only (i.e. those with diabetes but do not have obesity nor 
smoking habits), an ANOVA has revealed statistically significant differences in mean APACHE 
II scores for only two groups: African American patients in the CVICU and MSICU patients 
aged 50-59 in Table 10. African American CVICU patients without an HAI have a mean 
APACHE II score of 28.92 ± 3.25 in comparison to those with an HAI of mean APACHE II 
score of 15.00 (p = 0.001), while MSICU patients aged 50-59 without an HAI possess a mean 
APACHE II score of 23.61 ± 7.75 in relation to those with an HAI having a mean score of 6.00 
(p = 0.032).  Low sample sizes for patients with only diabetes may have contributed to statistical 
insignificance in many of the subpopulations for each ICU.  
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Table 10  
Severity of Illness as Measured by APACHE II across the ICUs, 2010-2014 by Demographics 
(Patients with only Diabetes) 
     
Unit 
Mean APACHE Score 
(SD)  
No HAI 
Mean APACHE Score 
(SD) 
with HAI  
N 
P-value 
(ANOVA) 
CVICU     
Gender     
Female 25.50 (8.22) 16.00 (0.00) 17 0.290 
Male 23.19 (9.83) 22.00 (9.90) 39 0.869 
Age Group     
18-29 11.67 (9.81) - 3 - 
30-39 28.00 (6.24) - 3 - 
40-49 20.33 (12.50) 29.00 (0.00) 4 0.609 
50-59 26.10 (11.00) - 10 - 
>60 24.26 (8.33) 15.50 (0.71) 36 0.151 
Ethnicity/Race     
Caucasian 21.61 (9.87) 16.00 (0.00) 32 0.580 
African American 28.92 (3.25) 15.00 (0.00) 14 0.001* 
Hispanic or Latino 24.44 (11.22) 29.00 (0.00) 10 0.710 
Other - - - - 
MSICU     
Gender     
Female 25.56 (7.74) 23.58 (8.13) 59 0.426 
Male 23.27 (9.35) 31.33 (2.52) 81 0.142 
Age Group     
18-29 24.33 (9.07) 26.00 (0.00) 8 0.814 
30-39 24.00 (12.03) 35.00 (0.00) 12 0.402 
40-49 23.46 (11.11) - 13 - 
50-59 23.61 (7.75) 6.00 (0.00) 34 0.032* 
>60 24.72 (8.34) 25.82 (6.43) 85 0.676 
Ethnicity/Race     
Caucasian 23.85 (9.16) 22.00 (8.91) 82 0.588 
African American 25.34 (7.98) 28.80 (6.06) 52 0.353 
Hispanic or Latino 22.93 (9.38) 28.50 (3.54) 17 0.430 
Other 23.00 (0.00) - 1 - 
NSICU     
Gender     
Female 24.11 (9.02) 12.00 (7.07) 46 0.352 
Male 25.00 (8.00) - 31 - 
Age Group     
18-29 21.25 (12.69) - 4 - 
30-39 25.13 (9.00) - 8 - 
40-49 24.40 (7.88) - 10 - 
50-59 25.17 (9.49) - 12 - 
>60 24.49 (8.34) 18.00 (7.07) 43 0.288 
Ethnicity/Race     
Caucasian 23.65 (8.82) 13.00 (0.00) 55 0.237 
African American 27.50 (6.94) 23.00 (0.00) 15 0.542 
Hispanic or Latino 24.86 (9.28) - 7 - 
Other - - - - 
Note. The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI 
patients, HAI patients, or both.  
  **N represents the Total for both HAI and Non-HAI patients for this specific Unit. 
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For people with smoking habits only (i.e. those with smoking habits but do not have 
obesity nor diabetes), an ANOVA reveals statistically significant differences in mean APACHE 
scores between those who have and do not have an HAI for some groups in each of the ICUs in 
Table 11. In the CVICU, male patients without an HAI were found to have a lower mean 
APACHE II score (20.43 ± 8.52) than male patients with an HAI (26.78 ± 7.40), being 
statistically different at p = 0.033. In contrast, the mean scores between female CVICU patients 
with and without an HAI do not have a statistically significant association (p = 0.622).  In the 
MSICU, patients aged 50-59 have a statistically significant difference in mean APACHE II 
scores between those without and with an HAI (20.49 ± 7.78 vs. 30.67 ± 14.57) respectively at p 
= 0.032. In the NSICU, patients aged 40-49 without an HAI have a higher mean APACHE II 
score (19.91 ± 6.60) than those with an HAI (13.29 ± 3.40), being statistically significant at p = 
0.014. Caucasian NSICU patients have a statistically significant difference in mean APACHE II 
scores between those without and with an HAI (20.84 ± 7.56 vs. 17.94 ± 7.94) respectively at p = 
0.047. Thus, patients with only smoking habits (i.e. no other risk factors) were likely more at risk 
of contracting an HAI in CVICU and MSICU, but not at NSICU, which may be due to 
unobserved factors in the NSICU that are unaccounted for in the data such as quality of care and 
medical history of the patient.  
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Table 11  
  
Severity of Illness as Measured by APACHE II across the ICUs, 2010-2014 by 
Demographics (Only Patients with Smoking Habits) 
     
Unit 
Mean APACHE Score 
(SD)  
No HAI 
Mean APACHE Score 
(SD) 
with HAI  
N** 
P-value 
(ANOVA) 
CVICU     
Gender     
Female 19.53 (6.21) 20.67 (7.14) 60 0.622 
Male 20.43 (8.52) 26.78 (7.40) 111 0.033* 
Age Group     
18-29 18.20 (6.01) - 10 - 
30-39 17.33 (5.91) 22.00 (0.00) 13 0.464 
40-49 19.68 (9.17) - - - 
50-59 17.85 (7.00) 20.33 (9.45) 36 0.569 
≥60 21.95 (7.90) 24.57 (7.78) 90 0.255 
Ethnicity/Race     
Caucasian 20.95 (7.84) 22.64 (7.61) 91 0.457 
African American 19.02 (7.12) 21.00 (4.24) 52 0.670 
Hispanic or Latino 19.71 (9.19) - - - 
Other 21.50 (7.78) 34.00 (0.00) 4 0.151 
MSICU     
Gender     
Female 20.55 (7.89) 20.00 (4.58) 230 0.878 
Male 20.20 (7.90) 23.27 (9.16) 302 0.147 
Age Group     
18-29 18.93 (7.45) 20.00 (0.00) 30 0.889 
30-39 19.37 (7.07) - - - 
40-49 19.11 (6.79) - - - 
50-59 20.49 (7.78) 30.67 (14.57) 95 0.032* 
≥60 20.81 (8.24) 21.06 (6.51) 312 0.906 
Ethnicity/Race     
Caucasian 20.82 (7.97) 22.62 (9.00) 313 0.431 
African American 19.51 (7.73) 24.50 (4.32) 140 0.119 
Hispanic or Latino 20.32 (7.93) 8.00 (0.00) 74 0.127 
Other 15.20 (2.05) - - - 
NSICU     
Gender     
Female 20.70 (8.00) 17.57 (6.61) 169 0.089 
Male 21.29 (7.62) 18.19 (8.26) 151 0.129 
Age Group     
18-29 19.55 (5.86) 20.00 (2.83) 22 0.917 
30-39 22.24 (8.38) 13.00 (8.49) 27 0.146 
40-49 19.91 (6.60) 13.29 (3.40) 41 0.014* 
50-59 21.10 (7.81) 17.45 (7.63) 83 0.152 
≥60 21.17 (8.28) 20.60 (7.81) 147 0.798 
Ethnicity/Race     
Caucasian 20.84 (7.56) 17.94 (7.64) 237 0.047* 
African American 22.31 (8.45) 17.00 (1.41) 51 0.384 
Hispanic or Latino 19.56 (8.58) 16.33 (8.14) 30 0.541 
Other 23.00 (0.00) 21.00 (0.00) 2 - 
Note. *Statistically significant at p ≤ 0.05. 
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, HAI patients, 
or both 
  **N represents the Total for both HAI and Non-HAI patients 
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For individuals with obesity only (i.e. those with obesity but do not have smoking habits 
nor diabetes) (Table 12), an ANOVA has revealed statistical significance in mean APACHE II 
scores for NSICU male patients: 24.31 ± 9.92 for male patients without an HAI and 12.83 ± 3.19 
for male patients with an HAI (p = 0.007). Because many other demographic groups in each ICU 
did not have statistically significant associations with contracting an HAI, obesity by itself may 
act as a weak confounding factor. 
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Table 12 
 
Severity of Illness as Measured by APACHE II across the ICUs, 2010-2014 by 
Demographics (Patients with only Obesity) 
     
Unit 
Mean APACHE 
Score (SD)  
No HAI 
Mean APACHE 
Score (SD) 
with HAI  
N** 
P-value 
(ANOVA) 
CVICU     
Gender     
Female 22.36 (8.60) 15.75 (10.75) 32 0.172 
Male 23.74 (10.07) 20.50 (12.02) 36 0.664 
Age Group     
18-29 26.00 (4.24) - 2 - 
30-39 22.71 (6.97 - 7 - 
40-49 21.50 (7.73) 13.75 (10.44) 16 0.132 
50-59 24.00 (12.11) - 16 - 
≥60 23.20 (9.45) 24.50 (6.36) 27 0.851 
Ethnicity/Race     
Caucasian 23.00 (10.37) 18.40 (11.04) 38 0.365 
African American 23.75 (8.70) 12.00 (0.00) 21 0.203 
Hispanic or Latino 22.11 (7.69) - 9 - 
Other - - 0 - 
MSICU     
Gender     
Female 24.02 (9.40) 24.89 (11.71) 130 0.792 
Male 24.41 (10.12) 27.17 (9.70) 134 0.516 
Age Group     
18-29 24.18 (10.11) 27.00 (4.24) 19 0.707 
30-39 22.11 (9.32) 26.00 (11.31) 20 0.587 
40-49 27.52 (8.38) 30.67 (6.66) 36 0.533 
50-59 24.29 (9.81) 20.33 (18.82) 48 0.523 
≥60 23.68 (10.02) 25.60 (10.95) 141 0.676 
Ethnicity/Race     
Caucasian 23.29 (9.32) 26.60 (11.42) 143 0.288 
African American 24.17 (10.15) 22.33 (13.20) 78 0.761 
Hispanic or Latino 27.57 (10.55) 27.00 (4.24) 37 0.940 
Other 26.00 (6.93) - 6 - 
NSICU     
Gender     
Female 22.56 (9.55) 20.00 (7.37) 78 0.467 
Male 24.31 (9.92) 12.83 (3.19) 54 0.007* 
Age Group     
18-29 19.43 (10.98) - 7 - 
30-39 22.31 (11.40) 17.00 (8.45) 17 0.407 
40-49 24.67 (11.20) 19.00 (7.94) 12 0.443 
50-59 23.38 (9.78) 10.00 (1.41) 28 0.069 
≥60 23.65 (9.14) 18.40 (6.02) 68 0.213 
Ethnicity/Race     
Caucasian 23.06 (9.54) 19.38 (7.71) 101 0.290 
African American 24.88 (11.79) 15.25 (3.86) 21 0.129 
Hispanic or Latino 22.25 (7.09) 10.50 (2.12) 10 0.057 
Other - - 0 - 
Note. *Statistically significant at p ≤ 0.05. 
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, 
HAI patients, or both 
**N represents the Total for both HAI and Non-HAI patients for this specific unit 
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For patients with both smoking habits and diabetes but do not have obesity (Table 13), 
only two groups are found to have statistically significant differences in mean APACHE II 
scores between those with and without an HAI: male MSICU patients (30.75 ± 11.15 with HAI 
vs. 19.71 ± 8.68 without HAI, p = 0.015) and Caucasian MSICU patients (28.71 ± 8. 71 with 
HAI vs. 18.97 ± 8.62 without HAI, p = 0.005). Because of the inconsistency in statistical 
significance across the ICUs for each of the demographic groups, there may exist unobserved 
aspects of the individual ICUs for which are not accounted in the data that could aid in 
explaining differences in statistical significance. Nonetheless, for what is provided, there is a 
noticeable indication that patients who both have diabetes and smoking habits (but do not have 
obesity) may be at more risk of contracting an HAI. 
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Table 13  
 
Severity of Illness as Measured by APACHE II by ICU Type, 2010-2014 by Demographics (Patients 
with both Smoking Habits and Diabetes) 
 
Unit 
Mean APACHE Score (SD)  
No HAI 
Mean APACHE Score (SD) 
with HAI  
N** 
P-value 
(ANOVA) 
CVICU     
Gender     
Female 20.00 (7.53) 23.75 (4.99) 27 0.350 
Male 20.32 (9.22) 19.13 (9.42) 42 0.743 
Age Group     
18-29 22.17 (9.22) - 6 - 
30-39 22.00 (8.49) 17.00 (0.00) 3 0.715 
40-49 19.00 (12.12) 28.00 (0.00) 4 0.586 
50-59 19.46 (7.42) 13.00 (0.00) 14 0.418 
≥60 20.12 (8.94) 21.11 (8.84) 42 0.770 
Ethnicity/Race     
Caucasian 20.97 (9.15) 21.67 (9.12) 42 0.840 
African American 20.00 (8.30) 13.00 (0.00) 16 0.428 
Hispanic or Latino 18.38 (6.50) 17.00 (0.00) 9 0.848 
Other 12.00 (0.00) 23.00 (0.00) 2 - 
MSICU     
Gender     
Female 20.00 (9.07) 24.00 (6.04) 81 0.335 
Male 19.71 (8.68) 30.75 (11.15) 118 0.015* 
Age Group     
18-29 21.56 (8.46) - 18 - 
30-39 17.82 (8.17) - 11 - 
40-49 17.82 (8.09) - 22 - 
50-59 19.00 (7.68) 32.00 (0.00) 40 0.103 
≥60 20.50 (9.50) 26.38 (9.20) 108 0.095 
Ethnicity/Race     
Caucasian 18.97 (8.62) 28.71 (8.71) 97 0.005* 
African American 21.69 (8.93) 21.00 (8.49) 64 0.914 
Hispanic or Latino 18.29 (8.72) - 35 - 
Other 25.00 (9.54) - 3 - 
NSICU     
Gender     
Female 19.31 (7.79) 18.00 (8.49) 54 0.817 
Male 21.17 (7.71) 16.60 (3.21) 53 0.198 
Age Group     
18-29 17.50 (13.44) - 2 - 
30-39 20.83 (8.30) 12.00 (0.00) 7 0.370 
40-49 20.74 (8.03) - 19 - 
50-59 22.48 (8.47) 17.67 (6.03) 24 0.357 
≥60 19.12 (7.22) 18.00 (2.65) 55 0.793 
Ethnicity/Race     
Caucasian 20.41 (7.78) 15.80 (3.83) 73 0.195 
African American 17.63 (6.61) 16.00 (0.00) 17 0.815 
Hispanic or Latino 21.88 (8.59) - 16 - 
Other 24.00 (0.00) - 1 - 
Note. *Statistically significant at p ≤ 0.05. 
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, HAI patients, or 
both. 
**N represents the Total for both HAI and Non-HAI patients for this specific unit. 
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For people with both obesity and diabetes but do not have smoking habits (Table 14), an 
ANOVA shows that there exists statistical significant differences in mean APACHE II scores in 
CVICU and MSICU patients. In the CVICU, patients aged 50-59 without an HAI have a lower 
mean score (18.10 ± 3.81) than those with an HAI (28.50 ± 12.02), being statistically significant 
at p = 0.028. African American CVICU patients have a higher mean APACHE II score (37.00) 
than the same patients without an HAI (19.30 ± 5.60), being statistically significant at p = 0.015. 
In the MSICU, patients aged 50-59 have a higher mean APACHE II score (36.00) than the same 
patients without an HAI (20.70 ± 6.46), being statistically significant at p = 0.030. 
Hispanic/Latino MSICU patients with an HAI possess a higher mean score of 36.00 than those 
without an HAI (18.79 ± 3.08) (p < 0.001). Although low sample sizes for patients with an HAI 
in each of the ICUs are a major possible factor in producing statistically insignificance for many 
of the subpopulation groups, statistical significance in the two ICUs may indicate that the 
interaction of obesity and diabetes may subject patients to be more at risk of contracting an HAI.  
Prior research has found that patients with obesity and diabetes are more vulnerable to HAIs 
(Masud & Vykoukal, 2011).   
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Table 14  
 
Severity of Illness as Measured by APACHE II by ICU Type, 2010-2014 by Demographics 
(Patients with both Obesity and Diabetes) 
 
Unit 
Mean APACHE Score (SD)  
No HAI 
Mean APACHE Score (SD) 
with HAI  
N** 
P-value 
(ANOVA) 
CVICU     
Gender     
Female 20.40 (7.41) 27.83 (10.07) 21 0.076 
Male 22.31 (6.68) 25.50 (10.61) 28 0.532 
Age Group .    
18-29 22.00 (8.29) - 4 - 
30-39 26.33 (11.55) - 3 - 
40-49 20.00 (0.00) - 1 - 
50-59 18.10 (3.81) 28.50 (12.02) 12 0.028* 
≥60 22.52 (7.08) 26.83 (9.79) 29 0.230 
Ethnicity/Race     
Caucasian 22.38 (7.10) 24.00 (8.65) 30 0.634 
African American 19.30 (5.60) 37.00 (0.00) 11 0.015* 
Hispanic or Latino 24.20 (8.70) 37.00 (0.00) 6 0.250 
Other 17.50 (6.36) - 2 - 
MSICU     
Gender     
Female 20.66 (5.59) 21.29 (9.62) 71 0.795 
Male 21.40 (6.26) 22.00 (0.00) 74 0.924 
Age Group     
18-29 23.14 (6.89) - 7 - 
30-39 16.60 (4.93) 26.00 (0.00) 6 0.157 
40-49 23.08 (6.17) - 13 - 
50-59 20.70 (6.46) 36.00 (0.00) 24 0.030* 
≥60 20.93 (5.70) 18.17 (7.19) 95 0.261 
Ethnicity/Race     
Caucasian 21.77 (6.51) 22.00 (4.00) 89 0.951 
African American 20.57 (5.48) 17.25 (8.96) 34 0.300 
Hispanic or Latino 18.79 (3.08) 36.00 (0.00) 20 <0.001* 
Other 19.00 (1.41) - 2 - 
NSICU     
Gender     
Female 20.63 (6.17) 20.00 (0.00) 31 0.920 
Male 20.73 (6.52) - 30 - 
Age Group     
18-29 27.50 (7.78) - 2 - 
30-39 19.25 (9.46) - 4 - 
40-49 19.69 (4.59) 20.00 (0.00) 14 0.950 
50-59 22.67 (7.09) - 15 - 
≥60 19.73 (5.85) - 26 - 
Ethnicity/Race     
Caucasian 20.32 (6.04) - 41 - 
African American 21.80 (6.86) 20.00 (0.00) 11 0.808 
Hispanic or Latino 20.57 (6.16) - 7 - 
Other 23.00 (14.14) - 2 - 
Note. *Statistically significant at p ≤ 0.05. 
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, HAI patients, or 
both. 
  **N represents the Total for both HAI and Non-HAI patients for this specific unit. 
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For individuals with both obesity and smoking habits (i.e. those who do not have 
diabetes) (Table 15), the results of an ANOVA have shown statistical significant differences in 
mean APACHE II scores only for three groups, all within the CVICU: male patients, patients 
aged 40-49, and African American patients. Male CVICU patients with an HAI have a higher 
mean APACHE II score (29.20 ± 11.80) than those without an HAI (17.48 ± 7.64), with the 
difference being statistically different at p = 0.003. CVICU patients aged 40-49 with an HAI also 
have a higher mean score (27.75 ± 11.00) than those without an HAI (15.56 ± 6.04) at p = 0.023 
(Table 16). Finally, African American CVICU patients with an HAI possess a greater mean score 
of 39.00 than those without an HAI at 18.94 ± 8.65 (p = 0.038). As a result, CVICU patients with 
both obesity and smoking habits may be at more risk of contracting an HAI. According to 
Karlsson & Beck, (2010), obesity can cause impairment of the immune system which can affect 
pulmonary functions making patients more susceptible to infections.   
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Table 15  
 
Severity of Illness as Measured by APACHE II by ICU Type, 2010-2014 by Demographics 
(Patients with both Obesity and Smoking Habits) 
 
Unit 
Mean APACHE Score (SD)  
No HAI 
Mean APACHE Score (SD) 
with HAI  
N** 
P-value 
(ANOVA) 
CVICU     
Gender     
Female 21.20 (7.28) 21.13 (10.63) 38 0.981 
Male 17.48 (7.64) 29.20 (11.80) 51 0.003* 
Age Group     
18-29 23.40 (10.16) - 5 - 
30-39 22.50 (9.59) 9.50 (0.71) 8 0.119 
40-49 15.56 (6.04) 27.75 (11.00) 13 0.023* 
50-59 17.46 (6.86) 25.33 (10.41) 16 0.122 
≥60 19.09 (7.53) 27.25 (12.18) 47 0.055 
Ethnicity/Race     
Caucasian 19.45 (7.31) 22.43 (12.41) 56 0.363 
African American 18.94 (8.65) 39.00 (0.00) 19 0.038* 
Hispanic or Latino 16.13 (8.43) 21.25 (9.18) 12 0.357 
Other 17.00 (0.00) 34.00 (0.00) 2 - 
MSICU     
Gender     
Female 18.50 (6.94) 20.33 (8.48) 124 0.533 
Male 18.68 (7.72) 20.33 (7.65) 129 0.537 
Age Group     
18-29 21.00 (6.59) - 19 - 
30-39 20.54 (7.77) - 13 - 
40-49 22.22 (7.20) 26.50 (6.36) 29 0.423 
50-59 16.77 (7.13) 17.00 (9.56) 64 0.951 
≥60 18.09 (7.21) 20.44 (7.00) 128 0.346 
Ethnicity/Race     
Caucasian 18.55 (7.39) 19.27 (8.57) 120 0.761 
African American 18.71 (7.72) 23.67 (4.73) 90 0.274 
Hispanic or Latino 18.45 (6.58) 22.00 (0.00) 41 0.597 
Other 18.50 (4.95) - 2 - 
NSICU     
Gender     
Female 18.13 (7.15) 21.40 (4.39) 58 0.322 
Male 19.00 (7.47) 14.00 (2.83) 58 0.353 
Age Group     
18-29 18.33 (8.71) - 6 - 
30-39 17.14 (7.99) 12.00 (0.00) 8 0.569 
40-49 16.50 (5.81) - 14 - 
50-59 19.89 (7.09) 20.00 (3.56) 32 0.977 
≥60 18.65 (7.61) 21.50 (7.78) 56 0.605 
 
Ethnicity/Race 
    
Caucasian 18.65 (7.50) 20.25 (3.10) 82 0.674 
African American 19.74 (7.61) 15.00 (0.00) 20 0.552 
Hispanic or Latino 16.25 (5.08) 19.50 (10.61) 14 0.474 
Other - - 0 - 
Note. *Statistically significant at p ≤ 0.05. 
The dash symbol (-) marks unproduced p-values due to low sample sizes of either the non-HAI patients, HAI 
patients, or both. 
  **N represents the Total for both HAI and Non-HAI patients for this specific unit. 
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To summarize, the possible confounders are smoking habits (Table 11, 13, and 15), 
obesity (Table 12, 14, and 15), and an interaction of one of the previous two risk factors with 
diabetes (Table 13, 14). Diabetes seems to only confound the relationships when patients also 
have smoking habits or obesity (Tables 13, 14). Diabetes is one of the largest emerging threats to 
health care due to the associated reduced response of T cells, neutrophil function and lack of 
humoral immunity which causes increased susceptibility to infections (Casqueiro, Casqueiro & 
Alves, 2012). Notably in this study, diabetes by itself has shown to be protective against 
contracting an HAI for African American CVICU and MSICU patients aged 50-59 (Table 10). 
The implications are that smoking habits and obesity may subject patients to be more at risk of 
contracting an HAI (Tables 11-15), while diabetes can produce the same effect only if the patient 
also possesses another risk factor (Tables 13-15). Risk factors such as diabetes, obesity and 
smoking are predisposing factors which may lead to a decreased host defense (Masud & 
Vykoukal, 2011).   
Research Question 3 and Hypothesis 
RQ#3: What is the association between age, gender, race, ethnicity and HAI status in 
three different adult ICUs within an academic medical facility? 
H03: There is no association between age, gender, race and ethnicity from the device 
associated HAIs identified in the three different adult ICUs within an academic medical facility? 
H13: There is an association between age, gender, race and ethnicity from the device 
associated HAIs identified in the three different adult ICUs within an academic medical facility? 
The data analysis for this research question was comprised of the entire population who 
entered into any of the three ICUs during 2010-2014. The total population was looked at to 
ascertain population diversity. The data analysis for this research question narrowed down the 
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involved specific demographics which were abstracted to determine particular associations in 
obtaining an HAI from one of three adult ICUs within an academic medical center. The mean 
age for the 319 patients who had HAI status was 59.2 (SD=16.2), while those without an HAI 
had a mean age of 58.5 (SD=14.4, n = 3,896). The mean age differences were not statistically 
significant p = 0.4508 by t-test. Most patients who acquired infections were in the ≥60 age group 
(n=172) (Table 17). Majority of the infections were CAUTI with 204 infections of the 319 
infections. More females had CAUTI; however, more males had CLABSI (Table 18). There was 
statistical significance found between those with no infections and those with infections within 
race and ethnicity in CVICU (X2=18.2, df=3, p<0.001) (Table 16). In MSICU, it was found that 
there was a statistical significance between those who acquired an HAI and those who did not in 
males and females (X2=14.8, df=1, p<0.001) (Table 16).  
The relationships between risk factors and patients contracting an HAI, CVICU patients 
who smoke tend to contract an HAI (p = 0.023), with most having CAUTI than other HAIs 
(Table 21). Across the ICUs, correlation was statistically significant association between 
smoking habits and whether the patient has HAI in the CVICU (p = 0.023), while diabetes was 
associated with HAI in the MSICU (p = 0.009), being weakly positive (r = 0.054) and the 
correlation is weakly negative at -0.087 and statistically significant at p = 0.003 in the NSICU 
(Table 21). Aggregating all the ICUs does not show statistically significant associations (pdiabetes 
= 0.594, pobesity = 0.223, psmoking = 0.191) (Table 22). 
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Table 16  
Demographic and Risk Factors of Patients with No HAI and with HAI in Three Adult ICUs 
Demographic 
and Risk 
Factors 
CVICU†† MSICU†* NSICU*** 
No HAI HAI No HAI HAI No HAI HAI 
       
Sex -- n (%)†*       
Male 392 (60.9) 45 (54.9) 1210 (55.0) 49 (37.7) 499 (47.5) 41 (38.3) 
Female 252 (39.1) 37 (45.1) 990 (45.0) 81 (62.3) 551 (52.5) 66 (61.7) 
       
Age -- n (%)       
18-29 43 (6.7) 0 (0.0) 134 (6.1) 9 (6.9) 67 (6.4) 5 (4.7) 
30-39 45 (7.0) 6 (7.3) 151 (6.9) 6 (4.6) 86 (8.2) 11 (10.3) 
40-49 77 (12.0) 11 (13.4) 234 (10.6) 9 (6.9) 137 (13.1) 19 (17.8) 
50-59 142 (22.1) 14 (17.1) 442 (20.1) 25 (19.2) 253 (24.1) 32 (29.9) 
≥60 
337 
(52.43) 
51 (62.2) 1239 (56.3) 81 (62.3) 507 (48.3) 40 (37.4) 
       
Race/Ethnicity 
-- n (%)†† 
      
African 
American 
182 (28.3) 12 (14.6) 640 (29.1) 36 (27.7) 179 (17.1) 17 (15.9) 
Caucasian 365 (56.7) 56 (68.3) 1209 (55.0) 80 (61.5) 763 (72.7) 73 (68.2) 
Hispanic or 
Latino 
90 (14.0) 9 (11.0) 325 (14.7) 11 (8.5) 102 (9.7) 14 (13.1) 
Other† 7 (1.1) 5 (6.1) 27 (1.2) 3 (2.3) 6 (0.6) 3 (2.8) 
       
Risk Factors       
Obesity 208 (85.6) 35 (14.4) 713 (93.2) 52 (6.8) 325 (92.6) 26 (7.4) 
Diabetes 180 (85.3) 31 (14.7) 553 (92.3) 46 (7.7) 273 (95.1) 14 (4.9) 
Smoking 315 (86.1) 51 (13.9) 1029 (94.7) 58 (5.3) 530 (90.6) 55 (9.4) 
       
Note. † Other category included American Indian/Alaska Native, Asian, and Native Hawaiian or Other Pacific 
Islander  
†† There was statistical significance found between those with no infections and those with infections within race and 
ethnicity in CVICU (X 2=18.2, df=3, p<0.001). CVICU HAI vs. No HAI by gender is not statistically significantly 
different.   
†* Statistical significance was also found between those with no infections and those with infections within gender in 
MSICU (X 2=14.8, df=1, p<0.001).  Males had less HAIs than females. 
***NSICU HAI vs. No HAI by gender is not statistically significant.  
**Male aggregated total = 2236 (No HAI = 2101; HAI = 135) 
**Female aggregated total = 1977 (No HAI = 1793; HAI = 184) 
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Table 17   
 
Associations between Age and HAI Type  
 
        Age       
UNIT 
HAI 
Type 
18-29 30-39 40-49 50-59 60+ Total 
CVICU CAUTI        0 3 3 7 32 45 
X 2 = 8.293 CLABSI        0 2 7 4 11 24 
p = 0.217 VAP        0 1 1 3 8 13 
  Total   6 11 14 51 82 
MSICU† CAUTI 6 3 7 12 59 87 
X 2 = 7.382 CLABSI 2 2 1 10 15 30 
p = 0.496 VAP 1 1 1 3 7 13 
  Total 9 6 9 25 81 130 
NSICU CAUTI 5 5 14 23 25 72 
X 2 = 7.466 CLABSI 0 1 2 2 2 7 
p = 0.487 VAP 0 5 3 7 13 28 
  Total 5 11 19 32 40 107 
Note. †Using Stata, Chi-square test shows statistical significance when controlling for sex (MSICU female 
patients: p = 0.023). The categorical age distribution across HAI patients is similar to that of the Non-HAI 
patients, there is a gradient such that with each increase in age category there was an observed increase in 
the proportion of patients within that category. HAIs increase as age increases.   
Across the ICUs in Table 17, none of the associations between age and HAI type are 
statistically significant: the test for CVICU has a p-value of 0.217 (X 2 = 8.293, n = 82), MSICU 
has p = 0.496 (X 2 = 7.382, n = 130), and NSICU has p = 0.487 (X 2 = 7.466, n = 107). Across the 
ICUs, older patients (50-59 and 60+) with an HAI outnumbered all other age groups in every 
type of HAI except in the CVICU for patients with CLABSI, in which the number of those aged 
40-49 (7) were greater than the number of those aged 50-59 (4). Notably for MSICU patients, 
controlling for sex results were statistically significant (MSICU female patients: p = 0.023), 
indicating that older female patients may be more likely to contract an HAI, especially a CAUTI, 
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than other patients. As such, the sex of the patient may matter more as a confounding factor than 
the age group. 
Table 18 
 Associations between Sex and HAI Type  
                    Sex   
UNIT HAI Type      Male               Female                    Total 
CVICU CLABSI 21 3 24 
X 2 = 19.831 CAUTI 15 30 45 
p <0.001* VAP 9 4 13 
  Total 45 37 82 
MSICU CLABSI 18 12 30 
X 2 = 8.618 CAUTI 26 61 87 
p = 0.013* VAP 5 8 13 
  Total 49 81 130 
NSICU CLABSI 3 4 7 
X 2 = 2.435 CAUTI 24 48 72 
p = 0.296 VAP 14 14 28 
  Total 41 66 107 
 
Comparing the ICUs in Table 18, CVICU and MSICU have shown statistical significance 
(pCVICU <0.0001 and pMSICU = 0.013), while NSICU has not (pNSICU = 0.296). In the CVICU, 
male patients outnumber female patients for CLABSI 7:1, female patients outnumber male 
patients 2:1 for CAUTI, and male patients again outnumber female patients for VAP 9:4. 
Overall, nearly 55% of patients with an HAI were male in the CVICU, with the statistical 
significance suggesting that male patients in the CVICU were more likely to contract an HAI. In 
the MSICU, female patients outnumber male patients for every HAI type except CLABSI: male 
patients outnumber female patients 3:2 for CLABSI, while female patients outnumber male 
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patients 61:26 for CAUTI and 8:5 for VAP. Approximately 58% of patients with any type of 
HAI were female, with the statistical significance implying that female patients in the MSICU 
were more likely to get an HAI. In the NSICU, female patients again outnumber male patients 
for all HAI types except VAP, which they tie: female patients outnumber male patients 4:3 for 
CLABSI and 2:1 in CAUTI, while the number of patients with VAP was the same for both sexes 
(i.e. 1:1). Statistical insignificance suggests that neither sex were more likely to contract an HAI.  
Table 19  
Associations between Ethnicity/Race and HAI Type  
      
  
  
Ethnicity/Race 
UNIT HAI Type Caucasian Hispanic/Latino 
African 
American 
Other Total 
CVICU† CLABSI 17 5 1 1 24 
X 2 = 
9.876 
CAUTI 29 2 10 4 45 
p = 0.130 VAP 10 2 1 0 13 
  Total 56 9 12 5 82 
MSICU CLABSI 21 3 6 0 30 
X 2 = 
7.624 
CAUTI 50 6 29 2 87 
p = 0.267 VAP 9 2 1 1 13 
  Total 80 11 36 3 130 
NSICU†† CLABSI 3 1 3 0 7 
X 2 = 
6.124 
CAUTI 48 10 12 2 72 
p = 0.409 VAP 22 3 2 1 28 
  Total 73 14 17 3 107 
Note. † Chi-square test shows statistically significance when controlling for age and gender (female CVICU 
patients aged 50-59: p = 0.017; female CVICU patients aged 60+: p = 0.019). 
†† Chi-square test shows statistically significance when controlling for age and gender (female NSICU patients aged 
50-59: p = 0.021). 
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Across the ICUs in Table 19, none of the associations between ethnicity/race and HAI 
type are statistically significant: the test for CVICU has a p-value of 0.130 (X 2 = 9.876, sample 
size = 82), MSICU has p = 0.267 (X 2 = 7.624, sample size = 130), and NSICU has p = 0.409 (X 2 
= 6.124, sample size = 107). However, when controlling for age and gender, female CVICU 
aged 50-59 (p = 0.017) and aged 60+ (p = 0.019) were statistically significant across the ethnic 
groups in relation to HAI types. Similarly, female NSICU patients aged 50-59 were found to be 
statistically significant (p = 0.021). In the CVICU, nearly 70% of patients with an HAI were 
Caucasian, while approximately 15% of patients with an HAI were African American—the 
remaining patient populations were Hispanic/Latino and other groups. For each HAI type, the 
number of Caucasians was greater than the number of the African Americans, Hispanic/Latinos, 
and other ethnicities/races. In the MSICU, the percentages were similar: over 60% of patients 
with an HAI were Caucasian, while almost 30% were African American and 10% were 
Hispanic/Latino and other ethnic groups. In the NSICU, close to 70% of patients with HAI were 
Caucasian, 16% were African American, and the rest were Hispanic/Latino and other 
ethnicities/races. Thus, race may not have a strict association with a type of HAI, but it may be 
confounded by age and gender. 
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Table 20 
Associations between Risk Factors and HAI Types 
Risk Factors 
    
       
  
    Diabetes Obesity    Smoking† 
UNIT HAI Type N Y     N Y     N Y   
CVICU CLABSI 17 7 
  
14 10 
  
14 10   
  CAUTI 27 18 
  
25 20 
  
16 29   
  VAP 7 6 
  
8 5 
  
1 12   
    X 2 = 1.239 
 
X 2 = 0.162 
 
     X 2 = 9.412 
p = 0.538 p = 0.922 p = 0.009* 
MSICU CLABSI 19 11 
  
14 16 
  
14 16   
  CAUTI 56 31 
  
57 30 
  
51 36   
  VAP 9 4 
  
7 6 
  
7 6   
       X 2 = 0.145 
 
X 2 = 3.531 
 
X 2 = 1.304 
p = 0.930 p = 0.171 p = 0.521 
NSICU CLABSI 6 1 
  
6 1 
  
3 4   
  CAUTI 62 10 
  
53 19 
  
37 35   
  VAP 25 3 
  
22 6 
  
12 16   
      X 2 = 0.188 
 
     X 2 = 0.678 
 
     X 2 = 0.686 
p = 0.910 p = 0.713 p = 0.710 
Note. * Statistically significant at p ≤ 0.05 
†Smoking is not statistically significant when controlling for age for each ICU. Chi-square test shows results to be 
statistically significant when controlling for gender (CVICU Males: p = 0.032) or ethnicity (CVICU Caucasians: p = 
0.042), but not for both simultaneously. 
 
All through the ICUs in Table 20, CVICU patients who smoke tend to contract an HAI (p 
= 0.009), with most having CAUTI than other HAIs. The association is not significant for 
patients who smoke when controlling for age for each ICU; however, when controlling for either 
sex or ethnicity but not both simultaneously, the p-values are statistically significant (CVICU 
males: p = 0.032 vs. CVICU Caucasians: p = 0.042). Changes in statistical significance with 
respect to different combinations of demographic variables imply that sex and ethnicity/race are 
confounding factors in those with smoking habits who contract an HAI in the CVICU. Thus, sex 
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and ethnicity/race behave as catalyst variables for those who smoke and contract an HAI. Across 
the ICUs in Table 21, association was statistically significant association between smoking 
habits and whether the patient has HAI in the CVICU (p = 0.024). Diabetes was associated with 
HAI in the MSICU (p = 0.009), being weakly positive (r = 0.054). For NSICU, the correlation is 
weakly negative at -0.087 and statistically significant at p = 0.003. In Table 22, the distribution 
between any HAI type and whether a patient possesses a risk factor on an aggregated basis is 
statistically similar (pdiabetes = 0.594, pobesity = 0.223, and psmoking = 0.191), indicating that the ICU-
specific level of analysis reveals more significant associations than aggregation (Table 22). 
Table 21 
Risk Factors of Patients Admitted to Each ICU 
 
UNIT 
HAI 
Diabetes** Obesity Smoking 
N Y N Y N Y 
CVICU 
NO 464 180 436 208 329 315 
YES 51 31 47 35 31 51 
chi-square 
           X 2=3.426, 
p=0.064 
X 2=3.523, 
p=0.061 
     X 2=5.133, 
p=0.023* 
MSICU** 
NO 1647 553 1487 713 1172 1029 
YES 84 46 78 52 72 58 
chi-square 
X 2=6.750, 
p=0.009* 
X 2=3.207, 
p=0.073 
X 2=0.230, 
p=0.632 
NSICU** 
NO 777 273 725 325 520 530 
YES 93 14 81 26 52 55 
chi-square 
X 2=8.685, 
p=0.003* 
X 2=2.034, 
p=0.154 
X 2=0.033**, 
p=0.855 
Note. *Smoking was correlated with acquiring a device-associated infection in CVICU (r = 0.085, p = 0.023). 
**In MSICU, Pearson correlation between HAI and diabetes is weakly positive at 0.054, but statistically significant 
(p = 0.009).  Thus, MSICU patients with diabetes have a weak association with acquiring a type of HAI.  For 
NSICU, the correlation is weakly negative at -0.087, being statistically significant (p = 0.003). 
100 
 
 
 
Table 22  
Risk-Factors of Patients with Device-Associated Infections and Patients with No Infections 
HAI 
Diabetes Obesity Smoking 
N  Y N Y N  Y 
CLABSI 42 19 34 27 31 30 
CAUTI 145 59 135 69 104 100 
VAP 41 13 37 17 20 34 
No Infection 2888 1006 2648 1246 2020 1874 
Chi-square 
X2=1.900,  
p=0.594 
X2=4.387,  
p=0.223 
X2=4.749,  
p=0.191 
Note. No statistically significant correlation found between comorbidities and device-associated infections. 
Research Question 4 and Hypothesis 
RQ#4: Are there significant differences in the types of microorganisms (e.g. genus, 
species, and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et 
al., 2015) which are associated with device-related HAIs in three adult ICUs within an academic 
medical facility?  
H04: There are no significant differences in the types of microorganisms (e.g. genus, 
species, and susceptibility according to the Clinical and Laboratory Standards Institute (Patel et 
al., 2015) associated with device-related HAIs in three adult ICUs within an academic medical 
facility.  
H14: There are significant differences in the types of microorganisms (e.g. genus, species 
susceptibility according to the Clinical and Laboratory Standards Institute (Patel et al., 2015) 
which are associated with device-related HAIs in three adult ICUs within an academic medical 
facility.  
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It was found from Chi-square analysis that the pattern of microbes was dissimilar for the 
three HAIs considered, 83% of yeast infections were associated with CAUTI (X2=56.759, 
p<0.001) (Table 23). Additionally, microorganism was significantly associated with ICU 
location (X2=28.536, p<0.001) (Table 24). The microorganisms contributing to CLABSI and 
CAUTI are listed in Tables 26 and 27, respectively. It was found that the majority of the 
CLABSIs were caused by gram-positive bacteria, while CAUTIs were predominantly gram-
negative bacteria, and the majority of VAPs identified were clinically defined without bacterial 
infections (see Appendix B for Pneumonia Flow Diagram). 
The number of multidrug resistant microorganisms identified in all three ICUs was thirty 
seven or 13% of the organisms identified (Figure 7).  The distribution of yeast was significantly 
lower in both males and females in NSICU.  The distribution of the microorganisms was 
statistically dissimilar with female patients in the three ICUs (X2 = 25.653, p < 0.001), while the 
distribution with respect to males was similar (X2 = 6.159, p = 0.188) (Table 25).  
Table 23  
Distribution of Microorganisms and Device-Associated Infections 
Microorganism2 
Device-Associated Infection 
Total 
CAUTI CLABSI VAP 
Gram positive cocci 21 31 8 60 
Gram negative rods 125 18 18 161 
Yeast 58 12 0 70 
Total 204 61 26 2911 
Note. 1Some Ventilator Associated Pneumonias are clinically defined 
2Microorganism was found to be associated with device-associated infections (X2=56.759, p<0.001) 
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Table 24  
Distribution of Device-Related Bacterial Infections Across the Three Adult ICUs 
Microorganism2 
ICU 
Total 
CVICU MSICU NSICU 
Gram positive cocci 17 25 18 60 
Gram negative rods 32 58 71 161 
Yeast 24 40 6 70 
Total 73 123 95 2911 
Note. 1Total excludes clinically defined Ventilator Associated Pneumonias (VAPs) 
2 Microorganism was found to be associated with type of intensive care units (X2=28.536, p<0.001) 
 
Table 25  
ICU-specific Gender Breakdown of Various Microbes 
   
ICU Type 
Gender Microorganism CVICU MSICU NSICU 
Female† GPC 4 14 9 
GNR 16 35 46 
YST 14 28 2 
Male GPC 13 11 9 
GNR 16 23 25 
YST 10 12 4 
Note. † Microorganism was significant in females between the three ICUs (X2=25.653, p < 0.001) but not for males 
(X2 = 6.159, p = 0.188). For Males & Females when considered together: (X2 = 28.536, p < 0.001). 
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Table 26  
Microorganisms Contributing to CLABSI 
CLABSI Organisms 
Gram-negative rods 
Acinetobacter baumanni 2 
Escherichia coli 4 
Enterobacter cloacae 1 
Klebsiella pneumonia 4 
Pseudomonas aeruginosa 4 
Serratia marcescens 1 
Stenotrophomonas maltophilia 2 
Gram-positive cocci 
Enterococcus faecalis 7 
Enterococcus faecium 1 
Methicillin-resistant Staphylococcus aureus 1 
Staphylococcus aureus 1 
Staphylococcus epidermidis 7 
Vancomycin-resistant Enterococcus 13 
Streptococcus milleri 1 
Yeast Candida species 12 
Total 61 
 
Table 27  
Microorganisms Contributing to CAUTI 
CAUTI Organisms 
Gram-negative rods 
Citrobacter amalonaticus 1 
Escherichia coli 62 
Enterobacter aerogenes 3 
Enterobacter cloacae 2 
Klebsiella pneumonia 25 
Morganella morganii 2 
Proteus mirabilis 4 
Pseudomonas aeruginosa 25 
Stenotrophonas maltophilia 1 
Gram-positive cocci 
Enterococcus faecalis 15 
Vancomycin-resistant Enterococcus 6 
Yeast  58 
Total  204 
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Figure 7. Multidrug resistant organisms compared to susceptible organisms.  
See Appendix F for additional MDRO information.  
Summary 
Chapter 4 provided the results overview of analyzed data for this research study.  
Majority of patients in the study from 2010-2014 were admitted to the MSICU (55.3%), 
Caucasians (60.4%), males (53.1%), and 60 years or older (53.6%) (Table 3). Those who 
acquired device-associated infections while hospitalized were primarily Caucasians (65.5%), 
females (57.7%), 60 years or older (53.9%), and were in MSICU (40.8%) (Table 3). The 
majority of the device-associated infections within the 5-year study period in the academic 
medical center were CAUTI (63.9%). It was found that there was no statistically significant 
difference in incidence rates of any device-related nosocomial infections between the three ICUs 
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between 2010 and 2014 (Table 4). There was no significant statistical difference in CLABSI and 
VAP SIR of device-related nosocomial infections between the three ICUs (Table 5). However, 
there was a statistically significant difference in CAUTI SIR (p = 0.027) (Table 5).  The 
difference was found in NSICU (Table 5). The study also analyzed the association between 
utilization of devices and infections rates, and no significant correlation was found (Table 6). 
Furthermore, there was no significant difference found in mean severity of illness scores 
(measured by the APACHE II) across the ICUs (Table 7). However, there was a significant 
difference in mean severity of illness scores of patients within the three ICUs, specifically in 
NSICU (Table 7). Significant difference of APACHE II scores was based on Bonferroni post-
hoc analysis in NSICU (p < 0.001) (Table 8). After analyzing risk associations (Tables 11-15), 
the difference in the mean APACHE II scores, between those who acquired an HAI and those 
patients who did not acquire an HAI among several demographic groups has revealed the 
possible confounders to be smoking habits (Table 11, 13 and 15), obesity (Table 12, 14, and 15), 
and an interaction of one of the previous two risk factors with diabetes (Table 13, 14) between 
those with and without an HAI. Correlation was statistically significant between diabetes and 
acquiring a device-associated infection in MSICU (r = 0.054, p = 0.009) and NSICU (r = -0.087, 
p = 0.003) (Table 21). Smoking was correlated with acquiring a device-associated infection in 
CVICU (r = 0.085, p = 0.023) (Table 21). In MSICU, Pearson correlation between HAI and 
diabetes is weakly positive at 0.054, but statistically significant (0.009) (Table 21). Thus, 
MSICU patients with diabetes have a weak association with acquiring a type of HAI. For 
NSICU, the correlation is weakly negative at -0.087, being statistically significant (0.003).   
Chi-square analysis found some significant differences between demographic 
characteristics and types of infections, as well as between types of organisms and types of 
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infections. The significant and non-significant findings of this research will be discussed in 
Chapter 5 and will include recommendations for future research and implications for social 
changes concerning healthcare.  
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Chapter 5: Discussion 
Introduction 
The purpose of the this study was to evaluate the characteristics and trends of device-
associated nosocomial infections (CLABSI, CAUTI, VAP) from 2010-2014 in three ICUs of a 
major teaching medical center. Guidelines from the NHSN served as the definitions for inclusion 
criteria for the study for device-associated infections. The research study was a quantitative 
analysis of secondary data abstracted from the electronic medical records of an academic 
medical facility in the state of Texas.  
Selected medical records of patients admitted to the three ICUs (cardiovascular, medical-
surgical, and neurosurgical) within two hospitals of an academic medical facility between 2010 
and 2014 were obtained from their department of informatics. Cases were defined as patients 
who developed a device-associated infection from either a central line, Foley catheter, or a 
ventilator while hospitalized greater than 2 calendar days. The majority of patients were 
Caucasian and older than 60 years of age; I found that female patients comprised 57.7% of all 
patients with an HAI (p < 0.001, Table 3). Differences in CLABSI, CAUTI, and VAP incidence 
rates within 5 years were not statistically significant across the ICUs (Table 4). The mean 
CAUTI SIR was different in NSICU within the 5-year study period compared to other ICUs (p= 
0.027; Table 5). SIRs for other device-associated infections were not statistically significant 
(Table 5). Furthermore, device utilization rates were not found to be correlated with specific 
device infection rates. The mean severity of illness scores was significantly lower in the NSICU 
patients who developed a device-associated infection (Table 7).  The mean severity of illness 
scores may be attributed to the fact that the NSICU patient population is primarily admitted with 
neuropathophysiology issues without concurrent renal, liver, or cardiopulmonary comorbidities.   
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Interpretation of Findings 
Research Question 1 
In Research Question 1, I examined differences in incidence rates associated with ICU 
device-related nosocomial infections.  I found that MSICU had the highest CAUTI rate with a 
mean of 3.98 for the entire 5-year period between the three ICUs. CVICU had the highest 
incidence rate for CLABSI with a mean of 1.16 and a standardization infection ratio of 1.4 
compared to the other two ICUs. The highest incidence rate for ventilator associated pneumonias 
was in the neurosurgical ICU with a mean of 4.67 (Table 4). I found that CVICU had the highest 
rate for use of ventilators and central lines (Figure 6). The highest usage of Foley catheters was 
observed in the neurosurgical ICU (Figure 3). The utilization findings were not correlated to 
infection rates (Table 6). However, with VAP cases, the neurosurgical ICU had a high rate 
during 2010 through 2012 and then leveled off the following 2 years (Figure 6). In findings for 
the three ICUs, I identified CVICU as having the lowest CAUTI rate (Figure 3).  The 
neurosurgical ICU had the lowest CLABSI rate, which could be attributed to the lower rate of 
utilization of central lines (Figure 2). The findings revealed that neurosurgical ICU had the 
highest VAP rate (4.6; Figure 5) and standardized infection ratio (2.24; Table 5) while utilizing 
the lowest number of ventilator days as compared to the other two ICUs (Table 6). However, in 
this study, the neurosurgical ICU had a lower rate of CAUTI and CLABSI (CAUTI 3.9; 
CLABSI 0.6) as compared to the national pooled mean of other academic medical centers 
(CAUTI 5.3; CLABSI 0.9; See Figure 6, Appendix E; Dudeck et al., 2015). There was a 
significant difference in mean CAUTI SIR by unit location (p=0.027; Table 5). The significant 
difference based on Bonferroni post-hoc analysis within unit (p=0.046) for neurosurgical ICU 
(NSICU; Table 5).  The ANOVA results revealed a statistically insignificant difference between 
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the CLABSI, CAUTI, and VAP rates between the three ICUs (Table 4: pCLABSI = 0.349, pCAUTI = 
0.187, pVAP = 0.052). 
Research Question 2 
In Research Question 2, I studied the association between the severity of illness 
(APACHE score) and CLABSI, CAUTI, and VAP for each of the three ICUs in an academic 
medical facility. The APACHE score is a severity of disease classification system that only looks 
at the first 24 hours after being admitted into the ICU. In this study, the difference in mean 
APACHE scores between the three types of device-associated infections was not statistically 
significant when aggregated (p=0.331; Table 8). When disaggregating by ICU, there were 
statistically significant differences (pCAUTI < 0.001, pCLABSI = 0.048, pVAP < 0.001), showing that 
aggregation has masked significant associations (Table 8).  The Bonferroni post-hoc analysis 
was used to help compare the groups and recognize differences between the groups. I found that  
patients admitted to NSICU who acquired a device-associated infection had a statistically lower 
mean APACHE II score based on Bonferroni post-hoc analysis (p <0.001) compared to those 
who were admitted to CVICU and MSICU (Table 7). In analyzing the ICUs individually, I found 
statistical significant differences in mean APACHE II scores between the specific ICU and 
patients contracting an HAI. For any type of HAI, there was a statistically significant difference 
in mean APACHE II scores (pCVICU = 0.004, pMSICU  < 0.001, pNSICU  < 0.001; Table 7). 
Additionally, there were statistically significant differences in mean APACHE II scores between 
the units for all three HAI types (pCAUTI < 0.001, pCLABSI = 0.048, pVAP < 0.001; Table 8).  
I determined that patients in the three ICUs who had the highest APACHE score were 
more vulnerable in acquiring a VAP as compared to those who acquired a CAUTI and/or a 
CLABSI. When controlling for age and gender differences, the mean scores were statistically 
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significant when comparing between APACHE II scores and ICU units (p < 0.001). 
Comparisons of the three types of device associated infections with severity of illness (p = 0.331) 
illustrated no significant differences when controlling for age and gender (p = 0.262; Table 8).   
Comparing the APACHE II means over several demographic groups by ICU with respect 
to different combinations of risk factors as shown in Tables 9 through Table 15 has revealed the 
possible confounders to be smoking habits (Table 11, 13, and 15), obesity (Table 12, 14, and 15), 
and an interaction of one of the previous two risk factors with diabetes (Table 13, 14) between 
those with and without an HAI. Smoking habits by itself may confound the relations between 
demographic groups and contracting an HAI (Table 11), as well as its interaction with the other 
risk factors (i.e., smoking habits and diabetes or obesity; Table 13 and 15). Diabetes seems to 
only confound the relationships when patients also have either smoking habits or obesity. 
Notably, diabetes by itself has shown to be protective against contracting an HAI for African 
American CVICU and MSICU patients aged 50-59 (Table 10). 
Research Question 3 
The third research question involved the association between age, gender, race, and 
ethnicity with regard to acquiring a HAI in three different adult ICUs within an academic 
medical facility. I found that most of the device-related nosocomial infections were attributed to 
patients who were over 60 years of age. The majority of the patient population was Caucasian for 
all three ICUs (Table 3), which did not aid in the determination of race and ethnicity being a 
factor for acquiring a device-associated infection. Chen et al. (2009) found that the most 
common nosocomial infection was CAUTI, and it was predominantly in the medical surgical 
ICU. Other scholars have shown that the most common nosocomial infections in ICUs were 
respiratory tract infections which were linked to mechanical ventilator pneumonias (Rosenthal et 
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al., 2012). In this study, I found that the most common infection was CAUTI followed by 
bloodstream infections, which were also identified in this study (Figure 5). The female gender 
had a higher occurrence for CAUTI, while the male gender represented the majority of the 
CLABSIs identified for all three ICUs (Table 18). Furthermore, I found MSICU as having the 
highest rate for CAUTI (4.1 per 1000 urinary catheter days), while CVICU had the highest rate 
of CLABSI (1.1 per 1000 central line days), and neurosurgical ICU had the highest rate for VAP 
(4.6 per 1000 mechanical ventilator days) (Figure 5).  
For the chi-squared tests involving the associations of demographic traits and risk factors 
across the ICUs for each HAI type, there is a statistically significant association with an HAI and 
age for female MSICU patients (p = 0.023, Table 17); otherwise, no statistically significant 
association was found between age and HAI type. As such, the gender of the patient may matter 
more as a confounding factor than the age group. Across the ICUs, none of the associations 
between ethnicity/race and HAI type are statistically significant at the ICU specific level: the test 
for CVICU has a p-value of 0.130 (X 2 = 9.876, n = 82), MSICU has p = 0.267 (X 2 = 7.624, n = 
130), and NSICU has p = 0.409 (X 2 = 6.124, n = 107; Table 19). Statistical insignificance 
remains even when controlling for age and sex. Thus, race may not be a confounding variable. 
Finally, for risk factors, CVICU patients who smoke tend to contract an HAI (p = 0.009), with 
most having CAUTI than the others (Table 20). The association is not significant for patients 
who smoke when controlling for age; however, when controlling for either sex or ethnicity but 
not both simultaneously, the p-values are statistically significant (CVICU males: p = 0.032 vs. 
CVICU Caucasians: p = 0.042; Table 20). Changes in statistical significance with respect to 
different combinations of demographic variables implies that sex and ethnicity/race are 
confounding factors in those with smoking habits and contract an HAI in the CVICU. Thus, sex 
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and ethnicity/race behave as an initiator for those who smoke and contract an HAI. Furthermore, 
Pearson correlations show statistically significance between diabetes and acquiring a device-
associated infection in MSICU and a negative correlation in NSICU (Appendix D). In MSICU, 
Pearson correlations between HAI and diabetes are weakly positive at 0.054, but statistically 
significant (0.009; Appendix D). Thus, diabetic patients in MSICU have a weak association with 
acquiring a device associated healthcare infection. As for the patients in NSICU who were 
statistically significant with a p-value of 0.003, had a Pearson correlations that was weakly 
negative at -0.087. Thus, NSICU patients with diabetes have a weak association with not 
acquiring an HAI infection. 
Research Question 4 
The last research question examined the differences in the types of microorganisms and 
susceptibilities which were associated with device-related HAIs in the three adult ICUs within 
the academic medical facility. The data analysis discovered that the majority of the HAIs were 
caused by gram negative rods (Table 23-24). The gram negative rods were associated with the 
majority of the CAUTI and VAP infections. Doshi et al. (2009) demonstrated comparable 
findings of gram negative rods associated with the majority of CAUTIs. In this study, the 
majority of CAUTIs were attributed to gram negative bacteria with the majority being identified 
as E. coli (Table 27). The gram negative bacteria were further grouped as 99 cases caused by 
bacteria from the Enterobacteriaceae family. The non-fermenting gram negative rods accounted 
for only 26 of the CAUTI cases with Pseudomonas aeruginosa being the majority of the cases. 
There were 58 cases of yeast and 21 cases of gram positive bacteria causing CAUTI. However, 
for the CLABSI cases, the major cause of infection was caused by gram positive cocci. The 
CLABSI organism distribution consisted of 31 gram positive bacteria, 18 gram negative bacteria 
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and 12 yeast. The CLABSI cases had the majority of multidrug resistant organisms (MDRO’s) 
with 20 identified as cause of infection. The most common MDRO identified was vancomycin 
resistant enterococcus (VRE) which were found to be the cause of 13 cases of CLABSI and 6 
cases of CAUTI. There were only 12.7% of MDRO’s identified for all three device-related 
infections within the three adult ICUs. There were a total of 161 gram negative bacteria 
contributing to the device-related infections in the ICUs. NSICU had the highest number of gram 
negative rods with a total of 71 followed by MSICU and then CVICU (Table 24). The second 
group of organisms contributing to the HAIs were yeast in which there was a total of 70 
infections associated with the three types of intensive care units. The results found that of the 
total HAIs in MSICU, 40 cases were attributed to yeast (Table 24). The yeast were found causing 
infections in patients who had Foley catheters followed by patients who had placement of central 
lines. Gram positive cocci contributed to the majority (51%) of central line-associated 
bloodstream infections. Of all the MDRO’s identified, 51.4% were vancomycin resistant 
enterococcus (VRE). VRE was the most commonly identified pathogen causing device-
associated HAIs at this academic medical center (Tables 26-27, Figure 7). The results from this 
study are different from what was identified in the literature. On the contrary, literature review 
has identified MRSA more often as the common pathogen causing healthcare associated 
infections (Doshi et al., 2009). In this study, there were only 5 MRSA infections contributing to 
13.5% of the MDRO cases. The MRSA infections were attributed to one CLABSI and four VAP 
cases. 
VRE was found to cause 21% of CLABSIs and only 2.9% of CAUTIs.  
Microbiologically speaking, one would think that VRE as an enteric bacteria would demonstrate 
higher device associated CAUTIs. This would be due to the proximity of the urethral indwelling 
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catheter to the enteric flora of the perirectal area. In this study, central lines were associated with 
a higher number of VRE device associated infections. These findings are in contrast to MRSA 
being identified in other studies as common pathogens causing HAIs.  Staph species, Staph 
aureus, Enterococcus species and Candida species have been found in literature to be the most 
prevalent bacteria with central line and other device associated infections (O’Grady et. al., 2011). 
According to O’Grady et al. (2011), MRSA was the most common reported bacteria causing 
device associated infections and accounts for more than 50% of the Staphylococcus aureus 
isolates identified in the ICUs. MRSA was demonstrated to cause 8.5% of the HAIs reported to 
the National Healthcare Safety Network during the period of 2009-2010 (Sievert et al., 2013). 
According to the literature review, VRE is associated with increased ICU cost, hospital mortality 
and length of stay. There is a high risk of acquisition of VRE from the hospital environment 
which could contribute to device associated HAIs (Sydnor & Perl, 2011). This information may 
be useful for future research and may provide additional information regarding the relationship 
of VRE with device associated infections. Other findings in this study, revealed that the 
microorganisms isolated from ICU patients were statistically significant in females between the 
three ICUs (X 2=25.653, p<0.001) but not for the male gender (X2 = 6.159, p = 0.188; Table 25). 
Lower socioeconomic status has been linked to poor health outcomes due to lack of 
access to health care services (Saydah, Imperatore, & Beckles, 2013). Therefore, once admitted 
to an acute care setting, the poor health conditions make these patients more susceptible to 
acquiring HAIs. In the broader picture, improving socioeconomic status for all demographics 
could help in reducing the likelihood of acquiring healthcare associated infections. The 
significance of this study was to examine the findings in order to understand the incidence rates 
and SIR associated with each ICU (Tables 4-6). The findings should be able to provide 
115 
 
 
 
information that was necessary in continuously improving patient safety and patient outcomes. 
This study allows the opportunities for exploration of some components of the eco-social theory 
and how each factor affects acquiring a healthcare associated infection. This can place emphasis 
on the patterns of HAIs which may develop within a set population (Krieger, 2001). The model 
provided a context of health analysis and could help to determine the overall understanding of 
health outcomes.   
Limitations of the Study 
This research study used three different intensive care units within an academic medical 
center in the state of Texas. It was assumed that patients in the three ICUs had unique clinical 
dispositions requiring them to be admitted to the different ICU locations (cardiovascular, 
medical-surgical, and neuro) with varying clinical services and characteristics. The findings from 
this study may not be generalizable to other academic medical facilities causing potential bias as 
well. The other limitations to consider involve predisposed patients that can develop particular 
illnesses and infections which can cause a high occurrence of devices associated infections. The 
varying types of ICUs may affect the types of infections and organisms revealed. Since the ICUs 
were different in characteristics for services provided based on clinical needs of patients (neuro, 
cardiovascular, medical-surgical), it was assumed that patients received unique clinical care 
based on individual unit, thus affecting infection rates. Because the patient populations are 
subject to multiple characteristics, such as differences in demographics and severity of illness, 
the nature of the patients confound interpretations of the results. Comparing the patient 
populations has revealed that while they were similar for most traits of the patient, comparing the 
sex of the patient with respect to the HAI type (i.e., analyzing male patients subject to the 
different types of HAI across the ICUs and then comparing those results to female patients 
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subject to the same characteristics) has revealed statistically significant differences (Table 3), 
notably for patients with smoking habits (Table 11). Similar differences in statistical significance 
were found for several ethnic/racial group constant when determining the subgroup of patients 
who smoke and acquire a type of HAI (Table 11). Although an attempt to control the 
confounding factors was made, a limitation of this approach in this study is that the lifestyles of 
the patients, such as specific dieting habits, are not recorded in the clinical data. The potential 
impact on the results may cause differences in the statistical significance in the chi-squared tests 
and thus possible estimation bias in the p-values. 
External factors such as different types of device brands and supplies used between the 
three ICUs, variables in collection of culture samples, and variances in insertion of devices and 
daily care by staff may contribute to an increased risk for developing a device associated HAI. 
Other limitations include definition changes which have led to fewer identified HAIs. For 
example, the NHSN CAUTI definitions for 2015 have excluded all yeast from the CAUTI 
criteria, whereas prior to 2015, yeast would have been considered a pathogen contributing to a 
CAUTI.  Future findings may show lower number of CAUTIs since Candida species have been 
found to be genitourinary tract colonizing organisms but are now excluded from the definition 
criteria.  Female gender and indwelling urethral catheters are known risk factors for candiduria. 
Incorporation of the exclusion criteria may cause under representation of female gender urinary 
tract infections caused by Candida. (Pallet & Hand, 2010).   
Recommendations for Future Research 
Additional studies may include device utilization ratios in order to focus on excess use of 
device usage for each intensive care unit in an academic medical center. Since this study was 
unable to capture length of stay for all patients, further data analysis regarding morbidity and 
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mortality can be examined along with the length of stay can be reviewed in comparing each 
intensive care unit respectively. There could be more investigation focused on demographics and 
length of stay to include patients who were admitted to the intensive care units and did have a 
device in place while in the ICU but who did not develop a healthcare associated infection within 
this academic medical facility. Future research could look specifically at the neurosurgical ICU 
to investigate the high rate of VAP and the factors which could be involved in contributing to 
this infection rate. The correlation between the microorganisms identified and device associated 
infection type needs to be further investigated as to mode of transmission, portal of entry and 
each susceptible host. Due to limited data, researcher was unable to conduct a case control study, 
however, future study could possibly be a case control study which will examine all patients with 
central lines, Foley catheters and ventilators within each specific ICU in an academic medical 
facility.      
Implications for Social Change  
Patients who are admitted into an intensive care unit of a hospital are likely to have an 
increased occurrence of device associated HAIs. Literature review has shown that during 
hospitalization, every patient who was admitted into an ICU and has a device such as a central 
line, Foley catheter or a ventilator placement has a higher chance of developing a device 
associated infection (Magil et al., 2014). The impact of these infections on patient outcomes are 
associated with increased length of stay, excess hospital cost, and an increased chance of 
morbidity. In this study, the researcher was unable to gather all the length of stay data for each 
patient and therefore was not able to evaluate LOS.  In the United States, the estimated medical 
costs of HAIs are nearly $45 billion each year (Krein et al., 2012). It is estimated that over 1.7 
million HAIs occur in patients who have been admitted into a hospital setting each year (Magill 
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et al., 2014). Literature review has shown that HAIs have resulted in 99,000 deaths in 2002, 
which places HAIs in the top ten causes of death in the United States depending on the risk 
factors and other disease factors the patient may already have present (Krein, et al., 2012). The 
social change implications from this research could aid in the understanding of the incidence 
associated with each device associated infection and the relationship attributed to each intensive 
care unit. Social change supports the need for guiding infection prevention and control for all 
three intensive care units to reduce the infection rates and produce healthier outcomes for 
patients and the community. Understanding the types of infections associated with each intensive 
care unit and the microorganisms attributing to the infections may provide further information 
providing interventions and best practice guidelines. A better understanding of knowledge for 
prevention and control of nosocomial infections could provide practice recommendations which 
may assist in the development of more effective guidelines. These types of changes and 
improvements could be used to process social attitudes in nursing care, antibiotic usage, 
behaviors, decision making, hand hygiene, maintenance and care of devices, and other important 
factors which could contribute to infection prevention. 
Conclusion 
Device associated HAIs are a threat to patient safety particularly those patients who are 
admitted into an intensive care unit. Additional attention should be given to each ICU relating to 
the types of organisms identified, and each type of device associated infection. The majority of 
gram positive bacteria identified in this study as the cause of CLABSI should be examined for 
proper skin preparation along with care bundles. According to Doshi (2009), over half of the 
CLABSIs identified are preventable with implementation evidence based practices for central 
line insertion and maintenance of lines. Skin flora such as gram positive bacteria are inclined to 
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be heavily present on the skin therefore potentially contributing to CLABSIs (Doshi et al., 2009). 
The link between CAUTIs and gram negative bacteria should be examined further. There should 
be standardized evidence based practices followed for all the ICUs.  Surveillance monitoring 
with educational sessions should be considered to help provide better opportunity to make the 
necessary changes in healthcare practices for device insertion and maintenance. The ultimate 
goal should be to achieve a reduction in device-associated HAIs. There needs to be additional 
research to determine best practice for Foley and central line care. Additional studies and further 
findings should be performed on VRE isolates to determine infection patterns for this gram 
positive multidrug resistant organism since the study showed the increase number of VRE cases 
with these device-related ICU patient infections. This information could be helpful by targeting 
the organisms identified with each type of device associated infection as well as the types of 
devices identified with each ICU. A multifaceted approach can be beneficial to dissect the causes 
and commonalities with each infection. Further studies may be necessary to gather additional 
information as to implement risk reduction measures.  
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Appendix A: Types of Device-related Healthcare Associated Infections 
Catheter Associated Urinary Tract Infections 
The SUTI criterion for 1a, as defined by the (Horan, Andrus, & Dudeck, 2008), include 
all of the following elements which must occur within a timeframe that does not exceed a gap of 
one calendar day between any two elements:  
1) The patient had an indwelling urinary catheter in place for >2 calendar days and the catheter 
was in place on the day when all elements of the criterion were first present together 
2) And patient displays at least one of the following signs or symptoms, with no other recognized 
cause(s): fever >38°C; suprapubic tenderness; costovertebral angle pain or tenderness. 
3) And a positive urine culture of ≥105 colony-forming units/ml with no more than two species of 
microorganisms. 
OR 
1) The patient had an indwelling urinary catheter in place for >2 days and had it removed <48 
hours before all elements of the criterion were first present together. 
2) And at least one of the following signs or symptoms, with no other recognized cause(s): fever 
>38°C; urgency; frequency; dysuria; suprapubic tenderness; costovertebral angle pain or 
tenderness. 
3) And a positive urine culture of ≥105 colony-forming units/ml with no more than two species of 
microorganisms. 
 The SUTI criterion for 2a include all of the following elements which must occur within 
a timeframe that does not exceed a gap of one calendar day between any two elements:  
1) The patient had an indwelling urinary catheter in place for >2 calendar days and the catheter 
was in place on the day when all elements of the criterion were first present together. 
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2) And a positive urinalysis with at least one of the following: a positive dipstick for leukocyte 
esterase and/or nitrite; pyuria; microorganisms seen on Gram’s stain of unspun urine. 
3) And a positive urine culture of between 103 and 105 colony-forming units/ml with no more 
than two species of microorganisms (Horan et al., 2008), 
OR 
1) The patient had an indwelling urinary catheter in place for >2 days and had it removed <48 
hours before all elements of the criterion were first present together. 
2) And at least one of the following signs or symptoms, with no other recognized cause(s): fever 
>38°C; urgency; frequency; dysuria; suprapubic tenderness; costovertebral angle pain or 
tenderness, 
3) And a positive urinalysis with at least one of the following: a positive dipstick for leukocyte 
esterase and/or nitrite; pyuria; microorganisms seen on Gram’s stain of unspun urine, 
4) And a positive urine culture of between 103 and 105 colony-forming units/ml with no more 
than two species of microorganisms (Horan et al., 2008). 
 The ABUTI criterion includes the following elements, all of which must occur within a 
timeframe that does not exceed a gap of one calendar day between any two elements: 
1) The patient has had an indwelling urinary catheter in place for >2 days and either still has it in 
place or had it removed <48 hours before all elements of the criterion were first presented 
together. 
2) And a positive urine culture of ≥105 colony-forming units/ml with no more than two species of 
uropathogen microorganisms. 
3) And a positive blood culture matching at least one uropathogen microorganism to the urine 
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culture, or at least two matching blood cultures drawn on separate occasions if the matching 
pathogen is a common skin commensal (Horan et al., 2008). 
Ventilator Associated Pneumonia 
PNU1 represents clinically defined pneumonia (CDC, 2012).  PNU1 requires at least one 
of the following symptoms: fever (>38°C) with no other recognized cause; leukopenia (<4,000 
white blood cells/mm3) or leukocytosis (>12,000 WBC/mm3); for patients >70 years old, altered 
mental status with no other recognized cause. Additionally, at least two of the following 
signs/symptoms must also be observed:  changes in sputum characteristics, increased ventilator 
requirements, or any other dysfunctional changes in the patients’ respiratory status (Peyrani, 
2009).   
PNU2 represents pneumonia with common bacterial or filamentous fungal pathogens and 
specific laboratory findings, and viral, Legionella, and other bacterial pneumonias with definitive 
laboratory findings (Peyrani, 2009).  As discussed by Peyrani (2009), for pneumonia with 
specific pathogens and laboratory findings, and a minimum of one required symptom such as: 
fever (>38°C) ; leukopenia (<4,000 WBC/mm3) or leukocytosis (>12,000 WBC/mm3); mental 
status changes for any patient older than 70 years of age.. In addition the criteria for PNU 1 must 
be met as well.  The following laboratory findings are also required as long as they are not 
related to another source of infection, a positive blood or pleural fluid culture, a positive 
quantitative culture from the lower respiratory track that is minimally contaminated, or a 
microscopic test which reveals ≥5% BAL-obtained cells that contain intracellular bacteria from a 
Gram stain.  Furthermore, the histopathologic exam should reveal at least one of the following 
evidences of pneumonia:  abscess and/or consolidation within the   bronchioles and alveoli which 
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demonstrates PMN accumulation; quantitative cultures of lung parenchyma which contain fungal 
or pseudohyphae elements (Peyrani, 2009).   
For PNU2 for viral, Legionella, and other bacterial pneumonias with definitive laboratory 
findings, only the laboratory criteria differ, the radiology and signs/symptom criteria are the 
same as PNU2 for pneumonia with common bacterial or filamentous fungal pathogens and 
specific laboratory findings (Peyrani, 2009). Definitive laboratory findings for Legionella, viral, 
and other bacterial pneumonias must be met. The laboratory findings must include at least one of 
the following:  
positive culture of virus or Chlamydia from respiratory secretions; positive detection of 
viral antigen or antibody from respiratory secretions; a fourfold rise in paired sera for 
pathogen; positive PCR for Chlamydia or Mycoplasma; positive micro-IF test for 
Chlamydia; positive culture or visualization by micro-IF of Legionella spp. from 
respiratory secretions or tissue; detection of Legionella pneumophila serogroup 1 
antigens in urine by RIA or EIA; fourfold rise in L. pneumophila serogroup 1 antibody 
titer to ≥1:128 in paired acute and convalescent sera by indirect IFA. (Peyrani, 2009, p. 
22-5)  
According to Peyrani (2009) in the APIC Text, the PNU3 classification is reserved for 
pneumonia in immunocompromised patients.  In addition to the radiology criteria, the 
signs/symptoms must include an immunocompromised patient who has at least one of the 
following: 
 fever (>38°C) with no other recognized cause; leukopenia (<4,000 WBC/mm3) or 
leukocytosis (>12,000 WBC/mm3); for patients >70 years old, altered mental status with 
no other recognized cause; new onset of purulent sputum, or change in character of 
136 
 
 
 
sputum, or increased respiratory secretions, or increased suctioning requirements; new 
onset or worsening cough, or dyspnea or tachypnea’s; rales or bronchial breath sounds; 
worsening gas exchange, increased oxygen requirements, or increased ventilator demand; 
hemoptysis; pleuritic chest pain. The laboratory findings must include at least one of the 
following: matching positive blood and sputum cultures with candida spp.; evidence of 
fungi or Pneumocystis carinii from minimally contaminated LRT specimen from either 
direct microscopic exam or positive fungal culture. (Peyrani, 2009, p.22-5)  
All of the pneumonia diagnostic criteria are listed in Table 1.  
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Appendix B: CDC Flow Diagrams for Device –Associated Infections 
The flow diagrams of device associated infections were guidelines set by the Centers for Disease Control and 
Prevention to identify and classify healthcare associated infections. 
Identification Central-line Bloodstream Infections (CLABSI) 
 Adapted from CDC NHSN HAI information (CDC, 2015c) 
Name: MR#: Unit: DOB: Age: M F 
      
Admitting Diagnosis: Admit Date: D/C Date: Attending Physician: 
Onset Date: Culture Date: # Bottles Positive: Birth weight (gms) (Neonates 
only): N/A 
 
†LABORATORY CONFIRMED BLOODSTREAM 
INFECTION (LCBI): LCBI Criteria 1 and 2 may 
be used for patients of any age, including patients 
≤ 1 year of age 
Type of Line Insertion 
Date 
D/C Date CL 
Checklist 
Completed 
CRITERION- LCBI 1*: 
    
Date      
 Recognized pathogen cultured from one or more 
blood cultures 
 AND organism cultured from blood is not 
related to infection at another site 
Central Line: An intravascular catheter that terminates at or 
close to the heart or in one of the great vessels which is used for 
infusion, withdrawal of blood, or hemodynamic monitoring. 
The following are considered great vessels for the purpose of 
reporting central-line BSI and counting central-line days in the 
NHSN system: 
- Aorta                                  - Pulmonary Artery 
- Pulmonary Artery              - Superior Vena Cava 
- Inferior Vena Cava             - Brachiocephalic Veins 
- Internal Jugular Veins       - Subclavian Veins 
- External Iliac Veins           - Common Iliac Veins 
- Femoral veins 
 
CRITERION- LCBI 2*: (at least one of the following) 
Date  
 Fever (>38
0
C) 
 Chills 
 Hypotension 
AND: 
 Common skin contaminant (i.e. diptheroids 
[Corynebacterium spp.], Bacillus spp. [not 
B.anthracis], Propionibacterium spp., 
coagulase-negative staphylococci [including S. 
epi], viridans group streptococci, Aerococcus 
spp., Micrococcus spp.) is cultured from two or 
more blood cultures drawn on separate 
occasions  NOTES: 
 
 †LCBI Central Line (CL) or Umbilical Catheter UC)   
was in place for >2 calendar days when all elements of 
the LCBI infection criterion were first present together, 
with the day of device placement being Day 1 
*Criterion elements must occur within a timeframe 
that does not exceed a gap of 1 calendar day 
NOTES: 
 An introducer is considered an intravascular 
catheter 
 Neither the insertion site nor the type of device 
may be used to determine if a line qualifies as a 
central line 
 Pacemaker wires & other nonlumened 
devices inserted into central blood vessels or 
the heart are not considered central lines, 
because fluids are not infused, pushed nor 
withdrawn through such devices 
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Identification of Catheter-Associated Urinary Tract Infection (CAUTI) 
Adapted from CDC NHSN HAI information (CDC, 2015b)
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Identification of Ventilator Associated Pneumonia 
 
Adapted from CDC NHSN HAI information (CDC, 2015d) 
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Appendix C: Data Use Agreement 
The Data Use agreement for research purposes effective as of March 30, 2015 is entered 
into by and between Doramarie Arocha and UT Southwestern Medical Center.  The purpose of 
this Agreement is to provide Data Recipient with access to a Limited Data Set (“LDS”) for use in 
research in accord with the HIPAA and FERPA Regulations. 
1. Definitions.  Unless otherwise specified in this Agreement, all capitalized terms used in this 
Agreement not otherwise defined have the meaning established for purposes of the 
“HIPAA Regulations” codified at Title 45 parts 160 through 164 of the United States Code 
of Federal Regulations, as amended from time to time. 
 
2. Preparation of the LDS.  UT Southwestern Medical Center shall prepare and furnish to 
Data Recipient a LDS in accord with any applicable HIPAA or FERPA Regulations. 
 
3. Data Fields in the LDS.  No direct identifiers such as names may be included in the 
Limited Data Set (LDS).  In preparing the LDS, UT Southwestern Medical Center shall 
include the data fields specified as follows, which are the minimum necessary to 
accomplish the research: 
 
a.  Age, gender, race, ethnicity, microbiological laboratory positive cultures, severity 
of illness which will be measured by chart review of each patients temperature, 
mean arterial pressure, heart rate, respiratory rate, oxygenation, arterial pH, serum 
potassium, serum sodium, serum creatinine, hematocrit, white blood cells and 
count, coma score and chronic health problems. 
 
b. All device associated healthcare infections patient list from three intensive care 
units during 2010 through 2014 which includes demographics (age, gender, 
ethnicity, and race), temperature, mean arterial pressure, heart rate, respiratory 
rate, oxygenation, arterial pH, serum potassium, serum sodium, serum creatinine, 
hematocrit, white blood cells count, coma score, age, and chronic health, and the 
microorganisms causing the device-associated infections from TheraDoc and 
EPIC software which include items listed above. 
 
c. Personnel from the Informatics Department will provide the Limited Date Set 
(LDS) requested above with unique patient identifier.  Access of patient records 
by the researcher will be limited to access rights as a student of Walden 
University and must adhere to HIPAA guidelines. 
 
4. Responsibilities of Data Recipient.  Data Recipient agrees to: 
 
a. Use or disclose of the LDS only as permitted by this Agreement or as required by 
law: 
 
b. Use appropriate safeguards to prevent use or disclosure of the LDS other than as 
permitted by this Agreement or required by law: 
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c. Report to Data Provider any use or disclosure of the LDS of which it becomes 
aware that is not permitted by this Agreement or required by law: 
 
d. Require any of its subcontractors  including the Informatics Department and the 
Infection Preventionists that receive or have access to the LDS to agree to the 
same restrictions and conditions on the use and/or disclosure of the LDS that 
apply to Doramarie Arocha under this Agreement: and 
 
e. Not use the information in the LDS to identify or contact the individuals who are 
data subjects. 
 
5. Permitted Uses and Disclosures of the LDS.  Data Recipient may use and/or disclose the 
LDS for its Research activities only. 
 
6. Term and Termination. 
a. Term. The term of this Agreement shall commence as of the Effective Date and 
shall continue for so long as Data Recipient retains the LDS, unless sooner 
terminated as set forth in this Agreement. 
 
b. Termination by Data Recipient. Data Recipient may terminate this agreement at 
any time by notifying the Data Provider and returning or destroying the LDS.  
 
c. Termination by Data Provider.  Data Provider may terminate this agreement at 
any time by providing thirty (30) days prior written notice to Data Recipient. 
 
d. For Breach.  Data Provider shall provide written notice to Data Recipient within 
ten (10) days of any determination that Data Recipient has breached a material 
term of this Agreement.  Data Provider shall afford Data Recipient an opportunity 
to cure said alleged material breach upon mutually agreeable terms.  Failure to 
agree on mutually agreeable terms for cure within thirty (30) days shall be 
grounds for the immediate termination of this Agreement by Data Provider. 
 
e. Effect of Termination.  Sections 1, 4, 5, 6(e) and 7 of this Agreement shall survive 
any termination of this Agreement under subsections c or d. 
7. Miscellaneous. 
a. Change in Law.  The parties agree to negotiate in good faith to amend this 
Agreement to comport with changes in federal law that materially alter either or 
both parties’ obligations under this Agreement.  Provided however, that if the 
parties are unable to agree to mutually acceptable amendment(s) by the 
compliance date of the change in applicable law or regulations, either Party may 
terminate this Agreement as provided in section 6. 
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b. Construction of Terms.  The terms of this Agreement shall be construed to give 
effect to applicable federal interpretative guidance regarding the HIPAA 
Regulations. 
 
c. No Third Party Beneficiaries.  Nothing in this Agreement shall confer upon any 
person other than the parties and their respective successors or assigns, any 
rights, remedies, obligations, or liabilities whatsoever. 
d. Counterparts.  This Agreement may be executed in one or more counterparts, 
each of which shall be deemed an original, but all of which together shall 
constitute one and the same instrument. 
 
e. Headings.  The headings and other captions in this Agreement are for 
convenience and reference only and shall not be used in interpreting, construing 
or enforcing any of the provisions of this Agreement. 
IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be duly 
executed in its name and on its behalf.  
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Appendix D:  Infection Numbers & Incidence Rates per 1000 Days for Each of the Three ICUs  
2010-2015 
CVICU CLABSI 
CL 
Days 
Rate CAUTI 
F/C 
Days 
Rate VAP 
Vent 
Days 
Rate 
2010 6 3842 1.56 10 3090 3.24 8 1941 4.12 
2011 8 4352 1.84 15 3245 4.62 1 1804 0.55 
2012 2 4120 0.49 10 3153 3.17 1 1968 0.51 
2013 3 4339 0.69 6 3331 1.80 2 2021 0.99 
2014 5 4303 1.16 4 2738 1.46 1 1798 0.56 
TOTAL 24 20956 1.15 45 15557 2.89 13 9532 1.36 
RATE 1.1   2.9   1.4   
       
   
MSICU CLABSI 
CL 
Days 
Rate CAUTI 
F/C 
Days 
Rate VAP 
Vent 
Days 
Rate 
2010 3 4636 0.65 23 4483 5.13 6 2456 2.44 
2011 6 5596 1.07 25 5009 4.99 2 2623 0.76 
2012 4 5304 0.75 16 4240 3.77 0 2623 0.00 
2013 9 6053 1.49 14 4161 3.36 2 3283 0.61 
2014 8 5188 1.54 9 3527 2.55 3 2742 1.09 
TOTAL 30 26777 1.12 87 21420 4.06 13 13727 0.95 
RATE 1.1   4.1   0.95   
       
   
NSICU CLABSI 
CL 
Days 
Rate CAUTI 
F/C 
Days 
Rate VAP 
Vent 
Days 
Rate 
2010 0 2684 0.00 13 3788 3.43 12 1150 10.43 
2011 3 2794 1.07 18 4126 4.36 6 1212 4.95 
2012 0 2392 0.00 18 3922 4.59 2 1237 1.62 
2013 4 2059 1.94 14 3512 3.99 6 1268 4.73 
2014 0 1468 0.00 9 2830 3.18 2 1284 1.56 
TOTAL 7 11397 0.61 72 18178 3.96 28 6151 4.55 
RATE 0.6   4   4.6   
 
Pearson Correlation Coefficients (P-value)  
CVICU MSICU NSICU 
CLABSI Rate 0.237 0.158 -0.395  
(0.395) (0.574) (0.145) 
CAUTI Rate -0.477 0.254 0.222  
(0.073) (0.360) (0.426) 
VAP Rate -0.26 -0.358 0.618  
(0.349) (0.190) (0.014)* 
* Statistically significant at p < 0.05 
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Appendix E: ICU SIR Ratios and Utilization Rates 
SIR – HOSPITAL CLABSI RATE TABLE FOR ICU 2010-2014 
TYPE OF 
LOCATION 
# 
CLABSI 
# 
CENTRAL 
LINE-Days 
CLABSI Rate 
per 1000 CL 
Days 
NHSN Rate 
per 1000 
CL Days  
EXPECTED 
# of CLABSI 
INDIVIDUAL 
SIR 
MSICU 30 26777 1.1 1.1 29.5 1.0 
CVICU 24 20956 1.1 0.8 16.8 1.4 
NSICU 7 11397 0.6 0.9 10.3 0.7 
              
TOTAL 61 59130 1.0   56.48   
Benchmark from NHSN Data Summary 2013 (Issued 2015)    
 p value = 0.136     SIR = 1.08   
 
SIR – HOSPITAL CAUTI RATE TABLE FOR ICU 2010-2014 
TYPE OF 
LOCATION 
# 
CAUTI 
# FOLEY 
CATHETER 
DAYS 
CAUTI 
Rate per 
1000 Foley 
Days  
NHSN Rate 
per 1000 
Foley days  
EXPECTED  
# of CAUTI 
INDIVIDUAL 
SIR 
MSICU 87 21420 4.1 2.7 57.8 1.5 
CVICU 45 15557 2.9 1.8 28 1.6 
NSICU 72 18178 3.9 5.3 96.3 0.7 
              
TOTAL 204 55155 3.7   182.18   
Benchmark from NHSN Data Summary 2013 (Issued 2015)    
 p value = 0.027 significant for NSICU     SIR = 1.12   
 
SIR – HOSPITAL VAP RATE TABLE FOR ICU 2010-2014 
TYPE OF 
LOCATIO
N 
# 
VAP 
# 
VENTILATOR 
DAYS 
VAP RATE 
per 1000 
Vent Days 
NHSN 
RATE per 
1000 Vent 
days  
EXPECTED 
# of VAP 
INDIVIDUAL 
SIR 
MSICU 13 13727 0.95 1.6 22 0.5 
CVICU 13 9352 1.4 1.7 15.9 0.8 
NSICU 28 6151 4.6 2.1 12.9 2.2 
              
TOTAL 54 29230 1.8   50.78   
Benchmark from NHSN Data Summary 2013 (Issued 2015) 
 
  
p value = 0.096     SIR = 1.06   
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Appendix F: Distribution of Organisms (%) by ICU and MDRO Status 
Distribution of Organisms (%) by ICU based on MDRO Status 
     
       
ICU 
Type     
 Microorganism  CVICU MSICU NSICU TOTAL 
MDRO 
X 2 = 1.524 
p = 0.467 
GNR  40.00% 44.00% 16.67% 38.89% 
GPC  60.00% 56.00% 83.33% 61.11% 
YST  0.00% 0.00% 0.00% 0.00% 
TOTAL   100.00% 100.00% 100.00% 100.00% 
Non-
MDRO GNR  44.78% 47.42% 78.65% 57.71% 
X 2 = 34.397 
p < 0.001* 
GPC  19.40% 11.34% 14.61% 14.62% 
YST  35.82% 41.24% 6.74% 27.67% 
TOTAL   100.00% 100.00% 100.00% 100.00% 
chi-squared test performed 
* Statistically significant at p < 0.05     
  
    
 
Distribution of Organisms (%) by HAI Type based on MDRO Status 
            
       HAI Type     
 Microorganism  CAUTI CLABSI VAP TOTAL 
MDRO 
X 2 = 2.731 
p = 0.255 
GNR  55.56% 26.32% 50.00% 38.89% 
GPC  44.44% 73.68% 50.00% 61.11% 
YST  0.00% 0.00% 0.00% 0.00% 
TOTAL   100.00% 100.00% 100.00% 100.00% 
Non-MDRO 
X 2 = 39.247 
p < 0.001* 
GNR  61.86% 29.27% 77.78% 57.71% 
GPC  8.25% 41.46% 22.22% 14.62% 
YST  29.90% 29.27% 0.00% 27.67% 
 TOTAL   100.01% 100.00% 100.00% 100.00% 
* Statistically significant at p < 0.05        
 
 
 
 
